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Summary
The study of the structure and function of the cell nucleus  has revealed a 
highly organized organelle that stores genetic information and in which the 
DNA metabolism takes  place. The nuclear interior is formed by a closed 
membrane system that divides the nucleoplasm from the cytoplasm. Although 
there are no separating membranes inside, the nucleus shows a manifold 
compartmentalization related to different functions  in nucleic acid metabolism 
and structural maintenance. The research of the last decade has brought great 
improvements in the understanding of nuclear structure and function. Yet little 
is  known about the molecular mechanisms that establish nuclear substructures 
and microenvi ronments as wel l as  the consequences of the 
compartmentalization on the nuclear metabolism of nucleic acids and proteins. 
In this  thesis I have investigated the question of how macromolecules move 
through the nuclear interior and what are the effects  of the nuclear 
subcompartments on their mobility and distribution. Specifically, I focused on 
analyzing the access of assorted polypeptides to different chromatin domains 
and subnuclear compartments. These investigations should give insight into 
the basic principles determining the association of proteins to functional 
compartments within the nucleus. 
This  project can be divided into three distinct parts. First, different fluorescent 
markers to visualize nuclear structures in living cells were generated and 
evaluated, including a peptide based nucleolar marker and the DNA dye 
DRAQ5. Secondly, techniques to deliver molecules into living cell nuclei by 
means of cell penetrating peptides have been developed and tested. This 
approach was combined with the basic principles  of specific targeting of 
bioactive molecules to subnuclear compartments, where they exert a biological 
function. The in vivo labeling of nuclear structures was combined with imaging 
of fluorescently tagged proteins of increasing sizes and different charge. By 
inducing changes in chromatin condensation it was possible to directly 
determine the effect of nuclear structure changes on the protein distribution in 
single cells. The data acquisition was  done in living cells using high resolution 
confocal fluorescence microscopy or very fast and sensitive detection of single 
molecules. Finally, image analysis was performed and combined with 
statistical methods to quantitatively determine molecule distributions and relate 
this information to different nuclear structures.
My results demonstrate that single nucleoplasmic proteins move rapidly in the 
nuclear interior and also in nuclear substructures. The protein movement is 
interrupted by short time trapping of proteins  in nuclear substructures. 
Considering chromatin, the condensation level in respect to the cell cycle and 
after induced changes has a profound influence on the distribution of nuclear 
non chromatin proteins as  well as an on the mobility of chromatin bound 
proteins. In the mass dense nucleoli, proteins lacking specific localization 
signals are mostly excluded and their mobility in this compartment is 
characterized by reduced trapping and a fast transit. Unlike this  small basic 
peptides with a positive charge show an accumulation in the nucleolus.
In summary, the structural framework, microenvironments and density of 
nuclear subcompartments have a dramatic influence on the distribution and 
mobility of molecules with different charges. The results elucidate basic 
principles and consequences of the functional nuclear organization.
II
SUMMARY
Zusammenfassung
Die Erforschung der Struktur und Funktion des Zellkerns enthüllte eine 
hochorganisierte Zellorganelle, in welcher die genetische Information gespeichert wird 
und der DNS-Stoffwechsel stattfindet. Der Zellkern entsteht durch ein geschlossenes 
Membransystem, wodurch das Zellkernplasma vom Cytoplasma abgegrenzt wird. 
Obwohl sich im Inneren des Zellkerns keine weiteren abgrenzenden Membranen 
befinden, ist eine vielfältige Unterteilung vorhanden, die im Zusammenhang mit den 
verschiedenen Aufgaben im DNS-Stoffwechsel und der Aufrechterhaltung der Struktur 
steht. Die Forschung in der letzten Dekade erzielte große Fortschritte hinsichtlich des 
Verständnisses der Struktur und Funktion des Zellkerns. Doch ist noch wenig darüber 
bekannt, welche molekularen Mechanismen zum Aufbau von Zellkernstrukturen und 
Mikro-Umgebungen führen, und welchen Einfluss die Organisation des Zellkerns auf 
den Stoffwechsel von Nukleinsäuren und Proteinen hat. In dieser Arbeit bin ich der 
Fragestellung nachgegangen, wie Makromoleküle sich im Inneren des Zellkerns 
bewegen und welchen Einfluss die Organisation des Zellkerns auf  deren Bewegung 
und Verteilung hat. Speziell wurde untersucht, ob und in welcher Weise ausgesuchte 
Poly-Peptide Zugang zu verschiedenen Chromatin-Domänen und Kompartimenten 
des Zellkerns haben. Die hier gezeigten Untersuchungen geben Einblick in 
grundlegende Prinzipien, welche die Assoziation von Proteinen mit funktionellen 
Strukturen des Zellkerns bestimmen.
Diese Arbeit kann in drei Unterteile gegliedert werden. Erstens wurden verschiedene 
fluoreszierende Markierungen für Zellkernstrukturen in lebenden Zellen hergestellt 
beziehungsweise charakterisiert, einschließlich einer auf  Peptiden basierenden 
Markierung des Nukleolus und des DNA-Farbstoffes DRAQ5. Zweitens wurden 
Techniken entwickelt und getestet, um Moleküle mit Hilfe von membran-
penetrierenden Peptiden in die Kerne von lebenden Zellen einzubringen. Das 
Verfahren wurde kombiniert mit den grundlegenden Prinzipien der Lokalisierung 
biologisch aktiver Moleküle in Zellkernstrukturen, um eine biologische Funktion zu 
bewirken. Anschließend wurde das in vivo Markieren von Zellkernstrukturen 
kombiniert mit dem Abbilden von fluoreszenzmarkierten Proteinen, welche 
unterschiedliche Größen und Ladungen besitzen. Durch die induzierte Veränderung 
der Chromatinkondensierung war es möglich, den direkten Einfluss von Änderungen 
in der Struktur des Zellkerns auf die Verteilung von Proteinen in einzelnen Zellen zu 
bestimmen. Die Datenaufnahme erfolgte dabei in lebenden Zellen mit Hilfe 
hochauflösender konfokaler Fluoreszenz-Mikroskopie oder mit sehr schneller und 
empfindlicher Erfassung einzelner Moleküle. Letztendlich wurde die Bildanalyse mit 
statistischen Methoden kombiniert, um die Verteilung der Moleküle quantitativ zu 
bestimmen und diese Informationen mit den verschiedenen Strukturen im Zellkern in 
Verbindung zu bringen.
Die hier präsentierten Ergebnisse zeigen, dass einzelne Proteine sich sehr schnell im 
Zellkernplasma und in den Zellkernstrukturen bewegen. Die Proteinbewegungen sind 
durch kurzzeitiges Verweilen und Festsetzen in Kernstrukturen unterbrochen. 
Berücksichtigt man das Chromatin, so hat der Grad der Kondensierung in 
Abhängigkeit vom Zellzyklus und nach induzierten Änderungen einen enormen 
Einfluss sowohl auf  die Verteilung der Proteine, die nicht an Chromatin gebunden 
sind, als auch auf die Mobilität chromatin-gebundener Proteine. Von den 
massereichen Nukleoli sind Proteine ohne ein spezielles Lokalisierungssignal 
weitgehend ausgeschlossen und die Bewegung dort ist bestimmt durch kürzere 
Verweildauer und ein schnelles Hindurchbewegen. Im Gegensatz dazu sind in den 
Nukleoli kurze basische Peptide mit einer positiven Ladung angereichert.
Zusammenfassend kann festgestellt werden, dass das strukturelle Grundgerüst, 
Mikro-Umgebungen und die Dichte von Kernstrukturen einen starken Einfluss auf  die 
Verteilung und Bewegung von Molekülen mit verschiedenen Ladungen haben. Die 
Ergebnisse zeigen einige grundlegende Prinzipien und Auswirkungen der 
funktionellen Organisation im Zellkern.
III
ZUSAMMENFASSUNG
1 Introduction
1.1 Dynamic organization of nuclear structure and function
The cell is  defined as an aqueous plasma separated from the environment by 
a lipid membrane that regulates the flow and exchange of molecules between 
the cytoplasm and the surrounding system. Functional substructures inside the 
cytoplasm are often surrounded and protected by membranes to maintain and 
regulate spatially separated biochemical processes e.g. mitochondria, vesicles 
and all vesicle derived organelles including the nucleus, endoplasmatic 
reticulum (ER), Golgi, lysosomes and peroxisomes.
The eukaryotic nucleus is  the organelle, that contains  the genetic and 
epigenetic information of the cell. It is the space enclosed by a double 
membrane system continuously connected to the endoplasmatic reticulum 
(Fig. 1) (Ellenberg et al., 1997; Anderson and Hetzer, 2007). In somatic cells 
the nucleus  has usually a diameter of 2 – 10 µm with a disc like to spherical 
shape. Nuclear pores formed by megadalton protein complexes span the 
double membrane layer and enable molecule exchange with the cytoplasm 
(Davis, 1995; Cronshaw et al., 2002). With the help of specialized import 
proteins, the nuclear pores selectively regulate the concentration of proteins 
with a molecular weight (MW) higher than about 60 kDa (Cronshaw et al., 
2002; Paschal, 2002; Stoffler et al., 2003). Although no membrane structures 
have been found inside the cell nucleus, its interior is characterized by highly 
organized subcompartments that are involved in different aspects of nucleic 
acid and protein metabolism (Fig. 1, 2, 3 and 4) (Cremer et al., 2000; Dundr 
and Misteli, 2001). Nevertheless there is a regulated crosstalk and exchange 
components between the nuclear substructures (Sleeman et al., 1998; 
Belmont, 2003). In the last decades numerous studies have identified and 
analyzed the molecular structure, content, function and interactions of nuclear 
substructures (Spector, 2001; Spector, 2006). A schematic drawing of known 
aspects of the steady state nuclear organization is depicted in Fig. 1. 
Chromatin is  the major molecular structure of the cell nucleus and is organized 
into chromosomes. In interphase nuclei, decondensed chromosomes occupy 
distinct territories and their positioning correlates with size and gene density 
(Tanabe et al., 2002; Mayer et al., 2005; Cremer et al., 2006). The 
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interchromatin space describes nuclear regions devoid of chromatin, that are 
often occupied by nuclear bodies like splicing speckles, cajal and promyeolytic 
leukemia (PML) bodies (Cremer et al., 2000; Ogg and Lamond, 2002). These 
nuclear bodies are accumulations of different proteins with regulatory or 
enzymatic function that take part in the nucleic acid metabolism (Sutherland et 
al., 2001). The nucleolus, the site of ribosome biogenesis, is in most cases the 
largest visible nuclear substructure and is  often surrounded by dense 
chromatin (Fig. 1 and 4) (Perry, 1962; Scheer and Hock, 1999; Lam et al., 
2005). The molecular organization of chromatin and nuclear bodies  is 
discussed in more detail in the following section.
Figure 1: Law and order in the cell nucleus. The eukaryotic cell nucleus is a highly 
compartmentalized cell organelle. Despite the lack of separating membranes inside, a 
variety of subnuclear compartments, nuclear bodies and chromatin domains can be 
identified. The different structures are characterized by their composition of specific 
proteins and nucleic acids, which are involved in distinct steps and pathways of the 
nuclear metabolism.
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1.2 The molecular organization of chromatin in the cell nucleus
The genetic information in e.g. human cells is  stored within the DNA double 
helix consisting of ~ 3 x 109 base pairs forming a triplet code. Additional 
epigenetic information regulating the expression of the genetic information is 
encoded in the complex assembly of chromatin including DNA, protein 
modifications and the formation of higher order structures. Chromatin is 
described as a chain like macromolecule made of connected subunits, which 
adopt different spacings and form higher order structures (Bednar et al., 1998; 
Sadoni et al., 2001). In eukaryotic cells  the DNA is wrapped around histone 
octamers to form the nucleosomal fiber as the basic chromatin structure, 
illustrated in Fig. 2 (Luger et al., 1997). The nucleosomal histones H2A, H2B, 
H3 and H4 are assembled by chromatin chaperones like the chromatin 
assembly factor (CAF1) and can form 11 nm fibers already by incubation with 
naked DNA in vitro (Verreault et al., 1996; Okuwaki et al., 2005). The 
organization of nucleosomes as building blocks into higher order structures 
involves additional chromatin proteins  interacting with the DNA and histones 
(Bednar et al., 1998). A more compact structural organization is achieved by 
the binding of histone H1, which leads to the formation of 30 – 40 nm sized 
fibers of closely packed nucleosomes arranged possibly in a zig-zag pattern 
(Fig. 2) (Karymov et al., 2001; Dorigo et al., 2004; Robinson et al., 2006). 
Subsequent level of DNA and chromatin fiber organization were suggested to 
involve matrix elements e.g. nuclear lamina with the formation of loops or 
rosette like structures (Ascoli et al., 1988; Heng et al., 2004). However, the 
proposed fibers of 30 nm or larger in diameter could not yet been observed in 
living cells (Rydberg et al., 1998; Tremethick, 2007). Finally the loops of 
chromatin are organized in structurally and functionally distinct chromatin 
domains and chromosome territories (Cremer and Cremer, 2001). Chromatin 
is  classified according to its condensation status, metabolic activity and 
molecular composition as eu- and heterochromatin. Euchromatin has a 
decondensed open structure and is transcriptionally active (Fig. 2) (Woodcock 
and Dimitrov, 2001). In contrast, heterochromatin is highly condensed similar 
to mitotic chromosomes and transcriptionally inactive (Fig. 2) (Dillon, 2004; 
Dimitri et al., 2005).
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Figure 2: Simplified model of the structural and epigenetic organization of chromatin
and putative higher order structures.
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1.3 The role of epigenetic information in the formation of functional 
chromatin
The eu- or heterochromatin properties of genome subsets are on a basic level 
defined by chemical modifications on chromatin that represent epigenetic 
information (Bird, 2007). These chromatin modifications include methylation of 
DNA at cytosines (5mC) and histone tails, which can be also acetylated, 
phosphorylated, ubiquitylated and sumoylated (Fig. 2) (Kouzarides, 2007). 
Beside this, epigenetics involves histone variants, remodeled nucleosome 
structures and non coding RNAs (Corona et al., 1999; Gilbert et al., 2000; 
Chow et al., 2005).
Euchromatin is linked to the hyperacetylation of specific lysines of histone H3 
at lysine 14 or histone H4 at lysine 20 (H3K14ac / H4K20ac) (Marvin et al., 
1990). The acidic charge of an acetyl group neutralizes  the basic charge of the 
histone lysines and weakens the electrostatic binding of the DNA to histones 
(Higashi et al., 2007; Shahbazian and Grunstein, 2007). This results  in a more 
open nucleosome conformation, which allows the access and assembly of the 
transcriptional machinery (Fig. 2). Furthermore, euchromatic nucleosomes are 
methylated at H3K4, K36 and K79, phosphorylated at H3S10 and additionally 
ubiquitylated at H2BK123 (Richards and Elgin, 2002). Transcription factors, 
chromatin modifying and remodeling proteins interact with these histone 
modifications. Once bound, they allow transcription or mediate the modification 
or replacement of neighboring nucleosomes to maintain the active chromatin 
status (Fig. 2) (McKittrick et al., 2004; Mito et al., 2007; Henikoff, 2008).
Heterochromatin was first described almost a century ago according to the 
condensation level reflected by the staining intensity in transmission light 
microscopy (Heitz, 1928; Heitz, 1929). The modern molecular definitions of 
heterochromatin show that it contains DNA enriched in cytosine methylation at 
CpG sequences, introduced by DNA methyltransferases dependent or 
independent of replication (Fig. 2) (Bird, 1986; Leonhardt et al., 1992; 
Easwaran et al., 2004; Smallwood et al., 2007). Methylated DNA is closely 
correlated with transcriptionally inactive, silenced or non-coding chromatin 
(Boyes and Bird, 1992; Ohtani-Fujita et al., 1993; Pikaart et al., 1998), and has 
been shown to be directly linked to histone deacetylation and heterochromatin 
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specific histone methylation (Fuks et al., 2000; Gregory et al., 2001; Xin et al., 
2003). Symmetrically methylated CpG sequences are recognized and bound 
by proteins containing a methyl cytosine binding domain (MBD) (Lewis and 
Bird, 1991; Boyes and Bird, 1991; Nan et al., 1996). The proteins that bind to 
methylated DNA like the methyl cytosine binding protein 2 (MeCP2) 
themselves act as  transcriptional repressors. They further recruit enzymes that 
introduce modifications  on neighboring histones, e.g. histone deacetylase and 
histone methyl transferase (Fig. 2) (Boyes and Bird, 1991; Nan et al., 1997; 
Nan et al., 1998; Yu et al., 2000; Fujita et al., 2003). The removal of acidic 
charge from histones increases their basic charge and results in a closed 
nucleosome conformation with strong binding to DNA via charge driven 
interactions. The epigenetic marks of heterochromatic nucleosomes are 
hypoacetylation of histones, methylation of histone H3 K9/K27 and H4K20 as 
well as  sumoylation of H2A, H2B, H4 and ubiquitylation of H2AK119 
(Kouzarides, 2007).
A large number of proteins bind to chromatin modifications and their combined 
action, interaction and cooperation results  in chromatin subsets with different 
condensation level and eu- or heterochromatin character, illustrated in Fig. 2 
(Gilbert et al., 2005; Schneider and Grosschedl, 2007; Taverna et al., 2007). 
The epigenetic states of the chromatin domains are transmitted to daughter 
cells in mitosis by the segregation of the sister chromatids. On the DNA level 
the 5mC modifications  are inherited by the methylation of the newly 
synthesized DNA strands during replication in S-phase by the DNA 
methyltransferase Dnmt1 (Stein et al., 1982; Leonhardt et al., 1992). 
Subsequently following replication, the nucleosomes of the parental DNA 
molecule, that contain already modifications, are redistributed to both DNA 
daughter strands also involving the CAF1 histone assembly complex (Verreault 
et al., 1996; Taddei et al., 1999; Zhang et al., 2000). For newly incorporated 
histones, lacking specific modifications, a copy mechanism introduces similar 
modifications on neighboring nucleosomes. This mechanism can involve 
members of the heterochromatin protein (HP1) family, which bind to present 
H3K9me3 and recruit the histone methyl transferase Suvar 39h (Suv39h) that 
introduces the same modification on adjacent nucleosomes (Felsenfeld and 
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Groudine, 2003; Schotta et al., 2004). Similarly, Suvar 4-20h (Suv4-20h) is 
recruited and trimethylates H4K20 as an important heterochromatin specific 
histone modification (Schotta et al., 2004). By this  mechanism specific 
chromatin modifications are self-amplified in adjacent chromatin, but can also 
spread into neighboring chromatin domains and establish heterochromatin 
formation. Insulator DNA sequence elements restrict this spreading of histone 
modifications between chromatin regions  by blocking the interactions of 
chromatin modifying factors with each other and the chromatin (Pikaart et al., 
1998; Felsenfeld and Groudine, 2003). Furthermore, the Suv39h mediated 
histone H3K9 methylation can also direct the methylation of DNA and thus 
target the respective genomic sequence for a stable inheritable imprinting and 
heterochromatin formation (Lehnertz et al., 2003). Independent of replication 
there are further mechanisms of assembling variant histones into nucleosomes 
to initially mark or maintain the epigenetic state of chromatin domains (Henikoff 
and Ahmad, 2005).
The change of epigenetic modifications on the DNA and nucleosome level 
results in structural changes, that are linked to alterations in the chromatin 
condensation level and transcriptional activity (Rice and Futscher, 2000; 
Nguyen et al., 2001). This can be the result of cell signaling or treatments with 
drugs inhibiting chromatin modifying enzymes and change chromatin 
structures and condensation (Yu, 1993; Görisch et al., 2005; Lopez-Larraza et 
al., 2006).
In summary, two closely connected properties characterize the organization of 
DNA and proteins into chromatin: On the one hand chromatin organization 
involves the distribution of structural elements that form chromatin domains 
with different condensation level. On the other hand the establishing and 
maintenance of the metabolic status in a genetic region is based on the 
interaction of nuclear factors on chromatin. These associations are regulated 
to a large degree by chromatin modifications. 
1.4 Chromatin condensation
As a result of the epigenetic modifications coupled to the genetic program 
throughout development and differentiation, the chromatin is organized into 
- 7 -
INTRODUCTION
subsets of different compaction level. Chromatin condensation starts with the 
aggregation of nucleosomes and the reduction of interleaving space between 
them, illustrated in Fig. 2 (Hammermann et al., 2000; Dorigo et al., 2004).
In heterochromatin for example, transcriptional repressors, which bind to 
regulatory genetic elements in the chromatin fiber, recruit enzymes that 
deacetylate histone tails and promote closer nucleosome stacking (Robertson 
et al., 2000; Terranova et al., 2005). In addition, MBD proteins like MeCP2 and 
polycomb group proteins can induce the formation of irregular condensed 
nucleosomal arrays (Georgel et al., 2003; Francis et al., 2004). Together with 
the formation of fibers from regularly stacked nucleosomes mentioned in 
section 1.3, the aggregation of complex condensed chromatin cluster can take 
place, although no structure has been described so far. One example for the 
clustering and formation of condensed chromatin domains is  the 
pericentromeric heterochromatin in mouse cells. This  specialized type of 
constitutive heterochromatin comprises  of a 6-17 Mbp genetic region adjacent 
to the centromeres (Joseph et al., 1989; Garagna et al., 2002). These so 
called chromocenters consist of repeats of a highly 5mC enriched 234 bp 
major satellite sequence (Miller et al., 1974; Mitchell, 1996). Hence these 
chromocenters are target sites for proteins that bind to 5mC like MeCP2, 
MBD1, 2 and 4, which have been found to accumulate at these chromatin 
domains (Lewis et al., 1992; Hendrich and Bird, 1998). Furthermore the 
pericentromeric chromatin includes the histone modifications characteristic for 
heterochromatin like H3K9me3, H3K27me and H4K20me3 and a lack of 
euchromatin linked modifications like methylation at H3K4 and acetylation of 
H4 (Peters et al., 2003; Kourmouli et al., 2004; Maison and Almouzni, 2004; 
Schotta et al., 2004). Accordingly, proteins that bind to these modifications can 
be found in the chromocenters like HP1α and HP1β  (Maison et al., 2002; 
Kourmouli et al., 2005). Following this the proteins interacting with HP1 can 
also be associated with pericentromeric heterochromatin such as the histone 
methyltransferase Suv39h or the lamin B receptor (Singh and Georgatos, 
2002). In mouse cells  the pericentromeric heterochromatin forms round 
condensed chromatin domains often located at the nuclear periphery or in the 
perinucleolar region and has important functions in chromosome segregation 
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and thus genome stability (Peters et al., 2001; Taddei et al., 2001). 
Furthermore there are implications for a role in genetic silencing in cases of 
spatial gene proximity to chromocenters (Brown et al., 1997). In addition to the 
formation of condensed nucleosomal arrays, it has been shown that MeCP2 
can induce the large scale aggregation of chromocenters during myogenic 
differentiation. This  leads to the formation of only a few big clusters consisting 
of several individual pericentromeric heterochromatin domains from different 
chromosomes (Brero et al., 2005).
The complex interactions of chromatin binding factors with each other, the 
nucleosomes and structural elements in a regulatory network, specific for DNA 
sequences and chromatin modifications, promote, mediate and induce 
chromatin condensation (Fig. 2). On a larger scale, chromatin condensation 
results in the formation of heterochromatin compartments, mitotic 
chromosomes or apoptotic chromatin by the aggregation of chromatin domains 
(Dillon, 2004; Lu et al., 2005; Mozziconacci et al., 2006). The formation of 
different chromatin substructures directly influences the functional 
compartmentalization of the cell nucleus.
In cycling cells the chromatin undergoes regularly a global conformation and 
condensation change in mitosis by the formation of condensed chromosomes 
(Fig. 3) (Belmont, 2006). The molecular events of the formation of condensed 
chromosomes are driven by the complex regulatory network governing the cell 
cycle via the function of cyclin dependent kinases and cyclins (Maldonado-
Codina and Glover, 1992).
Several processes including histone phosphorylation and the incorporation of 
histone variants  like the different centromere proteins (CENP) are crucial for 
the complete condensation of chromatin into compact chromosomes (Crosio et 
al., 2002; Maddox et al., 2006). The formation of the mitotic chromosomes 
involves protein complexes for anchoring and compacting the chromatin 
(Hirano et al., 1997; Collas  et al., 1999; Kimura et al., 1999). The actual 
condensation process is  a result of folding of large scale chromatin fibers 
along a axial scaffold (Kireeva et al., 2004). Concomitantly the DNA 
metabolism like transcription is stopped during the existence of condensed 
chromosomes in mitosis (Johnson and Holland, 1965; Weisenberger and 
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Scheer, 1995; Gottesfeld and Forbes, 1997). DNA replication and repair has to 
be finished before the entry into mitosis  is  permitted (Roberge, 1992; Weinert 
et al., 1994). Interestingly, during mitotic chromosome compaction not only 
transcription factors  are displaced from chromatin, but also proteins building 
functional interphase heterochromatin like HP1 are at least partially released 
(Martinez-Balbas et al., 1995; Hirota et al., 2005). The redistribution of proteins 
from mitotic chromatin results  from altered binding kinetics by phosphorylation 
of the target structure, e.g. histones by Aurora B kinase, or the binding protein, 
e.g. high-mobility group nucleosome binding proteins (HMGN proteins) (Segil 
et al., 1991; Prymakowska-Bosak et al., 2001). The status of interphase 
transcription is transmitted through mitosis  by specific histone modifications 
that mark active and silenced genomic regions. This suggests a de novo 
establishing of active and silent chromatin during chromosome 
decondensation by nucleosome binding factors. The different pathways of 
chromatin condensation for interphase heterochromatin and chromosomes in 
mitosis indicate a functional separation of the two types of condensed 
chromatin over the cell cycle. The condensation of chromatin structures is 
thought to have an effect on the reduction of DNA metabolism (Martinez-
Balbas et al., 1995). With the beginning of interphase a partial genome 
decondensation takes place, where euchromatin correlates with 
decondensation and heterochromatin with structures remaining condensed 
(Fig. 3). With the formation of the nucleus and functional chromatin in early G1 
the proteins involved in nucleic acid metabolism become relocated to the 
nucleus and bind to their respective interphase chromatin substrate (Dirks and 
Snaar, 1999).
It was also suggested that cellular ions may play a role in mitotic condensed 
chromatin with a function in maintaining the structural chromosome integrity 
(Strick et al., 2001). Further it is known that significant changes in the cellular 
ion concentration, especially calcium, have a drastic effect on chromatin 
structures and induce condensation (Jacobs et al., 1976; Hammermann et al., 
2000). In living interphase cells  a global chromatin condensation is induced by 
a hyperosmolar environment, which increases intracellular ion concentrations 
but is completely reversible (Albiez et al., 2006). In accordance with these 
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findings it is possible that the chromatin condensation that occurs in apoptotic 
or necrotic cells  is connected to the effect described for hyperosmolarity due to 
the leakage of cellular membranes accompanying cell death.
1.5 Nuclear bodies and nucleoplasmic proteins
The distribution of nuclear proteins is  influenced by their interactions with 
nuclear substructures and the components therein. The regulation of the 
enzymatic activity in a cell cycle dependent manner as well as the binding to 
specific target molecules, protein modification, storage and degradation lead to 
the accumulation in nuclear subcompartments. These sites of action in the 
different pathways of protein and nucleic acid metabolism can be visualized in 
fluorescence microscopy using proteins tagged with the green fluorescent 
protein (GFP) or immunofluorescence, often as focal accumulation sites. It has 
been shown that in the respective foci e.g. active transcription, replication or 
DNA repair takes place (Fig. 3) (Iborra et al., 1996; Cardoso et al., 1997; 
Mortusewicz et al., 2005). These  represent dynamic structures that exhibit 
turnover and exchange of molecules with varying dynamics (Sporbert et al., 
2002). In addition to being present at sites  of focal concentration many 
proteins and particles  are also temporarily or permanent diffusely distributed 
throughout the nucleoplasm (Fig. 3) (Politz et al., 1999; Shav-Tal et al., 2004). 
Multiple proteins also accumulate in the interchromatin space and form nuclear 
bodies such as splicing speckles, cajal and PML bodies. These nuclear bodies 
are often defined and named by the localization or accumulation of specific 
proteins e.g. coiled bodies and PML bodies contain the proteins coilin and 
PML, respectively. In addition, they contain numerous proteins  for storage, 
modification and degradation and serve as processing site for nucleic acids 
(Lamond and Spector, 2003). The formation of nuclear bodies  is  the result of 
the different biochemical processes in the compartment and the interactions  of 
the components, which leads to a concentration of specific proteins and 
nucleic acids. A fixed underlying structural network with e.g. a filamentous 
matrix that determines the nuclear structure and body formation is still a matter 
of debate but has not been shown in the nuclear interior (Hancock, 2000; 
Pederson, 2000). 
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Figure 3: Cell cycle dependent reorganization of chromatin and proteins in the cell 
nucleus. The figure displays chromatin labeled by H2B-GFP (Kanda et al., 1998) and 
the fluorescent replication protein fusion mRFP-PCNA (Easwaran et al., 2004). The 
PCNA distribution changes from diffuse in G1 to a focal accumulation at replication 
sites with progressing patterns during S-phase in accordance with other replication 
proteins (Easwaran et al., 2005). The dark nuclear areas correspond to nucleoli, 
depleted from the replication protein. Chromatin in interphase nuclei is dispersed in 
the nucleus with dense heterochromatin at the periphery and around nucleoli with less 
dense euchromatin and interchromatin space in between. At the beginning of mitosis 
the chromatin forms condensed chromosomes for the mitotic division until the 
beginning of interphase.
Protein accumulation in the nucleus is  dynamic and variable during cell cycle, 
differentiation and in disease (Fig. 3) (Belmont, 2003; Eskiw et al., 2003). 
Concurrent, metabolic changes in the cell and the nucleus are reflected in the 
localization, structure, content and function of these nuclear bodies (Shav-Tal 
et al., 2005). Furthermore nuclear bodies are not fixed structures  and show 
diffusion like motion in the interchromatin space delineated by the surrounding 
chromatin. These results  indicate an inert and rigid structure of the nuclear 
bodies and the capability of chromatin to create boundaries in the nuclear 
interior that influences the compartmentalization (Görisch et al., 2004). Though 
the dynamic nature of the components of nuclear bodies and the description of 
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speckles and cajal bodies as sponge like accessible structure suggests 
compartments open for entry and exit of proteins for a fast diffusive exchange 
of molecules (Handwerger et al., 2004; Handwerger and Gall, 2006).
1.6 The nucleolus
The nucleolus is  often the most prominent nuclear substructure already visible 
by phase contrast microscopy (Fig. 4). It was  first described in 1836 by G.G. 
Valentin and forms around the rDNA loci (Franke, 1988; Andersen et al., 2002). 
The nucleolus is  the site of both ribosomal RNA transcription as well as 
assembly and maturation of the ribosomal subunits (Brown and Gurdon, 1964; 
Perry, 1962; Scheer and Hock, 1999; Raska et al., 2004). Nucleoli in mammals 
have a tripartite substructure identified in the electron microscope as fibrillar 
centers (FC) (Thiry, 1992), surrounded by a dense fibrillar component (DFC) 
collectively embedded in the granular component (GC) (Fig. 4) (Derenzini et 
al., 2006). 
Figure 4: Structure and function of the nucleolus and the biogenesis of ribosomes. 
The phase contrast image shows the nucleolus (nu) as a large light dense region in 
the cell nucleus. The illustrated three dimensional nucleolar substructure depicts the 
spatial distribution of antigens and substructures of the nucleolus: A) 
immunofluorescence staining against nucleophosmin/B23 in the granular component 
B), immunofluorescence staining for fibrillarin in the dense fibrillar component and C) 
nucleolar DNA labeling in the fibrillar centers. A simplified model of the ribosome 
biogenesis is drawn in accordance to the nucleolar structure and function relationship.
The nucleolar structure is linked to the different steps of ribosome biogenesis 
starting with the transcription of rDNA genes in the periphery of the FC (Scheer 
et al., 1997; Mais and Scheer, 2001; Cheutin et al., 2002). The nascent rRNA 
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transcripts localize to the DFC, where they are modified and associated with 
nucleolar proteins to form hnRNP particles. Further processing occurs in the 
GC where pre-ribosomal RNA/protein particles develop into pre-ribosomal 
subunits  ready to be transported into the cytoplasm, illustrated in Fig. 4 
(Scheer and Hock, 1999). The metabolic activity of nucleoli is also reflected in 
their size and number (Hernandez-Verdun, 2006), and considerable progress 
has been made in the understanding of nucleolar functions and revealed e.g. a 
role in the regulation of stress response and cellular metabolism (Lyon et al., 
1997; Mekhail et al., 2005).  Furthermore, the establishment of high resolution 
imaging techniques  like electron spectroscopic imaging (ESI) has helped to 
resolve the internal molecular structure of nucleoli in more detail (Politz et al., 
2005). Also, the localization of proteins in the nucleoli can be explained by the 
discovery of nucleolar localization sequences often present in viral proteins 
(Dang and Lee, 1989; Hatanaka, 1990). However, little is  known about the 
assembly of this  structure in the cell nucleus or how it establishes its 
microenvironment (Carmo-Fonseca et al., 2000). Although the nucleolar 
structure seems to be accessible and nucleolar components are mobile, it 
remains unknown how numerous nuclear proteins are excluded from nucleoli 
and remain in the nucleoplasm (Politz et al., 2003; Handwerger et al., 2004). 
1.7 The consequences of the dynamic architecture of nuclear structures
The organization of the cell nucleus into functional subcompartments and the 
genome organization into transcriptionally active and inactive subsets reflects 
the specific gene expression profiles of cells and tissues as well as their 
developmental and differentiation status (Regha et al., 2007). Furthermore it 
allows spatial separation of biochemical reactions of DNA, RNA and protein 
metabolism in nuclear substructures. The dynamic organization of global and 
local chromatin preserves the possibility to change epigenetic modifications, 
condensation level and transcriptional status of a genetic region (Peaston et 
al., 2007; Stern et al., 2007). This principle of the plasticity of the genome on a 
dynamic molecular basis seems to be preserved throughout development and 
differentiation, and gives rise to the idea of inducing specific changes in the 
gene expression profile of cells, tissues or organs.
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The chromatin modifications influence the metabolic and structural status like 
the transcriptional activity, replication timing and condensation level via direct 
or indirect effects (Leonhardt et al., 2000; Alexandrova et al., 2003; Klose et 
al., 2006). Specific proteins  recognize and bind epigenetic marks and interact 
with the modified histones, e.g. heterochromatin protein 1 (HP1) binds to 
H3K9me3 (Nielsen et al., 2002). The factors binding to histone and DNA 
modifications interact further with a complex regulatory machinery, which 
includes other chromatin proteins, chromatin remodeling proteins and 
transcription activating or repressing factors, involved in the nucleic acid 
metabolism (Muchardt et al., 2002; Fujita et al., 2003; Fischle et al., 2005; 
Agarwal et al., 2007; Smallwood et al., 2007). Upon external stimuli epigenetic 
marks on histones can be removed directly by enzymes like histone 
deacetylases and demethylases or alternatively by replacing whole 
nucleosomes (Sun et al., 1990; Gallinari et al., 2007; Wissmann et al., 2007). 
The integration of these different factors  ultimately defines the functionality of 
chromatin, and determines how the genetic program is expressed in response 
to external stimuli and internal signaling. As such DNA and histone 
modifications as well as chromatin composition and structure is subjected to 
dramatic changes during development, differentiation, disease and cell death 
(Reik et al., 2001; Quina et al., 2006; Matarazzo et al., 2007). However it is not 
established how different chromatin condensation levels influence the 
distribution and access of nucleoplasmic proteins to chromatin and the direct 
effect on the nuclear compartmentalization and metabolism.
1.8 The dynamic behavior of molecules in the cell nucleus
The structural and functional nuclear compartmentalization also has an effect 
on the subnuclear distribution and dynamics of proteins. The focus is  now laid 
on the consequences of this organization for the dynamic behavior of proteins 
moving in and between nuclear structures.
Images of labeled proteins in a cell nucleus with fluorescence microscopy 
often give the mistaken impression that these proteins exist in static 
localization patterns. In fact many nuclear proteins are highly mobile and roam 
throughout the whole nucleus, interrupted by short or long time interaction with 
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binding partners and substrates (Misteli, 2001; Phair et al., 2004). The high 
diffusion coefficients  measured for diffuse nuclear proteins and inert probe 
molecules in several experimental studies indicate, that proteins can move at a 
timescale of milliseconds to seconds  through the whole nuclear interior 
(Seksek et al., 1997; Phair and Misteli, 2000; Verkman, 2002). These data 
raise the question of how proteins  are separated into distinct nuclear 
compartments and how these structures are established and constructed.
One idea is, that the accumulation of proteins  in nuclear compartments is the 
result of specific interactions and binding to molecules in the respective 
compartments via specific protein or peptide sequences (Cardoso and 
Leonhardt, 1998; Isogai and Tjian, 2003). The interaction and thus 
immobilization times can range from milliseconds for splicing factors  up to 
hours in the case of histones (Kimura and Cook, 2001; Grunwald et al., 2006). 
The effect of protein immobilization in a specific nuclear structure is an 
accumulation in comparison to neighboring nuclear compartments where the 
same protein distributes diffuse without binding. In microscopic images of 
immunostainings or of ectopically expressed fluorescent fusion constructs, an 
accumulation is  visible as a highlighting of a nuclear structure as shown for 
H2B-GFP incorporated into chromatin in Fig. 3 (Kanda et al., 1998). Molecules 
that diffuse freely in the nucleus, with no physical hinderances or interactions, 
are visible as homogeneous nuclear staining (e.g. replication proteins in non 
S-phase in Fig. 3). Temporal alterations of available interaction sites and the 
modulation of protein binding is central to regulatory mechanisms controlling 
nuclear structure and functions (Cardoso and Leonhardt, 1998).
A concentration of binding sites  in one distinct nuclear area combined with a 
lack of interaction sites  in other areas results in a low or high local mobility, that 
can be detected as protein enrichment or homogeneous distribution 
respectively (Carrero et al., 2003). The accumulation of proteins in the cell 
nucleus is illustrated in Fig. 5 as high number of binding particles (red) in the 
respective substructure with binding sites (yellow, chromatin). The level of 
accumulation is determined by the density of binding sites. Similarly, a different 
type of protein (dark grey) accumulates  in a structure with the appropriate 
specific interaction sites (light grey, nucleolus). Particles without binding 
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properties (green) have a similar concentration in all accessible areas. The 
reduction of the concentration of diffuse distributed particles  (green) in certain 
structures despite of a high mobility, could been explained by physical 
exclusion and inaccessible subcompartments (light grey).
Figure 5: Model for the relationship of mobility and distribution of nuclear proteins.
This  was reported for macromolecules that diffusely distribute in e.g. nucleoli 
and dense chromatin (Gorisch et al., 2003). Nevertheless, in these 
experiments the detailed dynamic behavior of individual molecules could not 
be analyzed using fluorescence bleaching and photoactivation due to the 
spatial and temporal resolution limits of confocal microscopy (Braga et al., 
2004; Beaudouin et al., 2006). Short time immobilization as well as the 
dynamics of individual molecules with respect to nuclear structures  could not 
be analyzed with standard microscopy. However the combination of 
conventional confocal microscopy techniques with rapid, high resolution single 
molecule tracking can give a more detailed and integrated view on nuclear 
molecule movements  (Goulian and Simon, 2000). For these experiments  it is 
necessary to develop and test labels for subnuclear structures and improve the 
delivery of molecules into living cells.
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2 Questions and aims of the thesis
The aim of this work was to investigate the molecular mechanisms of nuclear 
protein movement and distribution as well as the accessibility of nuclear 
subcompartments e.g. chromatin and nucleolus in living cells. The results 
should help to elucidate the principles and consequences of functional nuclear 
organization and effects of compartmentalization on the activity and fidelity of 
nuclear proteins.
Although past studies have considerably improved our knowledge and view on 
the cell nucleus, several aspects  of the dynamics of nuclear structure and 
function remain unclear: How are the different nuclear structures established 
and maintained without separating membranes? Which molecular mechanisms 
are responsible for spatial separation and coordination of biochemical 
reactions? How is  the protein mobility and distribution influenced by nuclear 
structures e.g. nucleoplasm, chromatin and nucleolus. And what are the effects 
of changes in nuclear structures like increased chromatin condensation on 
protein dynamics? To address these questions it was necessary to:
1. Test and develop markers, which can be used to highlight nuclear 
substructures, such as chromatin and nucleoli, for further analysis 
with different techniques of fluorescence microscopy.
2. Characterize and improve methods for the delivery of molecules as 
neutral or bioactive probe molecules into living cells. 
3. Analyze methods to induce changes in the nuclear structure e.g. 
chromatin condensation.
4. Examine protein mobility and distribution by different live cell 
microscopy techniques.
This  combination of techniques will be used to test the molecule distribution 
and mobility in subcompartments of live cell nuclei by single molecule and 
confocal fluorescence microscopy.
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3  Results
3.1 DNA labeling in living cells
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Background: Live cell ﬂuorescence microscopy experi-
ments often require visualization of the nucleus and the
chromatin to determine the nuclear morphology or the
localization of nuclear compartments.
Methods: We compared ﬁve different DNA dyes, TOPRO-
3, TOTO-3, propidium iodide, Hoechst 33258, and DRAQ5,
to test their usefulness in live cell experiments with contin-
uous imaging and photobleaching in wideﬁeld epiﬂuores-
cence and confocal laser scanning microscopy. In addition,
we compared the DNA stainings with ﬂuorescent histones
as an independent ﬂuorescent label to mark chromatin.
Results: From the dyes tested, only Hoechst and DRAQ5
could be used to stain DNA in living cells. However,
DRAQ5 had several advantages, namely low photoble-
aching, labeling of the chromatin compartments compar-
able to that of H2B-GFP fusion proteins, and deep red
excitation/emission compatible with available genetically
encoded ﬂuorescent proteins such as C/G/YFP or mRFP.
Conclusions: The DNA dye DRAQ5 is well suited for
chromatin visualization in living cells and can easily be
combined with other ﬂuorophores with blue to orange
emission. q 2005 Wiley-Liss, Inc.
Key terms: DNA dyes; DRAQ5; chromatin; nuclear struc-
ture; live cell imaging; ﬂuorescence microscopy
In the ﬁelds of biological research and medical diagno-
sis, staining techniques and chemicals to visualize DNA or
chromatin with ﬂuorescence microscopy are widely used
and have been of high importance for decades (1,2). Many
of these dyes are restricted to ﬁxed cell samples and show
only roughly the distribution of nuclei in cells and tissues
(3). Further, ﬁxation of cells often produces undesired
artifacts (4). DNA dyes for live cell ﬂuorescence micro-
scopy should match the criteria of low cytotoxicity and
phototoxicity combined with low photobleaching (5).
In addition, a suitable live cell DNA dye should speciﬁ-
cally label deoxyribonucleic acids stoichiometrically and
should be easy to combine with commonly used autoﬂuor-
escent proteins such as CFP, GFP, YFP, or mRFP (6). Sev-
eral of the available dyes such as TOPRO, the TOTO dye
family, ethidium bromide, and propidium iodide (PI)
require permeabilization or similar membrane disruptive
methods to label the DNA efﬁciently (3). Further, several
of these dyes bind strongly to RNA requiring a RNAse
treatment of ﬁxed and permeabilized samples (3,7). The
dyes 40,6-diamidino-2-phenylindole (DAPI) and Hoechst
are widely used DNA-speciﬁc dyes, which emit blue ﬂuor-
escence under ultraviolet (UV) illumination when bound
to DNA. Because UV light damages cellular DNA and other
components, the use of Hoechst in live cell microscopy is
very restricted in time (1,8). In addition, DAPI and
Hoechst have a preference to bind to A/T-rich DNA
sequences and highlight a subset of the genome. Thus,
the use of these dyes is impossible in long-term live cell
experiments and they also do not necessary reﬂect quanti-
tative variations in DNA condensation. Other approaches
such as expression of ﬂuorescent histone fusions, albeit
an extraordinarily useful tool in cell biology, require prior
transfection of cells and a several-hour period until the
microscopic visualization can start (9). In addition, several
cell types, in particular primary cultures, are very difﬁcult
or impossible to transfect (2). In the present study, we
compared DNA dyes with chromatin labeling using ﬂuor-
escent histones to identify a dye that could be used in
living cells and could reﬂect stoichiometrically the spatial
distribution of DNA content in living cell nuclei.
MATERIALS AND METHODS
Cell Culture and Viability
Human HeLa cells and HeLa H2B-GFP stable cell line (9)
were cultivated in Dulbecco’s Modiﬁed Eagle’s Medium with
10% fetal calf serum plus 5 mM L-glutamine and 5 lg/ml
gentamicin. Mouse C2C12 myoblasts and the C2C12 GFP-
PCNA stable cell line (10) were grown in Dulbecco’s Modi-
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ﬁed Eagle’s Medium with 20% fetal calf serum and the same
additives. For live cell microscopy cells were seeded into
four-well LabTek glass-bottom chambers (Nalge Nunc Interna-
tional, Naperville, IL, USA) and covered with the desired
growth medium the day before.
The effect of DRAQ5 on cell viability was assayed by
plating equal numbers of cells and 1 day later adding or
not adding the dye to the medium. The next day, cells
were trypsinized and counted using a hemacytometer.
Experiments were repeated twice and cells were counted
in duplicate dishes. To analyze the effect of DRAQ5 on
cell cycle progression, the DNA content of HeLa cells
treated in the same manner was analyzed after methanol
ﬁxation by PI staining in the presence of RNAse as
described before (10) followed by ﬂow cytometry (FACS-
calibur, BD Biosciences, Heidelberg, Germany). Ten runs
with 104 cells each were analyzed using ModFit 3.0
software and the mean values of cells in each cell cycle
stage were calculated for control and DRAQ5 incubated
cells.
DNA Stainings
Cells were grown to 50% conﬂuency on 12-mm Ø glass
coverslips. The samples were ﬁxed for 10 min with 3.7%
formaldehyde (Fluka Chemie GmbH, Buchs, Switzerland)
in phosphate buffered saline; for staining with PI, TOPRO-
3 and TOTO-3 were permeabilized for 10 min with 0.25%
Triton X-100. RNAse digestion was performed with
200 lg/ml RNAse for 30 min (Sigma, St. Louis, MO, USA).
The DNA dyes were applied at the concentrations listed in
Table 1 for 5 to 10 min. The coverslips were rinsed with
phosphate buffered saline between each incubation step
and at the end mounted with Moviol.
For live cell experiments, cells were grown in LabTek
chambers and the growth medium was supplied with
1 lM DRAQ5 or 1.6 lM Hoechst 33258 (ﬁnal concentra-
tions) for 5 min before image acquisition.
DRAQ5 was purchased from Biostatus Limited (Lei-
cestershire, UK), TOPRO-3 and TOTO-3 were obtained
from Molecular Probes (Leiden, The Netherlands),
Hoechst 33258 was obtained from Hoefer Scientiﬁc Instru-
ments (San Francisco, CA, USA), and PI was obtained from
Sigma.
Fluorescence Microscopy
Live cell microscopy was performed with an objective
heated to 37C using a confocal laser scanning micro-
scope (LSM510Meta, Carl Zeiss, Jena, Germany) equipped
with argon ion and HeNe lasers. Fixed cells were imaged
on the same confocal microscope (Fig. 1A) and on a wide-
ﬁeld epiﬂuorescence microscope (Zeiss Axioplan 2)
equipped with a 100-W mercury lamp. The latter was
used for general bleaching analysis (Table 1). In the live
cell photobleaching experiments (Fig. 3A), cells were con-
tinuously imaged over time. Excitation, beamsplitters, and
emission ﬁlters used for imaging of the various ﬂuoro-
phores are listed in Table 2.
Image Analysis
Image analysis (Fig. 3A) was carried out by selecting the
nuclei in the images and determining the mean ﬂuores-
cence intensity of all the pixels selected. Subsequently,
the relative ﬂuorescence intensity was calculated by set-
ting the mean ﬂuorescence intensity of the ﬁrst image in a
time series to 100%.
The line scan and colocalization analysis (Pearson’s
coefﬁcient; Fig. 3B–E) and the above image analysis were
performed with Zeiss LSM Image examiner 3.2 and Origin
7.5 software (Origin Lab Corp., North Hampton, MA,
USA).
RESULTS
We compared ﬁve different DNA binding agents for
their ability to ﬂuorescently label nuclear DNA in living
cells. In addition, we tested whether they precisely repre-
sent the chromatin content in different nuclear compart-
ments imaged by high-resolution confocal ﬂuorescence
microscopy. Further experiments were carried out to test
the photobleaching behavior of the DNA dyes and the via-
bility of cells in culture in the presence of the dye.
Figure 1A displays representative confocal optical sec-
tions of mitotic and interphase HeLa cells stably expres-
sing H2B-GFP (9) and stained with the different dyes with
and without RNAse treatment. From the ﬁve dyes tested,
only Hoechst 33258 and DRAQ5 showed membrane-
permeable properties and allowed the staining of DNA in
living cells (Table 1 and Fig. 1A). The nucleic acid dyes PI,
TOTO-3, and TOPRO-3 did not penetrate intact cellular
Table 1
Summary of Nucleic Acid Dyes Characteristics
TOPRO-3 TOTO-3 Propidium lodide Hoechst 33258 DRAQ5
Excitation/emission
maximum (nm)
642 / 661a 642 / 660a 535 / 617a 352 / 416a 647 / 670b
Cell permeable 2 2 2 1 1
Live/ﬁxed cell application 2/1 2/1 2/1 1/1 1/1
DNA sequence speciﬁcity noa some CTAG preferencea noa A/T preferencea nob
RNA staining 2 1 1 2 2
Bleaching behavior Very fast (5–10 s) Fast (20–30 s) Slow (1–2 min) Slow (1–2 min) No bleaching observed
Working concentration 50 lM 1 lM 1.5 lM 1.6 lM 1 lM
aMolecular Probes.
bBiostatus Limited.
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membranes and their application was restricted to per-
meabilized cells (Fig. 1A). Although TOTO-3 and TOPRO-3
have ﬂuorescence emission in the deep red spectral range,
PI emits at wavelengths similar to those of mRFP or rhoda-
mine and strongly compromises the simultaneous use of
these ﬂuorophores. Further, PI and TOTO-3 bind to cellu-
lar RNA as seen by the strong staining of the nucleolus
and required an additional RNAse digestion (Fig. 1A).
FIG. 1. A: Comparison of DNA staining by PI, TOTO-3, TOPRO-3, Hoechst 33258, and DRAQ5 with H2B-GFP chromatin labeling in HeLa cells. For all dyes
the H2B-GFP chromatin label and DNA staining were imaged in interphase and mitotic cells. The three ﬁxed-cell dyes TOTO-3, TOPRO-3, and PI were
imaged with or without RNAse digestion. Dye concentrations are as listed in Table 1. For Hoechst and DRAQ5, only live cell images are shown. In all cases,
confocal optical sections are presented with the corresponding phase contrast images. B: Combined imaging of DRAQ5 and two different autoﬂuorescent
proteins. Living C2C12 mouse myoblast cells expressing the cell cycle marker GFP-PCNA (10) and a protein (MeCP2-mRFP) that binds to pericentric hetero-
chromatin were stained with DRAQ5. The latter also shows that DRAQ5, in contrast to Hoechst/DAPI dyes, does not preferentially stain this type of hetero-
chromatin. The three different ﬂuorophores were excited and detected independently (imaging conditions as listed in Table 2) and no cross-talk was
observed. Scale bars 5 5 lm.
Table 2
Summary of Imaging Conditions
Fluorophore
Excitation
(nm)
Main
beamsplitter (nm)
Secondary
beamsplitter (nm)
Emission
(nm)
LSM510Meta confocal microscope
Hoechst 33258 2P 762a KP 680 — BP 435-485IR
GFP 488 UV/488/543/633 NFT 545 BP500-530IR
PI, mRFP 543 UV/488/543/633 NFT 545 BP585-615
DRAQ5, TOPRO-3, TOTO-3 633 UV/488/543/633 NFT 545 LP 650
Axioplan 2 wideﬁeld microscope
Hoechst 33258 365/12 395 — 397LP
GFP 450–490 510 — 515-565BP
PI 530–585 600 — 615LP
DRAQ5, TOPRO-3, TOTO-3 572–625 645 — 660-710BP
aTwo-photon excitation.
47LIVE CELL DNA LABELING
RESULTS
RESULTS
Only Hoechst 33258 and DRAQ5 could be used to label
nuclear DNA in living cells (Fig. 1A). Both dyes were
added to the growth medium and stained the nuclear
DNA in 5 to 10 min. One major advantage of Hoechst
33258 is the easy combination with many other ﬂuores-
cent dyes or proteins, from the green to the deep red
spectral range of visible light. However, the Hoechst
33258 dye requires excitation with an UV light source or
multiphoton laser excitation (Fig. 1A). The former pro-
duces additional problems including UV-induced cell
damage that decreases cell viability and bleaching due to
high-energy excitation light. A continuous imaging of
Hoechst-stained living cells with 762-nm two-photon exci-
tation resulted in very fast cell death (data not shown).
The ﬂuorescence signals from Hoechst 33258 and H2B-
GFP showed a complete overlap but differed in the inten-
sity of the chromatin compartments (Figs. 1A and 3D),
which results from the Hoechst 33258 preference to bind
to A/T-rich genomic DNA sequences, thereby highlighting
some genomic sequences, e.g., pericentric heterochroma-
tin in mouse cells (11).
In view of these caveats of the Hoechst/DAPI DNA
dye family, we tested the recently described DNA inter-
calator DRAQ5 (12,13). The comparison of DRAQ5
nuclear DNA staining with H2B-GFP–labeled chromatin
in live cells showed a costaining of the same nuclear
regions and the chromosomes in mitotic cells (Fig. 1A).
This nucleic acid dye was identiﬁed by directed deriva-
tization of ﬂuorescent anthraquinones, which are che-
mically related to the DNA intercalating anthracycline
antibiotic and the anticancer drug mitoxanthrene
(12,13). The name DRAQ5 stands for deep red ﬂuores-
cing anthraquinone Nr. 5 and this compound is a mem-
brane-permeable, DNA intercalating agent with an exci-
tation at 647 nm but is also excitable at a broad range
of wavelengths starting from 488 nm (13). These ﬂuor-
escent properties make DRAQ5 potentially suited for
use in combination with the available autoﬂuorescent
proteins. We directly tested this by adding DRAQ5 to
living mammalian cells coexpressing nuclear mRFP and
GFP fusion proteins. As shown in Figure 1B, no bleed-
through between the different channels was apparent
and the individual nuclear compartments were easy to
distinguish and image.
To investigate the dynamics of uptake/labeling of
DRAQ5 into living cells, we performed time-lapse ﬂuores-
cence microscopy. The latter showed a rapid entry of
DRAQ5 into the cells and binding to DNA by ﬂuorescence
enhancement upon DNA intercalation. The staining was
already visible after 3 min and reached the equilibrium at
13 min (data not shown).
To assess the potential toxicity of this intercalating dye
at the concentration used, we incubated cells in growth
medium with DRAQ5 at a concentration of 1 lM continu-
ously for 1 day (Fig. 2A-D) or for about 1 h followed by
changing to growth medium without the dye and incu-
bated the cells until the next day (data not shown). Both
types of incubation with DRAQ5 over a 24-h period did
not drastically affect cell viability. In the short DRAQ5
incubation experiment followed by 24-h growth medium
incubation, the DRAQ5 signal intensity was decreased in
the nuclei and cytoplasmic accumulations became visible
(data not shown). In the continuous DRAQ5 incubation
experiment, the nuclear DNA staining remained very
strong 1 day later (Fig. 2C,D). We further tested the effect
on cellular viability by plating equal numbers of cells, sub-
jecting them to the 24-h DRAQ5 incubation scheme as
before, and, 1 day later, trypsinizing and counting the
number of cells. Compared with untreated cells in the
same experiment, there were approximately 50% fewer
cells after 24 h of DRAQ5 incubation. This was not due to
cell death because the number of cells plated did not
decrease and apoptotic cells were not apparent but likely
lowered proliferation rate. To directly test this possibility,
we performed the same 24-h DRAQ5 incubation scheme
and analyzed the cell cycle progression by ﬂow cytometric
determination of the DNA content. The results clearly
showed no sub-G1 DNA population of cells, which would
be indicative of cell death, but a pronounced accumula-
tion of cells in G2 phase (Fig. 2E,F).
Next we compared the photobleaching behavior of
the different DNA dyes. Under continuous wideﬁeld epi-
ﬂuorescent excitation with a mercury lamp, we observed
a fast bleaching of TOPRO-3 (after 5 to 10 s) and to some
extent a slower bleaching of TOTO-3 (after 20 to 30 s;
Table 1). Accordingly, this allows the acquisition of only
one or two images with a laser scanning microscope
before the ﬂuorescent signals are bleached. The bleaching
rates of PI and Hoechst 33258 were comparable to those
of GFP and other more stable ﬂuorophores with the ﬂuor-
escence signal disappearing after 1 min (Table 1). Under
these illumination conditions, DRAQ5 showed no detect-
able photobleaching. We then directly compared the
photobleaching of DRAQ5 with GFP using a confocal
laser scanning microscope. In time series, we were able to
acquire about 120 images of DRAQ5-labeled nuclei of liv-
ing HeLa H2B-GFP cells at a high magniﬁcation and resolu-
tion with minor bleaching, whereas the ﬂuorescent his-
tone label bleached away after about 60 images (Fig. 3A).
We tested whether DRAQ5 accurately reﬂects the DNA/
chromatin distribution within the nucleus by correlating it
with the H2B-GFP chromatin label. For this purpose, we
FIG. 2. Viability test for DRAQ5-stained cells. DRAQ5 was added to the growth medium of HeLa H2B-GFP cells and confocal images were acquired at dif-
ferent time points. A: A cell nucleus 5 min after application of the dye. The DNA in the cell nucleus is already stained with DRAQ5. B: The same can be seen
1 h later, with only a few additional cytoplasmic DRAQ5 signals. After 24 h the overview (C) and the magniﬁed image of a nucleus (D) show that the cells
are viable and appear morphologically unchanged. HeLa cells incubated (F) or not (E) for 1 day with DRAQ5 were methanol ﬁxed and stained with PI fol-
lowed by DNA content analysis by ﬂow cytometry. DNA histograms were analyzed with ModFit software to determine the percentage of cells in the differ-
ent cell cycle stages. Although 11% of the control cells were in G2/M, the cells incubated for 1 day with DRAQ5 at 1 lM showed a drastic accumulation in
G2 phase (65% of all cells). Scale bar 5 5 lm.
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FIG. 3. Quantitative correlation analysis of DNA staining with DRAQ5 versus chromatin labeling with H2B-GFP and comparative photobleaching behavior.
A: Photobleaching behavior of DRAQ5 versus H2B-GFP. We performed time series with living Hela H2B-GFP cells and acquired 200 images with a confocal
microscope in about 30 min to compare the bleaching of both chromatin labels during imaging. The optical sections and the relative mean ﬂuorescence
intensity plotted over the number of images showed that the H2B-GFP label completely disappeared after about 60 images, whereas the DRAQ5 signal did
not fade substantially until 120 images. DRAQ5 ﬂuorescence even increased in intensity during the time course. B: Quantitative correlation analysis of DNA
staining with DRAQ5 versus chromatin labeling with H2B-GFP. The image shows a live HeLa H2B-GFP cell stained with DRAQ5 and the almost complete
colocalization in the merged image displayed by the yellow color. E: Graphs represent the intensity and localization of the two live cell labels along the line
in the merged image. The two graphs follow each other in the displayed structures and label intensity. Minor differences can be seen in one nucleolus (*) or
in interchromatin regions (#). C: The correlation plot describes the pixel colocalization depending on their intensity on the DRAQ5 and H2B-GFP channels
with region 3 displaying colocalizing pixels, whereas regions 1 and 2 contain the noncolocalizing pixels for each label, respectively. All signals with inten-
sity below 500 (region under the cross-line) are background. D: The distribution of the pixels in region 3 within a thin cone in a 45 angle reveals a very
high degree of pixel colocalization and intensity agreement, which is also reﬂected in the calculated Pearson’s coefﬁcient. The same analysis was performed
for Hoechst 33258 versus DRAQ5 or H2B-GFP and the respective Pearson’s coefﬁcients are presented in D. Scale bar 5 5 lm.
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compared quantitatively the spatial distribution of both
labels by (a) line scan analysis, which displays the pixel
intensity on a line of both ﬂuorescence labels, and (b)
colocalization analysis describing the overlay of pixels and
intensities of both labels. The line scan in Figures 3B and
3E shows that the same nuclear regions are labeled with a
similar intensity by DRAQ5 and H2B-GFP. Some minor dif-
ferences in the label intensity appear in the nucleoli (* in
Fig. 3B) where DRAQ5 shows slightly higher signals than
H2B-GFP. This observation is most probably due to weak
RNA binding by this dye. In other nuclear compartments
such as euchromatin or the interchromatin compartment
(# in Fig. 3B), the slightly more intense H2B-GFP label
could represent unbound and diffuse ﬂuorescent histone
fusion proteins. In general, no signiﬁcant differences
between DRAQ5- and H2B-GFP–labeled chromatin struc-
tures were observed by line scan analysis (Fig. 3B,E). The
same set of images (Fig. 3B) was used for a colocalization
analysis of DRAQ5 versus H2B-GFP, which displayed a high
degree of pixel colocalization with a Pearson’s coefﬁcient
of 0.832 6 0.034 (Fig. 3C,D). In contrast, Hoechst 33258-
labeled DNA versus H2B-GFP or DRAQ5 showed only
0.680 6 0.033 and 0.645 6 0.066, respectively, reﬂecting
the preferential afﬁnity of Hoechst 33258 to some DNA
sequences (Table 1). In summary, at high spatial resolu-
tion, DRAQ5 reﬂects the spatial DNA concentrations in
excellent agreement to the chromatin intensity depicted
by H2B-GFP.
DISCUSSION
The aim of this work was to ﬁnd and characterize an
easy-to-use live cell DNA stain to label nuclear chromatin
compartments for long-term live cell microscopy in com-
bination with the available autoﬂuorescent proteins.
From the ﬁve DNA dyes compared, three (PI, TOTO-3,
and TOPRO-3) are not suitable for staining living cells,
with TOPRO-3 also bleaching very fast (Table 1 and
Fig. 1A). Hoechst 33258 can be used to stain DNA in live
cells but requires UV excitation, which is toxic to the cells
and has a marked preference for A/T-rich sequences,
which can bias quantitative studies (1,8). The DNA dye
DRAQ5 showed no drastic cytotoxicity effects at 1 lM as
the cells slowed down proliferation but did not die
(Fig. 2). Decrease of nuclear DNA labeling of the dye visi-
ble the next day can be mechanistically related to the
efﬂux of dyes, such as Hoechst 33342 and rhodamine 123,
mediated by different ABC transporters reported in multi-
drug-resistant cells (14,15). These are characterized by
high levels of P-glycoprotein, which is responsible for
facilitating transport of anticancer drugs out of the cell.
DRAQ5 incubation at 1 lM for 24 h did hinder cell
cycle progression with accumulation of cells in G2 phase
of the cell cycle (Fig. 2). Because this dye is an anth-
racycline derivative that intercalates into DNA, it is concei-
vable that it blocks topoisomerase II, thus causing G2
arrest.
Because DRAQ5 is excited with red light and emits
deep red ﬂuorescence, it can be used in combination with
C/G/YFP and mRFP (Fig. 1B). From our live cell experi-
ments, we can conclude that DRAQ5 is not bleached
under normal imaging conditions (Fig. 3A). The labeling
of DNA and thereby of chromatin with DRAQ5 is nearly
identical with an H2B-GFP label (Fig. 3B-E). Some minor
differences in the label intensities could result from a
mobile fraction of H2B-GFP, which increases the back-
ground in the green channel or the incorporation of his-
tone variants (16). In contrast, DRAQ5 seems to bind to a
low extent RNA (13) as seen by a low signal in the
nucleoli, which contain mostly rRNAs (Fig. 3B,E).
In contrast to ﬂuorescently tagged histones, DRAQ5
DNA staining does not rely on the transfectability of the
cells or the evolutionary conservation of histones and is
therefore potentially applicable to all organisms.
Altogether DRAQ5 fulﬁls several of the requirements for
a live cell DNA dye, i.e., it (a) is an easy to use cell-per-
meant DNA dye, (b) is extremely photostable; (c) allows
simultaneous imaging of the available genetically encoded
ﬂuorescent proteins, and (d) reﬂects accurately the spatial
concentration of DNA in living cells.
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Abstract In the recent molecular and cell biological
research, there is an increasing need for labeling of
subcellular structures in living cells. Here, we present
the use of a Xuorescently labeled cell penetrating pep-
tide for fast labeling of nucleoli in living cells of diVer-
ent species and origin. We show that the short peptide
with ten amino acids was able to cross cellular mem-
branes and reach the nucleolar target sites, thereby
marking this subnuclear structure in living cells. The
treatment of cells with actinomycin D and labeling of
B23 protein and Wbrillarin provided evidence for a
localization to the granular component of the nucleo-
lus. The Xuorescently conjugated nucleolar marker
could be used in combination with diVerent Xuoro-
phores like Xuorescent proteins or DNA dyes, and
nucleolar labeling was also preserved during Wxation
and staining of the cells. Furthermore, we observed a
high stability of the label in long-term studies over 24 h
as well as no eVect on the cellular viability and prolifer-
ation and on rDNA transcription. The transducible
nucleolar marker is therefore a valuable molecular tool
for cell biology that allows a fast and easy labeling of
this structure in living cells.
Keywords Cell penetrating peptides · Fluorescence 
microscopy · Living cells · Nucleolus · Transducible 
nucleolar marker
Abbreviations
AMD Actinomycin D
DRAQ5 Deep red Xuorescing anthraquinone Nr. 5
DMEM Dulbecco’s modiWed eagle medium
FACS Fluorescence activated cell sorting
FCS Fetal calf serum
FITC Fluorescein isothiocyanate
FU Fluorouridine
GFP Green Xuorescent protein
HEPES N-2-hydroxyethylpiperazine-N-2-ethane-
sulfonic acid
HIV Human immunodeWciency virus
mRFP Monomeric red Xuorescent protein
PI Propidium iodide
PCNA Proliferating cell nuclear antigen
TAT Transactivator of transcription
Introduction
The nucleolus is the most prominent substructure in
the cell nucleus and it was Wrst described in 1836 by
Gabriel Gustav Valentin (Franke 1988). It took more
than one century to establish its role in ribosome bio-
genesis (Brown and Gurdon 1964; Perry 1962). The
nucleolus is a very dynamic structure and it forms
around the rDNA loci (Andersen et al. 2005). The
inner nucleolar structure is organized into Wbrillar cen-
ters (FC, where rDNA is located and at the periphery
of which transcription takes place) surrounded by the
dense Wbrillar component (DFC, into which nascent
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RESULTStranscripts migrate) and all around the granular com-
ponent (GC), which is Wlled with ribosomal precursors
(Cheutin et al. 2002; Derenzini et al. 2006; Scheer and
Hock 1999). Long ago, it has been noted that the
nucleolus size reXects the cellular activity, proliferation
and diVerentiation (Hernandez-Verdun 2006). Fur-
thermore, the nucleolus bears the hallmark of other
subnuclear compartments, in that is not delimited by
membranes, as is the case for cytoplasmic organelles.
Owing to its higher density and refractility in compar-
ison to the surrounding nucleoplasm, the nucleolus can
be visualized with phase contrast or diVerential interfer-
ence contrast microscopy. However, the three-dimen-
sional volume and localization within the nucleus as well
as its exact borders are hard to identify by contrast
microscopy alone and require a Xuorescence label (Lam
et al. 2005). In addition, such a marker would facilitate
high throughput analysis to sort nuclear proteins accord-
ing to their intranuclear localization. Finally, the devel-
opment of new high-resolution optical techniques allows
for the Wrst time optical analysis down to the nanometer
scale but require Xuorescent labels. This gain in informa-
tion could help to elucidate the functional nuclear and
genome organization in relation to the nucleolus in the
three-dimensional nuclear structure. SpeciWc antibodies
to nucleolar proteins or the transfection of cells with
plasmids encoding for Xuorescent fusions of nucleolar
proteins allow the visualization of the nucleolus by Xuo-
rescence microscopy. However, these methods require
either Wxation of the sample and immunostaining in the
case of antibodies or transfection of cells and expression
of the Xuorescence marker in the case of Xuorescent pro-
teins. The latter strategy has the advantage of allowing
live-cell microscopy but is Wrst time consuming and sec-
ond restricted to transfectable cells, which is not the case
of most primary cells. Furthermore the analysis of drug
eVects on the nucleolar organization and function could
be simpliWed by using a fast nucleolar label for living
cells. A membrane-permeable Xuorescent label for the
nucleoli, which is fast and easy to apply on living cells,
would therefore be a very useful molecular tool for diag-
nostics and cell biological research.
The ability of certain peptides and proteins with
concentrated basic charges to cross cellular membranes
was earlier discovered in 1988 for the HIV TAT pro-
tein (Frankel and Pabo 1988; Green and Loewenstein
1988), and the peptide domain responsible for mem-
brane transduction was mapped a decade later (Vives
et al. 1997). Further comparison of native and artiWcial
membrane transducing peptides indicated that argi-
nines are superior to lysines in transduction potential
(Mitchell et al. 2000; Thoren et al. 2003). Independent
studies found that peptide sequences present in several
viral and cellular proteins containing a stretch of 6–10
basic amino acids could serve as a targeting sequence
for the nucleus and the nucleolus (Dang and Lee 1989;
Hatanaka 1990). In this work we reasoned that if both
properties, membrane transduction ability and nucleo-
lar targeting signal, could be combined in the same
peptide made of a series of basic amino acids we could
exploit these independent biological functions to
directly label the nucleolus in living cells.
Materials and methods
Peptides and plasmids
Amino-terminal Xuorescein labeled deca-arginine pep-
tide (FITC-R10) was synthesized with D-amino acids by
Peptide Specialty Laboratories (Heidelberg, Ger-
many), dissolved in ddH2O and, for application on liv-
ing cells, further diluted in growth medium.
The mRFP-PCNA expression construct was
described before (Sporbert et al. 2005).
Cell culture and transfection
Human HeLa cells as well as Flp 3T3 mouse Wbroblast
cells were cultivated in DMEM with 10% FCS + 5 mM
L-glutamine and 5 g/ml Gentamycine. C2C12 mouse
myoblasts were grown in DMEM with 20% FCS and
the same additives. Transfection of C2C12 cells with
mRFP-PCNA was carried out by CaPO4 precipitation
method as described (Cardoso et al. 1997). For live cell
microscopy the cells were plated onto 4- or 8-well Lab-
Tek coverglass chambers (NalgeNunc) or 8-well Ibidi
chambers (Ibidi). Adult ventricular cardiomyocytes
were enzymatically isolated by retrograde perfusion
from excised adult male Wistar rat hearts at a constant
Xow of 6 ml per min with a Ca2+-free HEPES solution
containing collagenase (Worthington type II, 60 IU per
ml). The freshly dissociated cells were kept at physio-
logical solution with 0.3 mM Ca2+ and 0.5% bovine
serum albumin at room temperature (Alvarez et al.
2004). DRAQ5 (Biostatus Ltd) staining of DNA in liv-
ing cells was as described (Martin et al. 2005).
Transduction assays
All peptide transduction experiments were performed
with living cells plated on 4- or 8-well coverglass cham-
bers. Before observation, the medium was removed
and growth medium with the diVerent peptide concen-
trations was directly applied to the cells. To remove the
background Xuorescence of extracellular peptides a123
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RESULTSwashing step with PBS was included after 30 min of
incubation followed by incubation in growth medium
without peptide. For the concentration dependent
uptake (Fig. 3a) the cells were incubated with the pep-
tides for 1 h before washing with PBS while for the
continuous time series to study the uptake dynamics
(Fig. 3b) no washing step was performed. The uptake
of the marker peptide was studied under a Xuorescence
microscope for 1 h starting with the peptide applica-
tion. After observation and imaging of the nucleolar
label the cells were returned to the incubator and fur-
ther image collection was performed 24 h later. Trans-
duction eYciencies were determined in two
independent experiments by counting the number of
transduced cells with nucleolar label directly on the
Xuorescence microscope in ten Welds of view (n = 130–
180 cells).
Cell viability and proliferation assay
Cell viability and label stability after nucleolar marker
application were monitored by the ability of the cells to
undergo complete mitotic cell cycles and grow to
conXuency as well as monitoring the label intensity in
the nucleoli 24 h after application.
The membrane integrity was ascertained by the try-
pan blue exclusion assay. Into each well of a 4-well
LabTek chamber with 400 l medium 2 l trypan blue
solution (Sigma) was added and mixed by pipetting up
and down. The number of trypan blue positive cells
was counted at 30 min and in separate samples at 24 h.
The impact of the nucleolar marker on cell viability
and cell cycle progression was assayed by plating equal
number of cells and 1 day later adding or not 10 M
FITC-R10 to the media for 1 h followed by a washing
step in PBS and incubation in growth medium. The
next day, cells were trypsinized, Wxed with methanol
for 20 min and stained with 50 M propidium iodide
(PI) (Sigma) for 1 h in the presence of 0.1 mg/ml
RNase A (Sigma). DNA content was analyzed by Xow
cytometry (Becton Dickinson FACSVantage using
488 nm laser excitation and 675/20 nm bandpass Wlter
for detection) as a measure of cell cycle progression
(Plander et al. 2003). Five sets of 1 £ 104 cells and Wve
sets of 2 £ 104 cells were analyzed, and all the data sets
were used for the calculation of mean values of cells in
Fig. 1 Transducible nucleolar marker uptake into diVerent cell
types and in combination with other Xuorophores a This Wgure
shows the Xuorescently labeled nucleolar marker taken up into
cells of diVerent species and origin, which are either from cultured
cell lines (Wbroblasts, mouse; HeLa, human) or primary cells that
are terminally diVerentiated (adult cardiomyocyte, rat). The cells
were incubated with a medium containing the transducible nucle-
olar marker for 30 min and then washed in PBS and supplied with
the medium. In both cases the marker transduced fast into the cells
where it accumulated in the nucleoli and thereby marked this sub-
nuclear structure. b Displays a C2C12 mouse myoblast transfected
with a plasmid coding for mRFP-PCNA (red) and with DNA
stained by DRAQ5 (blue). The transducible nucleolar marker la-
beled with FITC (green) can be used in combination with Xuores-
cent protein labels like mRFP as well as Xuorescent dyes such as
the live cell DNA stain DRAQ5. Scalebar: 5 m123
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RESULTSG1, S and G2/M phase for FITC-R10 labeled and con-
trol cells using ModFit 3.0 software.
In situ transcription assay and inhibition 
with actinomycin D
Cells were grown on glass coverslips and 1 day later
incubated with FITC-R10 for 1 h or 24 h in a 12-well
plate. Actinomycin D (AMD) treatment was per-
formed at 0.04 mg/l for 2 h before adding FITC-R10 at
10 M to the same growth medium or for 2 h after the
incubation of cells with FITC-R10 for 1 h. For the
labeling of nascent RNA cells were incubated with
1.5 mM FU in growth medium for 10 min and washed
in PBS.
After the incubation schemes cells were Wxed in
3.7% formaldehyde in PBS for 10 min and permeabi-
lized with 0.25% (0.5% for AMD experiments) Triton
X100 in PBS for 10–12 min. The samples were immu-
nostained with anti-B23 mouse monoclonal antibody
(clone FC82291; Sigma) followed by detection with
donkey anti-mouse IgG antibody conjugated with Tex-
asRed (Jackson) and #346 anti-Wbrillarin human auto-
antibody (kind gift from P. Hemmerich, FLI Jena)
followed by donkey anti-human IgG biotin SP (Lot:
47441 Jackson) and streptavidin-Cy5 (Amersham).
Fluorouridine incorporated into RNA was detected
with anti-BrdU rat monoclonal antibody (clone BU1/
75; Harlan Sera Lab) followed by incubation with don-
key anti-rat IgG antibody conjugated with Cy5 (Jack-
son). For the labeling of DNA cells were
counterstained with TOPRO-3 at 1.3 M Wnal concen-
tration in PBS (Molecular Probes) and mounted with
Moviol.
Microscopy, image acquisition and analysis
Live cell microscopy was performed with a Zeiss
LSM510Meta confocal setup mounted on an Axiovert
200 M inverted microscope using a 63£ phase contrast
plan-apochromat oil objective NA 1.4 heated to 37°C.
For all acquisition settings the main beam splitter was
HFT UV/488/543/633 and the parameters speciWc for
each Xuorochrome are listed below: 
Imaging of AMD treated cells was done at a Leica
TCS SP5 confocal setup mounted on a Leica DMI
6000 CS inverted microscope using a 63£ HCX plan-
apochromat DIC oil objective NA 1.4. The image
acquisition was done sequentially to minimize poten-
tial crosstalk between the Xuorophores. The trypan
blue exclusion was determined with brightWeld illumi-
nation on the Zeiss LSM510 microscope setup. The
uptake kinetics analysis (Fig. 3b) was performed by
selecting ten nucleoli in ten individual cell nuclei in
the image of the last time point and determining their
mean Xuorescence intensity (FI) at each time point.
The Xuorescence intensity data for all individual
nucleoli were averaged and plotted against the time-
scale. Labeling of nascent RNA by FU was analyzed
by selecting 60 nuclei from confocal images and deter-
mining the mean Xuorescence intensity. Background
correction was done by applying a threshold according
to the mean Xuorescence intensity in images from con-
trol cells without primary antibody (anti-BrdU).
Image analysis was performed with Zeiss LSM Image
examiner 3.2 (Zeiss) and Origin 7.5 software (Origin
Lab Corp.).
Results and discussion
Our goal was to develop an easy to use live cell Xuores-
cent marker for the nucleolus. Therefore, we tested
whether nucleolar targeting ability could be combined
with cell penetrating ability in one peptide. The latter
would allow non-invasive application to all sorts of
cells. We chose a peptide composed of 10 arginines,
which had been shown to eYciently transduce into cells
(Wender et al. 2000). To prevent proteolytic degrada-
tion the peptide was synthetized with D-amino acids.
The Xuorescent label (FITC) was added to the N-ter-
minal end.
First, we tested the ability of this peptide (FITC-
R10) to be taken up by diVerent cells and its intracellu-
lar localization. We selected diVerent cell types (Wbro-
blasts, epithelial, muscle) from diVerent species
(mouse, rat, human) and not only cell lines (Flp 3T3,
HeLa) but also primary cultures (cardiomyocytes).
FITC-R10 was diluted in growth medium and applied
directly to the cells for 30 min. After the incubation
time the cells were washed and analyzed by confocal
microscopy. In all cells tested (Fig. 1a) the Xuorescence
label was found accumulated in the nucleoli identiWed
by the phase contrast images (except in cardiomyo-
cytes where the nucleoli cannot be detected due to the
sarcomeric structures) and also diVusely distributed in
the cytoplasm. The transfection of the cells with an S-
phase marker (mRFP-PCNA; Sporbert et al. 2005 and
simultaneous DNA labeling with DRAQ5 Martin et al.
2005) indicated that uptake of the peptide was not cell
Fluorochrome Ex (nm) Em (nm)
FITC 488 BP500–530
mRFP, L-Rhodamine 543 BP565–615
DRAQ5, Cy5 633 LP650123
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RESULTScycle dependent. Indeed, cells in diVerent stages of the
S-phase as well as in G1/G2 exhibited nucleolar label-
ing and also mitotic cells had taken up the marker
although the nucleus and the nucleoli are not present
(Fig. 1b and data not shown). These data also indicate
that combinations with other Xuorochromes (e.g., live
cell DNA staining with DRAQ5) and Xuorescent pro-
teins (e.g., mRFP) are possible. Since any other Xuo-
rescent label can be selected for the nucleolar marker
peptide, this allows multiple combinations with other
Xuorochromes.
The FITC-R10 label colocalized with the dark struc-
tures in the phase contrast images, which were sur-
rounded by dense chromatin detected by TOPRO-3
staining (Fig. 2a). To conWrm the nucleolar localization
of FITC-R10 we performed colocalization studies with
nucleophosmin/B23 (Fig. 2b), a protein present in the
granular component of the nucleolus and Wbrillarin
localized in the dense Wbrillar component (reviewed in
Olson and Dundr 2005). The FITC-R10 label
colocalized with the B23 antibody signal at the periph-
ery of the nucleoli and Wlled the nucleolar interior
showing a decreased concentration in the dense Wbril-
lar components labeled by Wbrillarin (Fig. 2b). This
demonstrated that the FITC-R10 peptide possesses
intracellular nucleolar targeting ability and further-
more localizes to the granular component of the
nucleolus.
To further test the exclusion of FITC-R10 from Wbril-
lar components we treated cells with AMD. Exposure
of cells to this transcription inhibitor leads to a separa-
tion of Wbrillar and granular components into distinct
caps (Reynolds et al. 1964; Chen et al. 1999). The
AMD treatment of cells before or after (data not
shown) labeling the nucleoli with FITC-R10 showed the
persistent localization of FITC-R10 to the granular
component remnant separated from the caps formed
by the Wbrillar components without FITC-R10 (Fig. 2b).
In contrast to B23, the nucleolar marker did not redis-
tribute throughout the nucleoplasm after AMD
Fig. 2 Intracellular localiza-
tion of the FITC-R10. a HeLa 
cells incubated for 1 and 24 h 
with 10 M FITC-R10 as well 
as unlabeled controls were 
Wxed in 3.7% formaldehyde in 
PBS and stained with TO-
PRO-3 to label the DNA. The 
FITC-R10 label colocalize 
with the nucleoli identiWed in 
the phase contrast during 
short- and long-term incuba-
tion of the cells. b The HeLa 
cells were immunolabeled for 
B23/nucleophosmin to high-
light the granular component 
of the nucleolus and Wbrillarin 
to label the dense Wbrillar 
components. One sample was 
treated with actinomycin D 
(AMD), which leads to a stop 
in rDNA transcription and the 
formation of nucleolar caps 
containing the Wbrillar compo-
nents. The FITC-R10 label was 
still localized to the nucleolar 
interior unlike B23, which was 
redistributed to the nucleo-
plasm and excluded from the 
nucleoli. The nucleolar mark-
er does not colocalize with the 
Wbrillarin labeled caps in 
AMD treated cells. Scalebar: 
5 m123
248 Histochem Cell Biol (2007) 127:243–251
RESULTStreatment indicating that it interacts with other mole-
cules of the granular component. Thus, the FITC-R10
can also be used in cells where rDNA transcription was
stopped to label the granular components of disassem-
bled nucleoli.
Furthermore, these immunostaining experiments
after live cell application of FITC-R10 demonstrated
that Wxation and further treatments could be per-
formed without loosing the label or changing its locali-
zation (Fig. 2 and suppl. Fig. 1A). When FITC-R10 was
applied to pre-Wxed samples though, it did not stain the
nucleolus (suppl. Fig. 1A).
The kinetics of uptake of the peptide into cells was
then studied by time-lapse confocal microscopy. The
time series analysis is shown in Fig. 3b and in the sup-
plementary online movie. The images at the Wrst and
last timepoints display the accumulation of the marker
over time inside the cells and on the cell membrane.
The graph represents the Xuorescence increase in the
nucleoli of 10 diVerent cells. The peptide was rapidly
internalized and labeling of the nucleoli started around
20 min and reached the equilibrium at 40 min. Earlier
nucleolar labeling could have been missed due to the
strong extracellular Xuorescence of non-internalized
peptides.
In a separate set of experiments we performed a dose
response uptake analysis. DiVerent concentrations of
the marker in the growth medium were applied for 1 h
to HeLa cell cultures. A threshold minimal concentra-
tion for nucleolar labeling was found at 2.5 M. Lower
peptide concentration (1 M) resulted in no uptake of
the marker into the cells (Fig. 3a). A possible explana-
tion for this Wnding is that a certain concentration of the
basic CPP on the cell membrane needs to be reached to
enable the membrane transduction process (Dietz and
Bdeltahr 2004; Tunnemann et al. 2006). Alternatively,
the Xuorescence detection method used might not be
sensitive enough to detect very low concentrations of
Xuorescent peptide over the background signal.
Next, we wanted to test the intracellular stability of
the marker and its localization. This was examined by
applying the transducible Xuorescent nucleolar marker
to living C2C12 myoblasts for 30 min, which as before
resulted in nucleolar accumulation, removing the
excess extracellular Xuorescent peptide by a washing
step with PBS and analyzing the cells by confocal
microscopy 24 h later. The Xuorescent nucleolar label
was surprisingly stable showing very bright nucleolar
signal 1 day later without detectable decrease in Xuo-
rescence intensity or the number of cells marked
(Fig. 3c). No proteolytic degradation or intracellular
recycling of the FITC-R10 was observed within this
time period. In addition, the morphology of the cells
was not changed, and the cultures grew to conXuency
indicating no overt eVect of the nucleolar marker on cell
cycle progression and mitotic division. The structure
Fig. 3 Kinetics of uptake and intracellular stability of the nucle-
olar marker The images in a show the concentration dependent
labeling of the nucleoli in HeLa cells with a threshold at a concen-
tration of 2.5 M FITC-R10. The kinetics of uptake in b display
the increase of the Xuorescent label in the nucleoli directly after
application of 10 M FITC-R10 in medium to living C2C12 cells
without a washing step. The uptake started immediately after the
application of the nucleolar marker and was clearly visible after
20 min. A maximum of the nucleolar label was reached 40 min af-
ter the start of the experiment (see supplementary movie). c
C2C12 cells were incubated for 30 min with FITC-R10 in a medi-
um followed by washing in PBS and imaged 24 h later. Represen-
tative images are shown and demonstrate the stability of the
transducible nucleolar marker over the 1 day period tested (see
also Fig. 2a). Scalebar: 5 m123
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RESULTSand localization of components of the granular compo-
nent visualized by antibody labeling of B23 was also
not altered between untreated cells and samples
labeled for 1 and 24 h with FITC-R10 (Fig. 2a and data
not shown).
To measure the eYciency of nucleolar labeling we
determined the percentage of labeled cells at diVerent
times after application. Nearly 89% of the cells showed
nucleolar Xuorescence after 30 min and the number even
increased to 98% at 24 h (Fig. 4a). Having FITC-R10 in
the growth medium for the initial 30 min or during the
entire 24 h period yielded no diVerence in the nucleolar
label and the cellular viability (Fig. 4a and data not
shown). To further investigate the impact of the peptide
transduction on membrane integrity we used the trypan
blue exclusion test. No diVerence was measured between
labeled and unlabeled control cells in the number of try-
pan blue positive cells, which was 1–2% (Fig. 4a).
Next, cells labeled for 24 h with FITC-R10 were incu-
bated for 10 min with Xuorouridine (FU), which is
preferentially incorporated into rRNA, and the incor-
porated nucleotide was detected by immunostaining to
determine the amount of synthesized RNA in compari-
son to cells without nucleolar marker (Boisvert et al.
2000). The diagram in Fig. 4b displays the mean Xuo-
rescence intensity of 60 nuclei measured from low mag-
niWcation confocal images. FU labeled cells with and
without FITC-R10 exhibited no diVerence in the level
of incorporated nucleotide, i.e., no eVect was detected
on rDNA transcription.
Finally, to assess potential eVects of FITC-R10 on
cell proliferation, we subjected HeLa cells with labeled
nucleoli and unlabeled control cells to PI staining and
Xow cytometric analysis of cellular DNA content. The
cells were incubated for 1 h with 10 M FITC-R10 and
then washed in PBS and grown at 37°C for 24 h. After
Fig. 4 EVect of the nucleolar marker on the cellular viability,
proliferation and rDNA transcription The table in a summarizes
the percentage of cells with labeled or unlabeled nucleoli and the
trypan blue exclusion test after short- and long-term incubation
of living cells with 5 M FITC-R10. In both cases a small number
of cells remained unlabeled, whereas the majority of cells showed
nucleolar labeling after 30 min and also after 24 h incubation with
the nucleolar marker. The quantity of trypan blue positive cells
during short- and long-time incubation is comparable to the con-
trol cells. The diagram in b displays in each bar the mean intensity
of Xuorescently labeled FU incorporated into rRNA from 60 nu-
clei measured in confocal images. The signals of labeled rRNA in
FITC-R10 labeled or unlabeled control cells diVered only a little
and within the range of the standard deviation. In c the histo-
grams represent Wtted curves of Xow cytometry measurements.
HeLa cells were incubated or not with the transducible nucleolar
marker for 1 h following a washing step in PBS and staining with
PI in the presence of RNase. The percentage of cells in the respec-
tive cell cycle stage, and the standard errors were calculated from
ten measurements each123
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RESULTSthis incubation scheme the labeled and untreated con-
trol cells were methanol Wxed and stained with PI
including RNase treatment to measure the DNA
amount for cell cycle distribution analysis. The control
cells showed a cell cycle proWle with 52% of cells in G1/
G0, 32% in S-phase and 16% in G2/M. In comparison
the cells incubated with 10 M of the nucleolar marker
for 1 h showed some deviations from the control cell
cycle proWle 24 h post-labeling. The quantity of cells in
G1/G0 was decreased to 43%, whereas the cells in S-
phase increased to 42% concomitantly. The fraction of
G2/M cells remained similar to the control cells (15%;
Fig. 4c). These data suggest some delay in cells pro-
ceeding through S-phase indicated by an increase and a
corresponding decrease of cells in G1/G0. The quantity
of cells that exit the S-phase and continued to G2 and
the mitotic division was stable also under the inXuence
of the nucleolar marker, which Wts the observation of
increased conXuency in cultures after 24 h.
Altogether, no major eVect of the nucleolar marker
on either membrane integrity, cell viability and prolif-
eration, RNA synthesis or distribution of nucleolar
components was observed at short- or long-incubation
times.
Such a label is totally non-invasive and importantly
works well in combination with other Xuorochromes
such as autoXuorescent proteins or various dyes. More-
over, most cells not only established cell lines but also
non-transfectable primary cultures were transduced
with 90% or higher eYciency, and the nucleolar label-
ing needed only about 20 min to be readily visualized.
Curiously, always a few cells remained unlabeled,
which could be due to genetic or epigenetic diVerences
in gene expression among the cells in the culture
(Tyagi et al. 2001).
We conclude that the FITC labeled deca-arginine
peptide does not interfere with major cellular pro-
cesses at the concentrations tested. The combination of
membrane permeability and nucleolar targeting in one
peptide makes this transducible Xuorescent marker for
the nucleoli applicable to most mammalian cells and a
novel and non-invasive tool for live cell microscopy.
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ABSTRACT Cell-penetrating peptides (CPPs) are ca-
pable of introducing a wide range of cargoes into living
cells. Descriptions of the internalization process vary
from energy-independent cell penetration of mem-
branes to endocytic uptake. To elucidate whether the
mechanism of entry of CPP constructs might be influ-
enced by the properties of the cargo, we used time
lapse confocal microscopy analysis of living mamma-
lian cells to directly compare the uptake of the well-
studied CPP TAT fused to a protein (>50 amino acids)
or peptide (<50 amino acids) cargo. We also analyzed
various constructs for their subcellular distribution and
mobility after the internalization event. TAT fusion
proteins were taken up largely into cytoplasmic vesicles
whereas peptides fused to TAT entered the cell in a
rapid manner that was dependent on membrane poten-
tial. Despite their accumulation in the nucleolus, pho-
tobleaching of TAT fusion peptides revealed their
mobility. The bioavailability of internalized TAT pep-
tides was tested and confirmed by the strong inhibitory
effect on cell cycle progression of two TAT fusion
peptides derived from the tumor suppressor p21WAF/Cip
and DNA Ligase I measured in living cells.—Tu¨nne-
mann, G., Martin, R. M., Haupt, S., Patsch, C., Eden-
hofer, F., Cardoso, M. C. Cargo-dependent mode of
uptake and bioavailability of TAT-containing proteins
and peptides in living cells. FASEB J. 20, 1775–1784
(2006)
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 PCNA  PBD  Cre recombinase
The phenomenon of transduction denotes the size-
independent in vivo delivery of a wide variety of cargoes
into cells and is mediated by cell-penetrating peptides
(CPPs). Although the internalization of fluorophores,
nucleotides, peptides, globular proteins, nanoparticles,
lipids, and drugs interconnected to CPPs into living
cells has been described in the literature and resulted
in measurable biological effects (1), the reported trans-
duction experiments need to be critically evaluated in
terms of the invasiveness of the detection methods
utilized (2). Most known CPPs are parts of viral proteins
or artificial derivatives thereof, and include several
arginines and/or lysines (reviewed in ref. 3). One of
the best-studied CPP is a basic amino acid peptide from
the transactivator of transcription (TAT) protein of the
HIV-1 with the minimal transduction domain compris-
ing amino acids 48–57 (4). The initializing step in the
mechanism of cellular entry of CPPs is thought to be
the strong ionic interaction between the positively
charged amino acid residues and negatively charged
plasma membrane constituents (5–7). Among the cat-
ionic groups mediating cellular uptake, the guani-
dinium group of arginine has been shown to be the
most effective (8–10). Subsequent events needed for
the internalization, however, differ between reports
and are often conflicting. The first mechanistic studies
led to the proposal that CPP internalization occurs
rapidly in a receptor- and energy-independent manner
(6, 9, 11–13) perhaps by destabilizing the lipid bilayer
or by the formation of inverted micelles with subse-
quent release of their contents within the intracellular
space (reviewed in ref. 14). More recently, an active
mechanism based on vesicular uptake has been pro-
posed as the general mode of internalization of CPP
constructs into cells (15–19).
To understand whether the mechanism of entry is
dependent on the cargo connected to the CPP, we
directly compared TAT fused to globular proteins and
TAT-containing peptides with respect to their uptake
kinetics and their intracellular distribution after inter-
nalization in living cells. Transduced constructs were
also analyzed for their ability to reach their targets
inside the cell and to exert their biological activity.
MATERIALS AND METHODS
Peptides and proteins
Peptides (complete description in Table 1) were synthesized
by Biosyntan GmbH (Berlin, Germany), Peptide Specialty
Laboratories (Heidelberg, Germany), and Bachem (Weil am
1Correspondence: Max Delbru¨ck Center for Molecular
Medicine, Robert-Ro¨ssle-Str. 10, Berlin 13125, Germany. E-
mail: cardoso@mdc-berlin.de
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Rhein, Germany). The PCNA binding domain (PBD) peptide
TAT-p21-PBD is derived from human p21WAF/Cip (20) and
the Lig1-PBD as well as TAT-Lig1-PBD from mouse DNA
Ligase I (21, 22). The peptides were analyzed by HPLC a
second time at the end of the experiments to assure their
stability under the storage conditions. The pI of the peptides
was calculated using the program ProtParam (http://au.
expasy.org/cgi-bin/protparam). His-NLS-TAT-Cre-recombinase
(TAT-Cre) protein was produced, purified (23), and labeled
with Alexa Fluor 633 or rhodamine as described (24).
BL21(DE3) cells (Novagen, Madison, WI, USA) were used for
production of His-PTD4-PCNA. Bacterial cultures were grown
at 37°C until early-mid log phase and expression was induced
by addition of 1 mM IPTG. Cells were harvested 3 h after
induction, lysed by lysozyme treatment and ultrasonification,
and His-tagged protein purified to 95% purity from cell
lysates by affinity chromatography using Talon resin material
(BD Bioscience, Franklin Lakes, NJ, USA) according to the
manufacturer’s instructions. The purified protein was labeled
with Atto 633 NHS ester (Fluka, St. Louis, MO, USA) in 0.1 M
bicarbonate buffer pH 8.5, then further purified and rebuffered
into PBS pH 7.4 over a G25-Sephadex column (Pharmacia,
Cambridge, MA, USA). BL21(DE3) CodonPlus-RIL cells (No-
vagen) were used to produce His-TAT-MK2 (MAPKAP kinase
2). Bacterial cultures were grown and induced as above, and
harvested cells were disrupted by 2-fold homogenization at a
1000 bar with a SLM AMINCO FrenchPress (Spectronic
Instruments, Leeds, UK). More than 98% pure protein was
obtained from the lysates upon Talon affinity chromatogra-
phy, as before (BD Bioscience). The purified protein was
labeled with Cy5 NHS ester (Amersham Bioscience, Arlington
Heights, IL, USA) in 0.1 M bicarbonate buffer pH 8.5, then
further purified and rebuffered into PBS pH 7.4 over a
G25-Sephadex column (Pharmacia). The Cy5-labeled strepta-
vidin (Amersham) was incubated for 30 min prior to the
experiments with NLS-biotin peptides at molar ratios of 1:1
for biotin and biotin binding sites at homotetrameric strepta-
vidin. The streptavidin-coated Quantum dots 525 were ob-
tained from Quantum dot Corp. (Hayward, CA, USA).
Cell culture
The C2C12 mouse myoblast cells and C2C12 mouse myoblasts
stably transfected with GFP-PCNA as a fluorescent cell cycle
marker were cultured as described (25, 26). Flp 3T3 mouse
fibroblasts were from Invitrogen (Carlsbad, CA, USA). 3T3-
FDR1.2 Cre reporter cells (27) were cultured in Dulbecco’s
modified Eagle medium (DMEM) containing 10% fetal calf
serum (Life Technologies, Inc., Grand Island, NY, USA). For
live cell microscopy, cells were plated onto 4- or 8-well LabTek
coverglass chambers (NalgeNunc, Rochester, NY, USA).
Transduction assays and inhibitor treatments
All peptide and protein transduction experiments, except for
the Cre recombinase assay (see below), were performed
exclusively with living cells plated on 4- or 8-well LabTek
coverglass chambers using an objective heated to 37°C. For
transduction experiments, the medium was removed and PBS
with the different peptides or proteins was applied directly to
the cells. After 10 min incubation, PBS was replaced with the
growth medium. Usually uptake was studied continuously
starting with the peptide application over a period of at least
2 h, followed by incubation of the cells at 37°C under
humidified atmosphere until additional image collection.
Transduction efficiencies of peptides were determined by
counting the numbers of cells with or without nucleolar
signals and internalization efficiencies of proteins by count-
ing cells with or without intracellular vesicles directly on the
fluorescence microscope in three fields of view, each contain-
ing 50 cells, or by a similar analysis performed on low
magnification overview images. Cell viability after peptide or
protein application was monitored by their ability to undergo
complete mitotic cell cycles and grow to confluency over a
period of 24 to 48 h. Membrane integrity was ascertained by
the Trypan blue exclusion assay. Cytochalasin D (Sigma, St.
Louis, MO, USA) was dissolved to 10 mg/ml in DMSO and
sodium azide (Sigma) to 10% (w/v) in ddH2O. Both stock
solutions were adjusted to 1PBS at the indicated final
concentrations (Fig. 2) before being applied to living cells.
The potassium buffer (Fig. 2) corresponds to PBS with all
sodium-containing compounds substituted for the equivalent
potassium-containing analogues. C2C12 mouse myoblasts
were preincubated for the indicated times (t in Fig. 2) with
different inhibitors in PBS or the potassium buffer. The
TAT-containing peptide and protein were applied directly to
the cells and mixed gently. For the potassium phosphate
buffer experiment, the protein was dialyzed against the
potassium buffer prior to application. After 10 min the cells
were washed twice and incubated for another 20–60 min (as
annotated in the phase contrast images for each treatment)
in DMEM medium, except for the potassium buffer treatment
where the medium was replaced by potassium buffer. Trans-
duction thresholds were determined by incubating C2C12
mouse myoblasts with CPP-containing peptides in medium at
different concentrations ranging from 0.1 to 500 M for 1 h.
The lowest peptide concentration leading to accumulation
TABLE 1. List of peptides and their uptake efficienciesa
Peptide and label aa sequence kDa pI
Peptide
concentration
Transduction
efficiency
Transduction
threshold
R-PTD4 YARAARQARA 1.13 11.71 10 m 0% 400 m
F(Ahx)-TAT YGRKKRRQRRR 1.93 12.31 1 m 90% 1 m
R-TAT (ri) rrrqrrkkrg 1.81 13.3 1 m 90% 1 m
bt-NLS SGYGPKKKRKVGG 1.93 10.68 10 m 0% n.a.
Lig1-PBD-F MQRDIMSFFQPTKEFKAKK 2.80 10.00 10 m 0% n.a.
R-TAT-HA2(ri) rrrqrrkkrg-gdimgewgneifgaiagflg 3.24 11.71 10 m 80% 0.1 m
F(Ahx)-TAT-Control YGRKKRRQRRR-TALDASALQTE 3.05 11.72 20 m 70% n.d.
R-TAT(ri)-p21-PBD rrrqrrkkrg-aaA-
GRKRRQTSMTDFYHSKRRLIFSa
4.96 12.43 20 m 90% 7.5 m
TAT-Lig1-PBD-R YGRKKRRQRRR-GGG-
MQRSIMSFFQPTKEGKAKK
4.38 12.14 10 m 80% 5 m
aR, TAMRA/rhodamine; F, FITC; Ahx, aminohexanoic acid; capital letters, L-amino acids; small letters, D-amino acids; ri, retro inverso; n.a., not
applicable; n.d., not determined.
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inside nucleoli was considered to be the transduction thresh-
old from which transduction occurs.
Microinjection and bead loading
Intracellular delivery of the Lig1-PBD-F peptide was accom-
plished by bead loading using 100 m silica beads. The beads
were washed first in ethanol, then in growth medium, and
finally pipetted onto the medium of cells grown in a self-made
culture dish with a coverglass bottom. The Lig1-PBD-F solu-
tion was added subsequently and the chamber was shaken a
few times. The beads were removed for microscopic observa-
tion of the labeled cells. Microinjection of the NLS-biotin
peptide complexed with streptavidin-Cy5 was performed us-
ing an Eppendorf microinjection and micromanipulation
system mounted on a Zeiss LSM510Meta inverted microscope
setup. The parameters for cytoplasmic microinjection were
set to 0.7 s injection time with 15 fPa injection pressure.
Cre recombinase double reporter assay
3T3-FDR1.2 cells (27) were cultured to 50% confluency in
6-well plates. The pFDR reporter gene construct allows detec-
tion of bioactive Cre recombinase by switching from consti-
tutive HcRed to GFP expression (Fig. 1 D). For transduction,
the cells were incubated with 2 M TAT-Cre protein diluted
into a 50:50 mixture of PBS and DMEM for 3 h, washed once
with PBS, then cultivated in normal medium. Fluorescence
microscopy was performed 24 h after transduction.
Live cell assay for cell cycle inhibition
C2C12 mouse myoblasts stably expressing GFP-PCNA (26)
were synchronized by mitotic shake-off and plated onto 8-well
LabTek coverglass chambers. After becoming adherent, the
number of cells that entered S-phase was counted and cells
Figure 1. Differences in subcellular distribution of proteins
and peptides fused to TAT after internalization in living cells.
TAT-Cre and TAT-HA2 were applied to the cells for 10 min,
followed by a washing step and change to growth medium
without the protein/peptide. Confocal microscopy of live
cells was started immediately and cells were returned to the
incubator between time points, which are indicated. Repre-
sentative images and time points are shown. A) Uptake of 2.5
M TAT fusion protein TAT-Cre (rhodamine-labeled) in
living mouse myoblasts. After application of TAT-Cre, inter-
nalization started throughout the plasma membrane in the
form of vesicles. The next day vesicles containing fluorescent
TAT-Cre accumulated in the cytoplasm. B) Diffused and
vesicular distribution of the TAT-HA2 peptide (rhodamine-
labeled, 5 M final concentration) soon and a long time after
application. C) Simultaneous application of 2.5 M TAT-Cre
protein (Alexa Fluor 633-labeled; 1.7 label to protein ratio)
and 5 M TAT-HA2 peptide (rhodamine-labeled) on living
cells resulted in prominent vesicular uptake of the protein
into the cytoplasm, whereas the TAT-HA2 peptide also dis-
plays a diffuse distribution in cytoplasm and nucleoplasm,
and accumulation in nucleoli. The fluorescent fusions colo-
calize in the majority of vesicles. Nucleoli are indicated by
arrowheads. Scale bar  10 m. D) Analysis of Cre recombi-
nase activity in TAT-Cre-treated reporter cells. 3T3-FDR1.2
reporter cells contain a loxP-flanked HcRed gene, followed by
a nonexpressed GFP gene. TAT-Cre treatment induces re-
combination of the reporter gene, resulting in a shift from
red to green fluorescence (scheme). Untreated control cells
do not exhibit green fluorescence. Cells were incubated with
2 M TAT-Cre for 3 h and analyzed by fluorescence micros-
copy 24 h later. Scale bar  50 m.
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were transduced with fluorescently labeled TAT-p21-PBD,
TAT-Lig1-PBD, and the unspecific TAT control peptide at 20
M concentration in PBS. 10 min later the solutions were
aspirated, and the cells were washed twice with medium and
kept in growth medium thereafter. The percentage of cells in
S-phase was determined directly from the subnuclear focal
pattern of GFP-PCNA by counting 10 fields of view at the
indicated time points for each peptide. Data of three inde-
pendent experiments were evaluated.
Microscopy, image acquisition, and analysis
Live cell microscopy was performed with a Zeiss LSM 510
Meta confocal setup mounted on an Axiovert 200 M inverted
microscope using a 63  phase contrast plan apochromat oil
objective NA1.4. For all acquisition settings, the main beam
splitter was HFT UV/488/543/633. The parameters specific
for each fluorochrome were: FITC, excited at 488 nm light,
detected with a 500-530 nm bandpass (BP) filter; TAMRA or
rhodamine excited with 543 nm, detected with 565-615 BP
and Cy5 or Alexa633 excited at 633 nm and detected with a
650 nm longpass filter.
Image acquisition was done sequentially to minimize cross-
talk between the fluorophores. Phase contrast images were
recorded simultaneously with FITC/GFP fluorescence in the
transmission channel. Fluorescence recovery after bleaching
(FRAP) experiments (Fig. 3) was performed on a Zeiss LSM
5 Live confocal microscope with 100% power of a 75 mW
DPSS 532 nm laser. The bleaching was performed in a stripe
for 0.44 s, followed by a time series with 400 images recorded
at 20 frames per second. Using the Zeiss LSM 510 software
version 3.2, the mean fluorescence intensity in the bleached
nucleoli and cytoplasm was determined over the time course
and averaged for 10 cells. Fluorescence intensity was normal-
ized to zero at the start of recovery and to one at equilibrium
to directly compare the curves for both subcellular regions.
The FRAP curves were generated with Origin 7 software.
RESULTS
Direct comparison of TAT-mediated peptide and
protein uptake in living cells
To study the characteristics of TAT-mediated introduc-
tion of globular proteins into living cells, the rhoda-
mine-labeled fusion protein R-TAT-Cre consisting of
the CPP TAT moiety and the site-specific Cre recombi-
nase of bacteriophage P1 (23) was applied onto C2C12
mouse myoblasts. As soon as the fluorescent solution
was washed off (after 10 min of incubation), fluores-
cent vesicles emerging from the intracellular side of the
plasma membrane were detectable by confocal micros-
copy (Fig. 2A, upper panel). After additional overnight
cultivation, all cells showed a substantial amount of
internalized protein stored in vesicles, but release of
the protein from the vesicles could not be detected by
this method (Fig. 2A, lower panel). Other recombinant
proteins showed identical trapping in cytoplasmic vesi-
cles (data not shown) independent of 1) which short
basic CPP they were fused to, 2) the fluorophore they
were conjugated to, and 3) their known subcellular
localization. For instance the nuclear protein His-PTD4-
PCNA (Atto 633-labeled) as well as the nuclear and
cytoplasmic protein His-TAT-MK2 (Cy5-labeled) could
only be detected inside cytoplasmic vesicles after inter-
nalization, and refused to localize at their targets
during an observation period of up to 48 h. Proteins
lacking a transduction domain could also be internal-
ized in the same manner but the efficiency of internal-
ization was shown to be much lower (23). TAT-Cre was
also tested at concentrations between 0.1 and 10 M with
no difference in the uptake behavior (data not shown).
A recent report proposed that the uptake of proteins
fused to TAT belongs to the class of rapid lipid raft-
mediated macropinocytosis and that the protein could
be released from macropinosomes by cotransduction of
the fusogenic peptide TAT-HA2 (17). We therefore
used TAT-HA2 (Table 1) to 1) work out the character-
istics of TAT-mediated peptide (50 amino acids; ref.
28) transduction and 2) try and liberate the TAT fusion
protein trapped into vesicles. Compared to the inter-
nalization of proteins, uptake of the TAT-HA2 peptide
occurred on a quite different time scale and also
showed dissimilarities in its subcellular localization.
During the first 3–5 min of incubation with the peptide
Figure 2. Different mode of uptake of proteins and peptides
fused to TAT in living cells. Simultaneous incubation of living
mouse myoblasts with 2.5 M TAT-Cre and 5 M TAT-HA2
was as shown in Fig. 2C. Confocal images show representative
snapshots at the indicated time points in the phase contrast
image. The numbers in the images reflect the overall percent-
age of cells showing intracellular vesicles for the TAT fusion
protein and the nucleolar signal for the TAT-HA2 peptide.
Substances at the concentrations indicated were preincu-
bated with the cells before addition of the TAT fusions for the
indicated time (t) and kept in the culture medium or buffer
throughout the experiment. A) Control C2C12 mouse myo-
blasts treated with the TAT-containing protein and peptide
mixture showed internalization in 100% and 90% of the cells,
respectively. B) Preincubation of the cells with 100 M of the
F-actin elongation inhibitor cytochalasin D blocked protein
uptake completely, but the peptide still transduced into the
cells. C) ATP depletion with 10 mM sodium azide reduced
entry of both species, albeit a third of the cells still took up the
peptide. D) 5 min incubation of the cells in sodium-deficient,
iso-osmolar PBS strongly reduced peptide transduction and
blocked protein uptake. tpreincubation time, scale bar10m.
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solution, fluorescence signals had already become visi-
ble in the nucleoli; after exchange of the fluorescent
solution against medium, a diffuse distribution
throughout the cell, with accumulation in the nucleoli,
could be detected (Fig. 2B, upper panel, arrowheads;
see also supplemental movie) in addition to a few
developing vesicles adjacent to the membranes. Over
longer periods of observation, the diffuse population of
the peptide in the cytoplasm, nucleoplasm, and nucle-
oli became markedly weaker, and in most of the cells
vanished overnight. In stark contrast, the peptide-
containing cytoplasmic vesicles seemed to be unaf-
fected and their number increased overnight, resulting
in a vesicular ring concentrated around the nucleus
(Fig. 2B, lower panel). The diffusely distributed frac-
tion of the transduced peptide was detected in 90%
of the cells (Table 1) whereas after overnight incuba-
tion all cells showed peptide uptake into vesicles. The
loss of diffusely distributed fluorescent peptide in the
cytoplasm and nuclei overnight cannot be just a conse-
quence of instability of the fluorophore/peptide in the
cell since 1) a rhodamine-labeled antibody (Ab) per-
sisted inside cells for  24 h (data not shown) and 2)
the fluorescently labeled peptide TAT-HA2 is com-
posed of protease-resistant D-amino acids.
To directly compare the mode and kinetics of uptake
of TAT peptides and globular proteins fused to TAT
into cells and determine whether TAT-HA2 could drive
release of the protein stored in macropinosomes, the
Alexa Fluor 633-labeled TAT-Cre protein and the rho-
damine-labeled TAT-HA2 peptide were applied simul-
taneously to living cells. The short- and long-term
uptake characteristics for both species remained mostly
unchanged (Fig. 2C). Detectable TAT fusion protein
was restricted to cytoplasmic vesicles whereas the TAT-
HA2 peptide, besides being trapped into vesicles, was
rapidly distributed throughout the entire cell. TAT-
HA2 and TAT-Cre colocalized in the majority of cyto-
plasmic vesicles (Fig. 2C, yellow color in merged images).
Although both species intermingled substantially, a re-
lease of the TAT fusion protein from macropinosomes
and entry into the nucleus could not be detected by this
method. To test the presence of a low level of TAT-Cre
within the nucleus, we used a far more sensitive reporter
assay based on Cre-mediated recombination. Since site-
specific recombination provides a stable and unambigu-
Figure 3. Subcellular localization and intracellular
mobility of TAT peptides. A) FITC- and rhoda-
mine-labeled TAT peptides (F-TAT 1 M, R-TAT 1
M) applied to mouse myoblasts were rapidly
internalized and accumulated in the nucleoli
(white arrowheads). The fluorescent label has no
influence on peptide distribution. B) In contrast,
the non-TAT-containing peptide Lig1-PBD (FITC-
labeled) delivered by bead loading showed a ho-
mogeneous distribution in nucleus and cytoplasm
whereas the addition of the TAT sequence in
TAT-Lig1-PBD (rhodamine-labeled) again led to
nucleolar accumulation. C) Mouse myoblasts were
transduced with 20 M of TAMRA-labeled TAT-
p21-PBD for 10 min, washed, then incubated in
growth medium. The FRAP experiment was per-
formed by bleaching a stripe (ba) encompassing
one nucleolus and a part of the cytoplasm as seen
in the prebleach image. After bleaching, a time
series was recorded at a time resolution of 20
frames/second over 20 s. False color images de-
picting the fluorescence intensity distribution as
color map (red denotes highest intensity) of one
photobleached cell are shown. The black arrow-
heads point to the bleached nucleolus and cyto-
plasmic regions in the first image after the bleach-
ing process (postbleach) and after full fluorescence
recovery (postrecovery). D) Curves represent the
normalized mean fluorescence intensity of the
fluorescence recovery in the nucleoli and cyto-
plasm averaged for 10 measurements. Albeit accu-
mulated in the nucleoli, the TAT-p21-PBD peptide
was highly mobile with a half-time of recovery of
1.98  0.097 s. In the cytoplasm, the half-time of
recovery is faster (1.170.013 s). Scale bar 5 m.
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ous read-out for protein transduction (23, 29–31), we
used a NIH-3T3 Cre reporter cell line containing a stably
integrated gene cassette consisting of a constitutively
expressed HcRed gene, followed by a nonexpressed GFP
gene. Upon Cre recombinase-mediated site-specific re-
combination, excision of the HcRed gene takes place with
concomitant expression of the GFP gene (Fig. 2D; L.
Nolden and F. Edenhofer, personal communication).
Using this more sensitive assay, several cells within the
culture exhibited GFP expression upon incubation with
TAT-Cre overnight (Fig 2D). These data indicate that a
low level of TAT-Cre below the detection range of confo-
cal microscopy was biologically available and could exert
its enzymatic activity.
Different mode of entry of proteins and peptides
fused to TAT in living cells
To test whether TAT fusion proteins and TAT-contain-
ing peptides use different routes of entry and can, as a
result, be affected differently in their uptake by treat-
ment with inhibitors, mouse myoblasts were preincu-
bated with inhibitors or buffers, followed by simulta-
neous application of TAT-Cre and TAT-HA2 (as in Fig.
2C). Subsequently, cells were washed twice and kept in
the indicated buffer or medium with constant inhibitor
concentration throughout the entire experiment.
Endocytosis requires the formation and migration of
vesicles along the cytoskeleton. Therefore, constant
concentrations of the F-actin depolymerizing drug cy-
tochalasin D should delay or block internalization of
the endocytosed TAT constructs at the membrane level
(32, 33). After cytochalasin D treatment, the TAT
fusion protein and TAT-HA2 showed strong membrane
association, but the diffused fraction of the TAT-HA2
peptide was still detectable inside the cells in nucleoli,
albeit the transduction efficiency (as scored by the
percentage of cells showing intracellular fluorescence)
was reduced to half. All vesicular uptake was abolished
(Fig. 1B). Despite the round appearance of the cells
indicative of the disruptive effect of the drug on the
actin cytoskeleton, the membrane integrity was not
decreased as assayed by Trypan blue exclusion (data
not shown).
Endocytosis is an energy-consuming process and is
therefore blocked by the metabolic inhibitor sodium
azide. Accordingly, treatment with 10 mM sodium azide
resulted in almost complete inhibition of the internal-
ization of the TAT fusion protein (scored by the
absence of intracellular vesicles), whereas the diffused
population of the TAT-HA2 was still detected in about
one-third of the cells (Fig. 1C).
A recent report proposed that synthetic guani-
dinium-rich molecules traverse biological membranes
by formation of lipophilic ion pairs between the guani-
dinium groups and abundant phosphate, sulfate, and
carboxylate functions on the membrane surface, allow-
ing cell entry by diffusion along the membrane poten-
tial and subsequent release of the positively charged
CPP into the cytoplasm (5, 10). The directionality of
this process is achieved by the membrane potential and
the latter can be efficiently reduced by addition of an
isotonic buffer with potassium concentrations equiva-
lent to those found intracellularly (34, 35). We tested
this hypothesis by preincubating the cells for 5 min with
potassium-enriched, isotonic PBS and adding the pep-
tide/protein solution in the same buffer. This treat-
ment abolished the vesicular internalization of both
TAT species. Furthermore, it resulted in strong inhibi-
tion of the uptake mode responsible for the intracellu-
larly diffused fraction of TAT-HA2 (Fig. 1D). In sum-
mary, in contrast to TAT fused to globular proteins,
TAT fusion peptides transduce into cells by a different
and very rapid mode that is dependent on the plasma
membrane potential. We therefore further investigated
the transduction potential and biological applicability
of TAT fusion peptides.
Uptake and intracellular availability of TAT-
containing peptides
In the first minutes of incubation, the TAT-HA2 pep-
tide flooded into living cells and accumulated in nucle-
oli; later it was also localized in cytoplasmic vesicles
(Fig. 2B, C). To test whether these uptake characteris-
tics were influenced by the HA2 moiety or instead were
a general feature of TAT-mediated peptide internaliza-
tion, several TAT peptide complexes were analyzed for
their transduction behavior and intracellular distribu-
tion after internalization. Table 1 summarizes the pep-
tides and their respective transduction efficiencies de-
termined, as earlier, by counting the percentage of cells
showing intracellular diffused fluorescence upon 10
min incubation with the indicated peptide concentra-
tions and analyzed by confocal microscopy of living
cells. The most efficient peptide was the 11 amino acid
TAT peptide covalently linked to either a FITC (F) or a
rhodamine (R) fluorophore, which was transduced
into 90% of all cells at 1 M concentration within the
first 3 min of observation. The fluorescent signal ap-
peared diffused in the cytoplasm and nucleoplasm and
showed strong accumulation of the labeled peptide in
nucleoli (Fig. 3A). To test whether the nucleoli accu-
mulation was due to the TAT moiety, we used non-TAT-
containing peptides (Lig1-PBD in Fig. 3B and NLS-
biotin peptide complexed with streptavidin-Cy5 [data
not shown]) and delivered them into the cytoplasm
using either bead loading or microinjection. Both
peptides were stable intracellularly and able to enter
the nucleus, but were not accumulated in the nucleoli
(Fig. 3B and data not shown). The same Lig1-PBD
peptide fused to TAT (TAT-Lig1-PBD) transduced into
cells and again showed nucleolar localization (Fig 3B),
indicating that the nucleolar localization is dependent
on the TAT characteristics. We investigated other re-
ported CPPs—namely, PTD4 (36)—which showed only
detectable uptake (Table 1) at very high concentrations
(400 M). This suggests that nucleolar association is
mediated by the high concentration of positive charges
due to arginine and lysine residues.
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Since TAT fusion peptides exhibited accumulation
in the nucleolar compartment whereas the cargo pep-
tide or protein may perform its function in a different
subcellular compartment, we tested the overall bioavail-
ability of cargoes connected to TAT by directly measur-
ing the mobility in living cells using fluorescence
photobleaching analysis. Cells transduced with a TAT-
containing peptide (TAT-p21-PBD, Table 1) were im-
aged, and a rectangular region was selected to include
one nucleolus and a stripe of cytoplasm. The peptide
fluorescence in this stripe was subsequently photo-
bleached with a high intensity laser beam, and redistri-
bution of fluorescence was measured over time until
full equilibrium was regained. The peptide intensity
distribution before (prebleach), immediately after
(postbleach), and at full recovery (postrecovery) is
shown in representative false color images in Fig. 3C.
The recovery of fluorescence in the bleached region
indicates the mobility of peptides from unbleached
cellular regions into the bleached area, and therefore is
a direct measure of peptide mobility in the living cells.
The kinetics of recovery (Fig. 3D) indicated that the
peptides, although concentrated in the nucleoli, were
mobile with a half-time of recovery of 1.98 and 1.17 s in
the nucleoli and cytoplasm respectively. This kinetic
difference between nucleoli and cytoplasm suggests
binding of the TAT-PBD-p21 within the nucleoli. The
high intracellular mobility of the TAT peptides raises
the possibility of achieving successful biological effects
despite the unfavorable subcellular accumulation.
Cell cycle inhibition by transduced PCNA binding
peptides
To directly test whether the transduced TAT peptides
in view of their high mobility could be effective in
reaching their intracellular targets and exerting a bio-
logical effect, we used fusions of TAT with two different
peptides comprising the proliferating cell nuclear anti-
gen (PCNA) binding domain (PBD) of p21WAF/CIP and
DNA Ligase 1 (Table 1). These two peptides have been
shown to bind to PCNA (20, 22). We reasoned that
since several PCNA interacting proteins required for
S-phase progression utilize the same binding interface
on the surface of PCNA, competition for binding
should ensue and inhibition of cell cycle progression
would be expected. Mouse myoblasts stably expressing
the cell cycle progression marker GFP-PCNA (26) were
synchronized in the G1 phase of the cell cycle by mitotic
shake off. After becoming adherent, the G1 synchro-
nized cells were incubated for 10 min with either of
these two TAT-PBD peptides as well as a control TAT
fusion peptide (37). After washing, peptide uptake
efficiency was controlled for by counting the percent-
age of cells showing intracellular peptide fluorescent
signal as before. At different times thereafter, the ability
of cells to progress into S-phase was determined by
counting the number of S-phase cells scored by the
characteristic focal GFP-PCNA subnuclear distribution
pattern (see green subnuclear signal in the examples
shown in images in Fig. 4 and ref. 26) directly under
the fluorescent microscope. The results of this live cell
cycle assay are summarized in Fig. 4. While 70% control
cells and cells incubated with TAT control peptide were
in S-phase 6 h after peptide incubation, only 40%
TAT-PBD-treated cells entered S-phase within the same
time. This inhibition is even more noteworthy if one
considers that the peptides were incubated with the
cells for only 10 min, after which they were washed
away. Toxic effects were not detected by either the
Trypan blue exclusion test or by changes in cell mor-
phology. These data demonstrate that both TAT-PBD
peptides were bioactive and capable of decelerating cell
cycle progression despite the short incubation time and
their accumulation in the nucleolus (see also red
fluorescence peptide signal in the images in Fig. 4).
DISCUSSION
Although it is generally agreed that the first step in the
internalization process of CPP-mediated transduction is
the strong ionic interaction between the cationic CPP
and negatively charged plasma membrane constituents
(6, 15, 38), subsequent steps for CPP-induced cell entry
differ in the recent literature and range from endocytic
(15, 19) to a rapid and energy-independent process (6,
12). Most studies so far have used fixed cell analysis,
which has been shown to result in artificial internaliza-
Figure 4. Effect of transduced PBD-containing TAT peptides
on cell cycle progression. After mitotic shake-off, GFP-PCNA-
expressing mouse myoblasts were allowed to attach and were
incubated with different peptides (20 M) for 10 min,
followed by washing and a change to growth medium. The
percentage of S-phase cells was determined at various time
points by the subnuclear replication foci pattern of GFP-
PCNA. Representative confocal microscopy images of mouse
myoblasts transduced with the TAMRA-labeled TAT-p21-PBD
peptide (red) show either a diffused distribution of GFP-
PCNA (green) in the nucleus, indicating G1- or G2-phase or
focal GFP-PCNA labeling of replication foci during early, mid
and late S-phase. Data points of three independent experi-
ments were fitted logarithmically. Control cells, pink squares;
TAT control peptide, green spheres; TAT-Lig1-PBD peptide,
yellow triangles; and TAT-p21-PBD peptide, blue diamonds.
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tion of CPP-containing constructs. In this work we used
exclusively live cell analysis and tested whether the
mode of entry is dependent on the cargo connected to
the CPP and what the fate and bioavailability of the
transduced peptides is.
By directly comparing the uptake of TAT connected
to peptides and globular proteins into living cells, we
found that the mechanism of entry depends on the size
of the cargo fused to TAT. The major fraction of
TAT-containing proteins or peptides was taken up into
living cells by distinct modes, with the proteins mostly
ending up in cytoplasmic vesicles and the peptides
distributing throughout the cell and accumulating in
the nucleoli (Fig. 2).
The vesicular storage inside the cytoplasm was a
general feature of different recombinant proteins fused
to a CPP and was independent of protein function, CPP
(data not shown), and fluorescent label (Fig. 2A, C). A
small population of TAT fusion protein reached the
cytosol and nucleus via a different pathway or leaked
out from the vesicles, as we detected Cre recombination
activity in the nuclei using an extremely sensitive and
unambiguous reporter assay for TAT-Cre. This fraction
of bioavailable TAT-Cre was not high enough, however,
to be detected by direct confocal microscopy of the
labeled TAT-Cre protein whereas the population
trapped in vesicles was easily detectable. Furthermore,
cotransduction of the fusogenic peptide TAT-HA2 (17)
did not substantially increase the release of the differ-
ent TAT fusion proteins from cytoplasmic vesicles as
assayed by live cell confocal microscopy (Fig. 2C).
Unlike CPP fusion proteins, TAT fusion peptides
could be seen diffusely distributed throughout the cell
and concentrated in nucleoli (Fig. 2 and Table 1).
Uptake occurred rapidly within 3–5 min after applica-
tion of the TAT construct on living cells. Upon longer
observation times, the diffusively distributed fraction of
the TAT peptides disappeared and cytoplasmic vesicles
containing the peptides became apparent, suggesting
that the peptides were either redistributed or under-
went an additional vesicular uptake.
In addition to different uptake kinetics and localiza-
tion after internalization of proteins and peptides fused
to CPPs, inhibitors of endocytosis efficiently blocked
the vesicular uptake of both species while having a
minor effect on the TAT peptide transduction (Fig. 1),
indicating that the latter does not depend on vesicle
formation and/or traffic along the cytoskeleton. In
fact, the only treatment capable of blocking not only
the vesicular uptake of CPP-containing proteins and
peptides, but also the rapid translocation of TAT
peptides leading to a diffuse intracellular distribution,
was incubation of the cells with a sodium-deficient iso-
osmolar buffer (Fig. 1), indicating an alternative distinct
cellular entry pathway based on membrane potential.
To understand which properties of cargoes fused to
TAT allow the rapid membrane transduction, we com-
pared the cellular entry of various TAT-containing
constructs (Table 1). Fluorescently labeled TAT had
already appeared inside the nucleoli of 90% of living
cells at a concentration of 1 M. The uptake efficien-
cies were decreased for TAT fusion peptides. By com-
parison, differences in the overall pI of TAT due to the
addition of a cargo resulted only in minor effects on
transduction efficiencies, whereas the amino acid com-
position of the CPP itself seemed to be more important.
For instance, PTD4 containing three arginines trans-
duced into living cells only at concentrations of 400
M whereas TAT peptides with eight positive charges
(six of them arginines) transduced quite efficiently in a
range of 0.1–10 M (Table 1). Most transduction
efficiencies were tested for the CPP TAT at concentra-
tions of 10 M and resulted in comparable high
percentages of transduced cells. However, differences
for individual peptides were found to be dependent on
the concentration used; for instance, the TAT-HA2
peptide was already diffusively distributed inside cells at
a concentration of 0.1 M, whereas for TAT-p21-PBD
uptake was restricted to endocytosis below a concentra-
tion of 7.5 M, and only above 7.5 M did the peptide
enter rapidly and appear in the nucleoli (Table 1). The
existence of such a concentration threshold can also
explain conflicting reports assigning CPP-mediated
membrane translocation to endocytosis (19, 39) or to
an unknown mechanism, resulting in a homogeneous
distribution in the whole cell (7). Another parameter
that should be taken into account is the stability of the
transducible peptides themselves since it was shown
that CPP peptides could be degraded by extra- and
intracellular proteases (40). However, we have not
observed dramatic differences in the transduction effi-
ciencies between TAT-HA2 consisting of D-amino acids
and other potentially degradable peptides consisting of
L-amino acids at comparable concentrations (Table 1).
The TAT-containing peptides exhibited a strong
affinity to the nucleolar compartment, with a lower
steady-state concentration in the rest of the cell. Alter-
natively, their enrichment in the nucleoli could be due
to a higher viscosity in this subnuclear compartment.
However, our fluorescence photobleaching results
(Fig. 3) revealed that despite their accumulation in the
nucleolus, TAT peptides were mobile and able to reach
their targets in the nucleus and cytoplasm. Measure-
ments of protein dynamics in the cell nucleus showed
half recovery times of 3 s, and so the peptide dynam-
ics measured for TAT-p21-PBD in nucleoli and cyto-
plasm (2 s) can be considered to be similar (41). As a
direct test of their bioavailability, we investigated the
cell cycle effects of TAT fusion to PBD peptides. PCNA
forms a sliding clamp around DNA and plays a central
role in DNA replication (reviewed in ref. 42). Multiple
factors required for DNA synthesis and cell cycle pro-
gression bind PCNA (20) via a consensus PBD Qxx(M/
L/I)xxF(Y/F) (43). We fused two different PBD pep-
tides to TAT and tested their effect on cell cycle
progression using a novel live cell cycle progression
assay. In fact, incubation of the cells with both peptides
for as little as 10 min substantially inhibited cell cycle
progression (Fig. 4). These data clearly showed that,
albeit accumulated in nucleoli, the peptides are fully
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able to reach their biological targets elsewhere in the
cell and exert a biological effect.
In summary, our data indicate that the translocation
of TAT-containing constructs through biomembranes
takes place with high efficiency, but at least two func-
tionally distinct mechanisms are involved. Complexes
with a globular structure like TAT fused to Q-dots (Fig.
5) or TAT fusion proteins seem to be mostly restricted
in their uptake to an endocytic mechanism that is
associated with trapping in cytoplasmic vesicles. A mi-
nor fraction of internalized TAT fusion proteins, unde-
tectable by confocal microscopy but sufficient to induce
enzymatic activity, seems to escape vesicles in the cells.
Besides being endocytosed, TAT-containing peptides
have the ability to enter living cells by a different
pathway. The exact underlying mechanism for this
rapid translocation is unknown and could be explained
by transient membrane perturbations (14) or lipophilic
ion pair diffusion along the membrane potential (5,
10). In general, increasing positive charge of the CPP
itself and decreasing size of the cargo fused to the CPP
allows rapid internalization to occur in addition to the
slow process of adsorptive endocytosis (Fig. 5). The
latter implies that CPP-mediated uptake of globular
proteins is restricted to cell types capable of endocyto-
sis. CPP-containing peptides can rapidly transduce all
cell types tested and, despite their high affinity to the
nucleolus, transduced peptides have access to all intra-
cellular compartments, thus making them an ideal tool
for therapeutic applications.
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Abstract: Cell penetrating peptides (CPPs) are useful tools to deliver low-molecular-weight cargoes into cells; however, their mode
of uptake is still controversial. The most efficient CPPs belong to the group of arginine-rich peptides, but a systematic assessment
of their potential toxicity is lacking. In this study we combined data on the membrane translocation abilities of oligo-arginines in
living cells as a function of their chain length, concentration, stability and toxicity. Using confocal microscopy analysis of living
cells we evaluated the transduction frequency of the L-isoforms of oligo-arginines and lysines and then monitored their associated
toxicity by concomitant addition of propidium iodide. Whereas lysines showed virtually no transduction, the transduction ability
of arginines increased with the number of consecutive residues and the peptide concentration, with L-R9 and L-R10 performing
overall best. We further compared the L- and D-R9 isomers and found that the D-isoform always showed a higher transduction as
compared to the L-counterpart in all cell types. Notably, the transduction difference between D- and L-forms was highly variable
between cell types, emphasizing the need for protease-resistant peptides as vectors for drug delivery. Real-time kinetic analysis
of the D- and L-isomers applied simultaneously to the cells revealed a much faster transduction for the D-variant. The latter
underlies the fact that the isomers do not mix, and penetration of one peptide does not perturb the membrane in a way that
gives access to the other peptide. Finally, we performed short- and long-term cell viability and cell cycle progression analyses
with the protease-resistant D-R9. Altogether, our results identified concentration windows with low toxicity and high transduction
efficiency, resulting in fully bioavailable intracellular peptides. Copyright  2007 European Peptide Society and John Wiley &
Sons, Ltd.
Supplementary electronic material for this paper is available in Wiley InterScience at http://www.interscience.wiley.com/jpages/
1075-2617/suppmat/
Keywords: arginine-rich peptides; cell cycle; cell penetrating peptides; cell viability; membrane integrity; membrane
translocation; oligo-lysines; oligo-arginines
INTRODUCTION
Cell penetrating peptides (CPPs) possess the unique
ability to shuttle linked cargoes such as drugs [1], pep-
tides [2–6], proteins [7–9], peptide nucleic acids (PNAs)
[10–12] and nanoparticles [13,14] across the plasma
membrane which is otherwise virtually impermeable
for hydrophilic compounds. CPPs can be subdivided
into two major groups: model amphiphilic peptides
(MAPs) [15,16] developed on the basis of spatial sep-
aration of positively charged and hydrophobic amino
acid residues; and arginine-rich peptides (R-RPs) delin-
eated from natively occurring minimal transduction
domains of proteins, e.g. TAT from HIV-1 TAT pro-
tein [7,17–19] and penetratin from the homeobox of
antennapedia protein [20–22]. However, plasma mem-
brane translocation of MAPs structurally requires at
*Correspondence to: M. Cristina Cardoso, Max Delbrueck Center for
Molecular Medicine, Robert-Roessle-Str. 10, D-13125 Berlin, Germany;
e-mail: cardoso@mdc-berlin.de
‡ This article is part of the Special Issue of the Journal of Peptide Science
entitled ‘‘2nd workshop on biophysics of membrane-active peptides’’.
least four helical turns but does not depend on the
positively charged amino acid residues [15], whereas
the transduction ability of R-RPs depends on a mini-
mum number of arginines [23,24], suggesting that the
entry mechanisms of both types of CPPs are unrelated.
The translocation ability of R-RPs does not seem to
be solely a matter of charge, but has been proposed
to reside in the guanidinium group of the arginine
itself [25]. The formation of lipophilic ion pairs with
abundant sulfate, phosphate or carboxylate groups of
membrane constituents via the two amino functions
of arginine provides a mechanistic framework for the
translocation of a highly charged compound through
the plasma membrane [26]. CPP-mediated delivery of
cargoes into the cytoplasm can be achieved by at least
two independent mechanisms: (i) adsorptive endocyto-
sis and subsequent release of the enclosed compounds
from endosomes or lysosomes [7,27–29]; and (ii) rapid
crossing of the membrane by a seemingly energy-
independent, not-well-understood mechanism referred
to as transduction [5,30–32]. Whereas R-RPs coupled
Copyright  2007 European Peptide Society and John Wiley & Sons, Ltd.
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to high-molecular-weight cargoes are restricted to the
endocytic mode of uptake [5,33,34], R-RPs themselves
or interconnected to low-molecular-weight cargoes have
both options. Above a certain concentration (trans-
duction threshold), which varies between 1 and 10 µM
depending on the cell type and the size of the cargo [5],
R-RPs directly translocate across the plasma membrane
into the cell. Several live-cell studies have shown that
functional peptides attached to R-RPs exert biological
effects after the transduction event [2–6]. Importantly,
R-RP-mediated transduction circumvents the inefficient
step of release from cytoplasmic vesicles after the endo-
cytic uptake. However, a systematic evaluation of the
cell penetration ability, in combination with an assess-
ment of potential short- and long-term toxic effects of
R-RPs, is lacking. In this study, we combined data on
the membrane translocation abilities of oligo-arginines
in living cells as a function of their chain length, con-
centration, stability and toxicity.
MATERIAL AND METHODS
Peptides
Consecutive arginines (5–12) and lysines (5–12) as L-isomers
and TAMRA-R9 and Fluos-R10 also as D-isomers were
synthesized and coupled directly to fluorescein (Fluos) or 5,6-
TAMRA at the N-terminus by Peptide Specialty Laboratories
GmbH (Heidelberg, Germany). The peptides were purified
by HPLC and their appropriate masses confirmed by mass
spectrometry. The isoelectric points (pI ) were estimated using
the freeware tool ProtParam.
Cells
All cell types were cultured in Dulbecco’s modified Eagle
medium (DMEM) with fetal calf serum (FCS) (Life Technologies,
Inc., USA) at the following concentrations: C2C12 mouse
myoblasts 20%, human HeLa cells 10%, MDCKII dog epithelial
kidney cells 10% and BJ-hTERT human fibroblasts 10%.
Primary cultures from male WKY rats aged 3 months were
performed as described previously [35].
Transduction Experiments
As peptide transduction is influenced by the peptide-to-
cell ratio [36], for all transduction experiments µ-Slide
VI observation chambers were used (Ibidi, Martinsried,
Germany), which guarantee a defined and equal liquid volume
above the cells throughout the entire observation channel.
The respective cell types were seeded at 70% confluency into
the observation chambers and incubated overnight at 37 °C
at 5% CO2. Special care was taken that cell densities were
equal throughout sets of experiments. The oligo-arginines and
oligo-lysines were diluted in DMEM medium without FCS
to avoid precipitation of the peptides. For the chain-length-
dependent transduction assay, 2 µg/ml propidium iodide (PI)
was added directly to the diluted peptide solution prior to
the transduction experiment. The culture medium was gently
aspirated from the cells and exchanged against the respective
peptide dilutions in a volume of 60 µl. The cells were kept
for 1 h in the incubator until imaging at the microscope
under the same conditions. For each peptide concentration,
between 140 and 250 cells were analyzed and the experiments
were performed in duplicate. The images were collected with
two different laser settings, one set resulting in images
without overexposed signals and one set with higher laser
intensities, so that weaker signals could not be missed. The
microscope settings per concentration and within these two
sets were identical. Acquired images were analyzed visually,
and cells unambiguously showing fluorescent signal inside
the nucleus were scored as transduced. The graphics were
generated using the Origin version 7.5 software (OriginLab
Corp., Northampton, USA).
Cell Cycle and Viability Assays
For the modified (3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyl-
tetrazolium-bromide (MTT) assay, C2C12 cells were incubated
for 2 h with different concentrations of the peptides D-
R9 and L-R9. MTT was dissolved at 0.4 mg/ml in DMEM.
Subsequently, the cells were washed once, followed by addition
of 100 µl of the MTT solution and were returned to the
incubator for 5 h. Cells were then analyzed by confocal laser
scanning microscopy (CLSM). The transduction frequency
was monitored by the fluorescence of the Fluos- or TAMRA-
labeled peptides, respectively, and the formation of the blue-
violet formazan complex was monitored by excitation with
488 nm and detection in the transmission channel. For each
peptide concentration, five fields of view with a 40× objective
corresponding to a total number of ∼150 cells were collected.
Cells with less formazan signal intensity than the control cells
were counted as nonviable.
For the analysis of the plasma membrane integrity during
and after transduction, we used 2 µg/ml PI mixed together
with the transducing peptides in DMEM to detect transient
pore formation or membrane perturbations, and 0.5% (V/V)
trypan blue to distinguish, after the transduction period of
2 h, the cells with permanently compromised membranes.
Data were displayed by using Microsoft Excel.
To analyze relatively short-term effects on DNA condensa-
tion by the peptides, C2C12 cells were preincubated for 10 min
with the DNA dye DRAQ5 (Biostatus Limited, UK) as described
[37] and then incubated with different concentrations of the
D-R9 peptide. Cells were imaged by CLSM before and after the
treatment. Long-term effects on the cell cycle progression were
determined by fluorescence activated cell sorting (FACS) anal-
ysis of PI-stained C2C12 cells. For this purpose, C2C12 cells
were plated onto 150 mm diameter dishes and incubated with
different concentrations of the respective peptides at a density
of 40% in DMEM for 2 h. Then the medium was replaced by
DMEM with 20% FCS and the cells were cultivated for further
16 h until they reached a density of 60%. For FACS analysis
the cells were trypsinized, washed with PBS, fixed with ice-cold
90% EtOH, washed with PBS, treated with 0.1 mg/ml RNAse
and stained with 33 µg/ml PI, and DNA content was measured
with a FACSCalibur (Becton Dickinson). Data were analyzed
and plotted with the flow cytometry software FLOWJO (Tree
Star, Inc., USA).
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Microscopy, Image Acquisition and Analysis
Confocal images were acquired with a Zeiss confocal laser
scanning microscope, LSM510 Meta, mounted on an Axiovert
200M inverted microscope equipped with a live-cell microscope
incubation cage (Okolab, Italy) using either a 40× plan-
neofluar NA1.3 or a 63× plan-apochromat NA1.4 oil-
immersion, phase-contrast objectives. For all settings the main
beam splitter was HFT UV/488/543/633, and the specific
parameters for the single fluorophores were as follows: Fluos,
excited at 488 nm, detected with a 500–530 nm band-pass
filter; TAMRA, excited at 543 nm, detected with 565–615 nm
band-pass filter; and trypan blue, PI and DRAQ5, excited with
633 nm, detected with 650 nm long-pass filter. Phase contrast
images were recorded with excitation at 488 nm and detection
in the transmission channel. Laser power for observation was
typically 1–5% (488 nm, 25 mW), 50–60% (543 nm, 1 mW) and
3–5% (633 nm, 5 mW) unless otherwise indicated. Settings
were adjusted in a way that image pixels were not over- or
underexposed with the range indicator function in the Zeiss
LSM software version 3.2. To ensure that weak intracellular
fluorescence signals of the peptides were not missed, a set of
overexposed images were collected in addition.
RESULTS AND DISCUSSION
The decisive role of arginine clusters for translocation
over the plasma membrane has been known for
some time. Therefore, several studies were aimed
at determining the optimal number of arginines or
minimal structural requirements that permit efficient
transduction. Surprisingly, most of them analyzed
either fixed cells [23,24,38] and/or used FACS analysis
without a protocol to efficiently remove the cationic
peptides sticking to the extracellular side of the plasma
membrane [39]. To exclude the above artifacts, we
analyzed the transduction frequency of oligo-arginines
and -lysines with chain length from 5 to 12 directly by
CLSM of living cells. In addition, we compared only data
from experiments using the same incubation times for
all peptides and at the same cell density and varied
only the concentrations for each peptide. Figure 1(A)
displays the possible uptake phenotypes of C2C12
mouse myoblasts after addition of the fluorescent
peptide for 1 h. The images on the left side, upper panel,
show cells that endocytosed the L-R9 peptide incubated
at a concentration of 10 µM, where the fluorescence of
the peptide solely resided in cytoplasmic vesicles, and
no free cytoplasmic peptide was detectable by means of
fluorescence microscopy. The images on the right side,
upper panel, depict cells that incorporated L-R6 peptide
added at a concentration of 50 µM with fluorescence
detected throughout the cytoplasm and nucleus, which
we hereafter refer to as transduction. Cells with mixed
phenotypes (Figure 1(A), lower panel) that show in
addition to transduction vesicular uptake were also
scored as transduced cells. Only the uptake mode of
transduction yields peptide available in all intracellular
compartments and, therefore, is able to reach all
potential targets. In order to detect any possible
membrane perturbations or transient pore formation,
the vital dye PI was added to mouse myoblast cultures
simultaneously with the oligo-arginines (see scheme
in Figure 1(A)). The plots in Figure 1(B) summarize
the transduction results for all oligo-arginine peptides.
None of the oligo-arginines tested (R5–R12) was able
to transduce at a concentration of 0.5, 1 or 5 µM in a
total volume of 60 µl. Transduction could be observed at
10 µM for the peptides R8–R12, with frequencies over
50% for the peptides R10–R12. Whereas R5 did not
transduce over the whole concentration range tested
(between 0.5 to 100 µM), R6 appeared intracellularly
only in 4% of the cells at 50 µM and 28% at 100 µM.
R7–R9 transduced between 18 and 42% of the cells at
50 µM and reached frequencies between 75 and 90%
at 100 µM. The peptides R10–R12 transduced already
to a level of 70–90% at 10 µM concentration and the
percentage of transduction increased only slightly at
5- or 10-fold higher concentration. In stark contrast,
either no or very low frequency of cell penetration could
be detected with all the oligo-lysines tested (K5–K12)
at an even wider concentration range (data not shown).
The uptake of PI by the oligo-arginine transduced cells
(Figure 1(B)) indicated severe toxicity only with R8,
R10, R11 and R12 at the highest peptide concentration
tested (100 µM) and for R11 and R12 already at 50 µM.
For the transducing peptides with lower chain length,
the percentage of PI-stained cells in all cases was below
10%. At 10 µM, except for R12 all transducing peptides
caused no membrane damage that could be detected by
simultaneous PI staining. Notably, PI was not observed
inside transduced cells by peptides with a low number
of arginines or at low concentrations. This fact argues
against the formation of transient pores or strong
membrane perturbations. Whereas previous studies
found an optimum number of consecutive arginines
for transduction [24,38], our results support a linear
dependence of the transduction frequencies on the
number of consecutive arginines. Considering also the
PI uptake data, R9 or R10 peptides combine a medium
to high transduction level associated with a tolerable
toxicity. To verify and extend our live-cell analysis, we
selected three oligo-arginine peptides (namely, R5, R7
and R9) and tested their uptake potential into artificial
membranes. The R5 peptide was chosen, as it did
not transduce into cells, whereas the R7 was able
to transduce, albeit at a low level, and R9 was the
most efficient while still retaining low toxicity. The 7-
nitro-2-1,3-benzoxadiazol-4-yl (NBD) labeled peptides
were applied to large unilamellar vesicles (LUVs) and
the percentage of transduced peptide over time was
measured with a spectrofluorometer after quenching
the outer fluorescence with the NBD quencher,
dithionite. The percentage of transduction rose with
the number of consecutive arginines in a manner
Copyright  2007 European Peptide Society and John Wiley & Sons, Ltd. J. Pept. Sci. (2007)
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Figure 1 Assessment of dose-dependent transduction frequency of oligo-arginine peptides. (A) Confocal microscopy images
displaying examples of endocytic uptake (upper, left panel, L-R9 at 10 µM) versus transduction (upper, right panel, L-R6 at 50 µM)
of oligo-arginines (L-Rn; n = 5–12) into mouse C2C12 myoblasts. Two mixed forms of transduction + endocytosis are shown below:
transduction and endocytic peptide vesicles (left panel L-R9 at 10 µM) versus transduction and peptide enclosed in endocytic
vesicles (+) as well as excluded from endocytic vesicles (−) (right panel L-R6 at 50 µM). Scale bars 10 µm. The experimental
procedure is shown above. Only cells showing the transduction mode of uptake (including the mixed phenotypes shown in the
lower panels) were counted for the quantification in B. (B) The peptide transduction frequency shown as a fraction of C2C12
cells (in %) was scored as explained in A. Peptide transduction frequencies are shown plotted against peptide concentration (0.5,
1, 5, 10, 50, 100 µM) and corresponding estimated isoelectric point (pI ). The fraction of PI-stained C2C12 cells (in %) within
the transduced cell population is plotted similarly. The lower peptide concentration plots are also shown magnified for better
visualization. Error bars display the standard deviation of two independent experiments. The total number of cells counted was
between 140 and 250 for each experiment.
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analogous to that in the living-cell uptake analyses
(Supplementary Figure S1).
Octa-, nona- and deca-arginines have been shown to
transduce successfully into living cells under noninva-
sive conditions and at lower concentrations [31,32,40],
but different cell types as well as D- and L-isomers were
used in those studies. Therefore, we next assessed the
influence of D- and L-isomeric forms on the transduc-
tion efficiencies in different cell types. For that purpose,
we incubated different cell types of various mammalian
species and also primary cells with 10 µM of the TAMRA-
labeled D-isomer and the Fluos-labeled L-isomer of R9
and determined the percentage of transduced cells after
1 h incubation (Figure 2(A)). In general, the transduc-
tion frequencies for the L-form in all cell types were
lower than that of the D-form, illustrating that pep-
tide stability is an important issue for transduction.
By calculating the index for the percentage of cells
transduced by the L-isomer divided by the percentage
of cells transduced by the D-isomer, we found char-
acteristic values for individual cell types, which most
probably reflect their extracellular proteolytic activity
[41]. Whereas diploid human fibroblasts were very inef-
ficiently transduced, rat cardiomyocytes and mouse
myoblasts showed higher levels of transduction for the
L-form, approaching the level of the D-form. As the D-
isomer of R9 reached transduction efficiencies of over
95% in all cell types, the isomer-specific differences can-
not be due to cell-type-specific membrane composition.
The loss of only one arginine from L-R9 would already
reduce the transduction efficiency to half at a concen-
tration of 10 µM and lead to the disappearance of the
transduction potential with further proteolysis (see plot
in Figure 1(B)). To ensure that the different indices were
not a result of the distinct fluorescent labels attached
to the peptides, the same set of experiments was per-
formed with Fluos-labeled D- and L-isomers of R10
with the same outcome (data not shown). The overview
images of the different cell types after transduction also
revealed that the fluorescence intensity varied between
individual cells. This variation was not correlated to
(A)
(B)
Figure 2 Cell-type-specific differences in transduction frequencies and kinetics of L- and D-isomers of R9. (A) Confocal microscopy
sections of different cell types from various mammalian species 1 h after application of 10 µM of the Fluos-labeled L-isomer (upper
panel, green fluorescence) and the TAMRA-labeled D-isomer (lower panel, red fluorescence) of R9. For each cell type, merge images
of phase contrast and fluorescence and fluorescence images alone are displayed. The index corresponds to the ratio (% transduced
cells by L-isomer/% transduced cells by D-isomer) ± standard deviation. (B) Confocal microscopy time lapse (minutes : seconds)
of the transduction of the L- and D-isomers of R9 simultaneously applied to C2C12 mouse myoblasts at a concentration of
10 µM each. Red and green arrowheads indicate the initial detection of the transduced corresponding peptides in intracellular
compartments. The cells are counterstained with the live-cell DNA dye DRAQ5 (blue). Scale bar 50 µm.
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the size and, therefore, to the total accessible mem-
brane surface of the transduced cells. Next, we tested
whether kinetic differences between the transduction of
D- and L-isomers occurred. For this, we applied 20 µM
of a 1 : 1 mixture onto mouse myoblasts and moni-
tored the uptake in real time by CLSM. Surprisingly,
several cells selectively took up the TAMRA-labeled D-
isomer but not the Fluos-labeled L-form, although some
cells also showed yellow color seen in the overlay of
the two fluorescence images (Figure 2(B) and Movie 1).
Nevertheless, the kinetics of transduction was quite dif-
ferent for both isomers, even though after a certain time
both species had been internalized. This result argues
against the formation of mixed D- and L-isomers into
multimeric assemblies. We can, however, not rule out
the existence of single-species multimers. In addition,
no change in the transduction efficiency of the indi-
vidual D- or the L- chiral forms was observed, which
would be expected from the higher total peptide con-
centration. Finally, these data clearly show the absence
of membrane damage by the penetration of one peptide
species since the other species in the same cell at the
same time was not taken up concomitantly.
In view of the therapeutic potential of peptide vectors
for the delivery of low-molecular-weight compounds
and considering the relatively high transduction rate
and low percentage of PI-stained cells (Figure 1(B)
and 2), we selected the nondegradable D-isomer of
R9 for further detailed analysis of toxicity on mouse
myoblasts. Transduction was observed starting from
a concentration threshold of 5 µM with a transduction
frequency of about 10% (Figure 3(A)). Ten micromolar
D-R9 was transduced into more than 50%, and 25 µM
into 70% of the cells. For concentrations of 50 and
100 µM, transduction was nearly complete. Next, we
examined the viability of mouse myoblasts after 2 h of
incubation with different concentrations with D-R9. The
ability of the cells to exclude the vital dye trypan blue
was used to judge membrane integrity. Furthermore, we
assessed by an MTT assay whether the transduction of
D-R9 influences enzymatic activities inside the cells
detected here by their ability to produce formazan
[42]. Starting from the transduction threshold of 5 µM,
a constant decrease in viability by both assays was
observed, which was mild between 5 and 25 µM peptide
concentration. At a concentration of 50 µM, about 17%
of the cells stained positive for trypan blue, and 15%
of the cells produced formazan to a lesser extent than
the controls. Cell death in 60% of cells resulted from
100 µM of D-R9, and also the formazan levels of those
cells were greatly reduced in comparison to the control
cells. The slope of the trypan blue exclusion curve
is steeper than that of the viability assayed by the
MTT test, indicating that the membranes are the first
location where massive damage occurs. Arginine-rich
clusters can be found in RNA-binding proteins and are
targeted to the nuclear compartment. To test long-term
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Figure 3 Short- and long-term dose-dependent effects
of D-R9 transduction on cell viability and proliferation.
(A) Transduction frequencies of D-R9 in C2C12 mouse
myoblasts determined as in Figure 1. (B) Cell viability deter-
mined by trypan blue exclusion and enzymatic activity MTT
assay after 2 h of incubation with different concentrations
of D-R9. (C) Long-term effects on the cell cycle distribution
assayed by flow cytometry analysis of DNA content stained
with PI. The respective experiments are explained in the
schemes. For (A) and (B) the error bars display the standard
deviation of two independent experiments. The total number
of cells counted was between 140 and 250 for each experi-
ment. In (C), one example of three independent experiments is
depicted.
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effects on DNA replication and cell cycle progression,
mouse myoblasts were incubated for 2 h with the D-R9
peptide, the medium was exchanged and they were kept
in culture until the next day. Cultures were then fixed,
DNA was stained with PI and the cell cycle distribution
was analyzed by flow cytometry. The cell cycle profiles
and the statistics are displayed in Figure 3(C) and show
no concentration-dependent effect of the D-R9 peptide
on the cell cycle. Altogether, the toxicological effects of
the D-R9 peptide in a range of 5–25 µM can be classified
as mild and cell proliferation was also not affected.
CONCLUSIONS
In summary, we evaluated the transduction frequency
of the L-isoforms of oligo-arginines and monitored
their associated toxicity. This risk-benefit analysis of
transduction led us to the selection of R9 for further
analysis. With its nondegradable counterpart D-R9, we
established an assay that allows the quantification
of the proteolytic activity of different cell types, and
emphasize the need for protease-resistant peptides
as vectors for drug delivery. Importantly, the D-
isoform always showed a higher transduction as
compared to the L-counterpart in all cell types. The
transduction difference between D- and L-forms was
highly variable between cell types. Finally, our toxicity
results indicate concentration windows with low toxicity
and high transduction efficiency, not requiring further
treatments to force endocytic vesicle rupture.
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Supplementary Figure 1     Penetration of artificial membranes by oligo-
arginines. 
LUVs (Large Unilamellar Vesicles) were prepared from a mixture from 70 mol% of 
DOPC (dioleoylphosphatidylcholine) and 30 mol% of DOPS 
(dioleoylphosphatidylserine). In total 1 µmol of lipids were mixed in chloroform. A dry 
lipid film was formed by solvent evaporation under a nitrogen stream. The dried lipids 
were resolubilized in 2 ml of PBS (pH 7.4) by 5 min of vortexing. To yield LUVs the lipid 
suspension was processed by freeze/thaw-cycles (5x) and extrusion through a 0.1 µm filter 
(10x). Consecutive arginines (R5, R7, R9) as D-isomers were synthesized and coupled 
directly to the NBD (7-nitro-2-1,3-benzoxadiazol-4-yl)-group at the N-terminus by 
Peptide Specialty Laboratories GmbH (Heidelberg, Germany). For the quenching assay 
740 µl of PBS were mixed with 60 µl of LUV suspension and incubated with the NBD-
labeled peptides at 5 µM for different time spans. NBD fluorescence from peptides 
remaining in the exterior of the LUVs was then quenched by adding 25 mM of the non 
membrane permeable sodium dithionite. Fluorescence was detected with a FluoroMax-4-
spectrofluorometer (Horiba Jobin Yvon, Edison, USA). NBD was excited at 460 nm and 
the fluorescence was recorded at 544 nm. For measuring the maximal quenchable 
fluorescence of the peptides present in the exterior and also in the interior of the LUVs, 
0.5 % Triton X-100 was added afterwards to dissolve the vesicles. Counts for total 
fluorescence and fluorescence after quenching were corrected by subtracting this non-
quenchable fraction. The intravesicular peptide in LUVs was displayed as percentage of 
total fluorescence after dithionate quenching for the different NBD-peptides (●) R5-
NBD, (▲) R7-NBD and (■) R9-NBD. At a first glance the percentage of transduction as 
measured by the non-quenched intra-LUV peptide fluorescence seemed to be low in 
comparison to the experiments in living cells. However, under our experimental 
conditions the total volume of LUVs corresponded to about 0.2 % of the suspension 
volume assuming a LUV diameter of 100 nm and a surface area of lipids of 0.6 nm2. In 
the light of this estimate the results indicate an enrichment of peptides in the lumen of 
LUVs at least for R9.  
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Energy metabolism and calcium homeostasis play a central role in cell cycle progression 
and other cellular functions making them important targets for high throughput drug 
screenings. In the course of our studies on molecule dynamics and chromatin throughout 
the cell cycle we uncovered an unexpected link between energy metabolism, calcium 
release and chromatin condensation. To differentiate cellular processes driven by molecule 
diffusion versus active transport, cellular energy depletion experiments are commonly 
performed.1‑4 One of the chemicals often used is sodium azide (NaN3), which inhibits 
the cytochrome oxidase and thus the mitochondrial respiratory chain resulting in ATP 
depletion.5
During our experiments on the live‑cell dynamics of chromatin labeled with fluorescent 
histones throughout the cell cycle we made the observation that 10 min NaN3 incubation 
causes a concentration dependent condensation of nuclear chromatin and a correspond‑
ingly enlarged interchromatin space (Fig. 1A).2 In NaN3 treated Hela cells the chromatin 
volume decreased down to 64 % of its size in untreated cells (Fig. 1A). In images of 
untreated cells, the diffuse borders of the chromatin result from decondensed chromatin 
fibers too small to be resolved by conventional microscopy. After NaN3 incubation, this 
type of chromatin structure disappears in the images and only condensed chromatin is 
visible (Fig. 1). A similar effect was recently reported when living cells were subjected to 
hyperosmolar media. We, therefore, tested whether the NaN3 induced chromatin conden‑
sation could be the result of intracellular changes of ion levels.6
First we tested the direct effect of different cations (Na+, K+, Ca2+ and Mg2+) on 
chromatin in cells. We permeabilized the plasma membrane briefly with digitonin7 and 
incubated the cells with hypertonic salt solutions (Fig. 1B). Fluorescently labeled dextrans 
were added to the media to monitor the permeabilization since the plasma membrane 
of untreated cells excludes dextrans (Fig. S1). In agreement with previous results6 we 
could observe chromatin condensation in intact cells incubated with any of the four 
cations tested (Fig. S1). However, in permeabilized cells only Ca2+ ions caused chromatin 
condensation, while even at high concentrations the other ions had no effect (Fig. 1B and 
Fig. S1). Calcium as a bivalent cation binds to DNA and was shown to be associated with 
chromatin during mitosis.8 We measured the change in chromatin volume by following 
cells progressing from mitosis into interphase and treating them with NaN3. In this 
manner we overcome the problem of high variability within the cell population (Fig. 1C). 
While NaN3 treatment caused a decrease of the chromatin volume to 74%, in mitosis this 
was further reduced to 41 % compared to untreated interphase cells. These data indicate 
that the NaN3 causes chromatin condensation within a physiological range, which is lower 
than mitotic chromosomal condensation.
Next we tested whether intracellular calcium level changes in living cells during NaN3 
incubation using a fluorescent sensor molecule Fluo 3.9 The cell permeable Fluo 3 AM was 
loaded for 30 min into living cells and the Fluo 3 fluorescence emission measured before 
and during NaN3 incubation. The data indeed revealed a 1.5 fold increase of the calcium 
levels following the NaN3 incubation (Fig. 2A). The drop of the Fluo 3 fluorescence over 
time is likely due to the depletion of free calcium from the cytosol and nucleoplasm by 
binding to chromatin. The dynamic range of Fluo 3 fluorescence was tested by adding 
5 mM ionomycin to the medium and reached a maximum of five‑fold increase leading 
concomitantly to chromatin condensation (Fig. S2). The fact that NaN3 induced chro‑
matin condensation also in calcium free PBS with 10 mM EGTA (Fig. S3) indicates that 
the calcium increase is caused by release from intracellular stores and not by uptake from 
the extracellular milieu. Beside the endoplasmatic reticulum, mitochondria are potent 
buffering sites for calcium and NaN3 impairs mitochondrial functions.
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Linking Energy Metabolism, Calcium, Chromatin Condensation and Cell Cycle
NaN3 on mitochondria in living cells can be directly tested with 
dyes (e.g., MitoTrackerRed) that are taken up into the organelle and 
accumulated via the membrane potential. We incubated living cells 
with MitoTracker for 30 min followed by change to media without 
dye for 45 min. Cells were imaged before and after adding NaN3 to 
monitor possible changes in the mitochondria. Within a few minutes 
of NaN3 incubation the filamentous mitochondrial population were 
fragmented into small sphere like remains (Fig. 2B). Furthermore the 
decrease of the dye signal from the mitochondria indicates a lowering 
or loss of the membrane potential. Altogether, these results show 
that NaN3 disrupts the mitochondrial membrane potential inducing 
an increase in the calcium level in the nucleus. Since extracellular 
calcium was not required for chromatin condensation, the intracel‑
lular calcium rise could be due to release from mitochondria or from 
the endoplasmatic reticulum. The lowering of the ATP production 
by NaN3 should concomitantly prevent calcium buffering by inhib‑
iting the transport of free calcium by ATP dependent ion pumps into 
the mitochondria, endoplasmatic reticulum as well as to the outside 
of the cell.10
These findings have important consequences for the interpreta‑
tion of experiments using NaN3 for ATP depletion and the analysis 
of molecule dynamics within the nucleus. Although the diffusive 
mobility of nuclear proteins is not ATP dependent,11 the enlarged 
interchromatin space on the one hand and the higher condensation 
of chromatin on the other hand likely affects local protein concen‑
tration, mobility and access. Most importantly, our results show 
that external stimuli, manipulations and drugs directly or indirectly 
changing cellular calcium levels, by either energy depletion or direct 
interference with calcium homeostasis, have an effect on chromatin 
condensation and arrest cell cycle progression. These unexpected 
links between energy metabolism, calcium homeostasis, chromatin 
condensation and cell cycle should be taken in account for the design 
of drug screenings and the interpretation of cellular responses. Even 
small changes of free intracellular calcium levels may affect chromatin 
condensation and gene expression with still unknown consequences.
Figure 1. Chromatin condensation in living cells induced by NaN3. 
(A) NaN3 (Calbiochem) induces within 10 min a condensation of the nuclear 
chromatin in living HeLa cells expressing a histone H2B‑GFP chromatin label. 
The chromatin volume is reduced progressively with increasing amounts of 
NaN3 and the interchromatin space extends. The quantitative evaluation of 
the chromatin volume relative to the untreated cells was performed using 
ImageJ software and is given in the lower panels ± standard deviation 
(n = 10 cells). The analysis was performed by determining and subtracting 
the background, followed by Gauss filtering and applying a fluorescence 
intensity threshold that included all chromatin. Finally, the thresholded chro‑
matin volume for whole 3D image series was calculated using the voxel coun‑
ter tool. (B) The effect of different salt ions on the chromatin condensation 
level. The plasma membranes of the living cells were mildly permeabilized 
by digitonin to test for direct effects of ions on chromatin. The top images 
show the intact cells in medium and the bottom images the same cells after 
digitonin treatment in the different 250 mM salt solutions. A condensation of 
the nuclear chromatin occurs only as a result of incubation in Ca2+ solution. 
The other ions Na+, K+ and Mg2+ do not induce condensation. The addition 
of Mg2+ caused a rather homogeneous distribution of chromatin, which prob‑
ably is the result of nuclease activation by this cation. (C) The bar diagram 
displays the percentage of the chromatin volume of mitotic and NaN3 treated 
G1 cells compared to the chromatin volume in the same G1 cell before 
treatment (see scheme below). For the comparison, the combined chromatin 
volume of the two G1 daughter cells was taken to keep the total amount 
of chromatin constant relative to the mitotic cell. The chromatin is most 
condensed in mitosis with only about 41% of the interphase chromatin 
volume, while in cells treated with 45 mM NaN3 the chromatin volume 
decreases to 74 % of the interphase volume. Scale bars, 5 mm. pc, phase 
contrast.
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Figure 2. NaN3 triggers cellular calcium rise and fragmentation of mitochondria. (A) Microscopic fluorescence imaging of the calcium sensor Fluo 3 
(Molecular Probes) in living cells. The fluorescence image shows Fluo 3 loaded into HeLa cells in normal growth medium (corresponding to 10 s in the 
curve). The areas of measurement (white circles) were choosen according to the position of the nuclei identified in the phase contrast image. The curve 
describes the mean nuclear Fluo 3 fluorescence over time (n =10 cells ± standard deviation), showing a rise of fluorescence shortly after addition of NaN3 
to the culture medium, indicated by the arrow. The Fluo 3 fluorescence increases up to 1.5 fold over the normal level before NaN3 addition and in control 
cells (gray curve) which corresponds to a calcium rise of about two‑fold according to the fluorescence calibration curve given by the manufacturer. (B) The 
mitochondria of living HeLa cells expressing histone H2B‑GFP were imaged using MitoTrackerRed (Molecular Probes). The images display confocal optical 
sections of control cells (left) and 10 min after NaN3 incubation (right). The tubular and filamentous mitochondrial structure in the left image and inset col‑
lapse into small dot‑like remains and indicate a loss of mitochondrial fission and fusion events. Scale bar, 5 mm. pc, phase contrast.
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Letter to the Editor  
An Unexpected Link Between Energy Metabolism, Calcium, Chromatin 
Condensation and Cell Cycle
Figure S1. Effect of different cations combined with digitonin permeabilization on chromatin conden‑
sation. The effect of digitonin visualized in living HeLa cells was controlled by the exclusion or not of 
fluorescently labeled 10 kDa dextrans added to the cell medium. In permeabilized cells the dextrans 
reach also the nucleus (left panel) and the effect of the different ions is displayed as in Figure 1. 
In intact cells all of the hyperosmolar ion solutions (250 mM) induce chromatin condensation (right 
panel). Scalebar 5 mm. pc = phase contrast.
Figure S2. Extracellular calcium influx triggered by ionomycin causes chromatin condensation. 
Adding ionomycin (5 mM; Calbiochem) to the medium of living cells results in a transport of extracel‑
lular calcium to the cellular interior. The fluorescence intensity increase of Fluo 3 displays the maximal 
intensity of the calcium sensor with the highest intracellular calcium concentration. Our measurements 
(mean nuclear fluorescence intensity, n=10 cells ± standard deviation) show a five‑fold increase of 
the Fluo 3 fluorescence over the basic fluorescence intensity in untreated cells. The influx of extracel‑
lular calcium causes also chromatin condensation, which is shown in the images. Scalebar 5 mm. 
pc = phase contrast.
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Figure S3. NaN3 induces chromatin condensation independent of extracel‑
lular calcium. The condensation of chromatin using NaN3 is also achieved 
in a calcium free buffer, which excludes extracellular calcium as a possible 
source for the intracellular calcium rise. The cells were incubated in PBS 
supplemented with 10 mM EGTA for 15 min to deplete extracellular calcium 
and subsequently 45 mM NaN3 was added. Scalebar 5 mm. pc = phase 
contrast.
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Abstract
The condensation level of  chromatin is controlled by epigenetic modifications and associated 
regulatory factors that change throughout differentiation and cell cycle progression. To test whether 
changes of chromatin condensation levels per se affect access and binding of proteins we used a 
hypertonic cell treatment. This shift to hyperosmolar media caused increased nuclear calcium 
concentrations and induced a reversible chromatin condensation comparable to levels in mitosis 
but independent of mitotic histone H3  serine 10 phosphorylation. Photobleaching experiments with 
H2B-GFP and GFP-HP1α before and after induced chromatin condensation showed that the 
exchange of  integral as well as associated chromatin proteins is affected. Photoactivation of 
PAGFP-HP1α demonstrated that hypercondensation reduces the dissociation rate and stabilized 
HP1 chromatin binding. Finally, measuring the distribution of nucleoplasmic proteins in the range 
from 30 to 230 kDa we found that even relatively small proteins like GFP are at least partially 
excluded from hypercondensed chromatin in living cells. These results suggest that structural 
changes in condensed chromatin by themselves affect chromatin access and binding of  chromatin 
proteins independent of regulatory histone modifications.
Key words
Chromatin accessibility, chromatin condensation, fluorescence microscopy, photoactivation, 
photobleaching
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The cell nucleus is a highly organized organelle storing and translating genetic information. 
Although there are no substructures separated by membranes, the nucleus is compartmentalized 
for different functions in nucleic acid metabolism.1 The nuclear DNA is organized together with 
structural proteins into dynamic higher order chromatin structures, which reflect and control gene 
expression during the cell cycle and cellular differentiation.2,3 As a consequence of  a complex and 
not yet understood interplay between chromatin condensation state, transcriptional activity and 
modifications of chromatin organizing proteins, chromatin subsets are termed eu- and 
heterochromatin.4,5 Euchromatin in interphase cells is actively transcribed and less condensed 
while heterochromatin is transcriptionally inactive with a condensation level similar to mitotic 
chromosomes.6  During mitotic chromatin condensation, DNA metabolism (e.g., transcription and 
replication) stops and only resumes after chromatin decondensation in early G1 phase. The 
condensation of chromatin is characterized by a reduction of  volume due to a spatial organization 
into densely packed higher order structures.7 Specific histone modifications, e.g. histone H1 and 
H3 phosphorylation, occur at mitosis and contribute to the individualization and condensation of 
chromosomes. The consequences of this compaction into condensed chromosomes at mitosis are 
reduced free volumes and less exposed surface of the chromatin substructures on which 
molecules could interact.8,9 However, it is unclear whether and how  changes in the chromatin 
condensation state and/or histone modifications affect the distribution and access of  nucleoplasmic 
proteins and the mobility of chromatin organizing proteins.
Interphase chromatin has been shown to be accessible to macromolecules10,11, chromatin 
proteins12 and neutral inert proteins even at the single molecule level 13. Furthermore, certain 
transcription and chromatin factors have been shown to still have access to chromosomes in 
mitosis when the DNA metabolism stops.14 Therefore, the relationship between nuclear protein 
distribution, chromatin accessibility and how  changes in chromatin condensation over the cell cycle 
impact on DNA metabolism remains unclear. In this study, we have manipulated chromatin 
condensation in interphase cells to test whether the level of  chromatin condensation independently 
of mitotic histone modifications can impact on mobility and accessibility of nuclear proteins.
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Manipulation and quantitative evaluation of chromatin condensation mechanisms
The maximal chromatin condensation takes place at every mitosis in cycling cells and results in a 
cessation of  DNA metabolism. The latter could be the result of M-phase specific modifications of 
chromatin proteins (e.g., histone modifications) directly preventing the access of factors to the 
genome and/or structural changes of  chromatin hindering access by increased compaction. To 
distinguish between these possibilities, we made use of an approach to induce hypercondensation 
of chromatin during interphase.15 
We first compared the chromatin volumes of individual living HeLa cells labeled with histone H2B-
GFP fusion proteins in different cell cycle stages and after chromatin condensing treatment. The 
same cells were imaged beginning in mitosis and through reentry into G1 followed by induced 
chromatin condensation by incubation in hyperosmolar medium for 5 minutes. We then measured 
the chromatin volumes in the three conditions to test whether the treatment reduced interphase 
chromatin volumes to the level of  mitotic chromosome volumes (Fig 1). The chromatin volume 
measurements for mitosis and hyperosmolar condensation in G1 showed similar levels of 39% ± 
sd 9% and 40% ± sd 11% respectively, relative to G1 chromatin in the same cells before treatment 
(Fig 1). This hypercondensation of chromatin was reversible within 10 minutes of returning to 
normal osmolar medium and resulting in cessation of DNA metabolic processes such as 
transcription and replication (data not show  and 15). We, therefore, conclude that this approach 
generated condensation of chromatin in interphase nuclei to the same extent as mitotic chromatin. 
Next, we assessed the occurrence of  typical chromatin modifications in mitotic chromosomes and 
hypercondensed interphase chromatin. At mitosis, phosphorylated histone H3 at serine 10 is 
associated with the individualization and condensation of chromosomes.16 Although we found 
similar levels of chromatin condensation (Fig 1), no mitosis specific histone H3 phosphorylation 
was detected (Fig 2A). Hence, the process of  hyperosmolar chromatin condensation relies on a 
different pathway, which does not involve cell cycle specific histone modifications but rather 
profound structural changes. 
Since we had previously reported that cellular energy depletion using Na-azide leads to interphase 
chromatin condensation with increased calcium level in the nucleus17, we measured the levels of 
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this cation using the fluorescent calcium sensor Fluo 3 before and after hypertonic treatment. Our 
data demonstrates that the condensation of  chromatin by hyperosmolarity is accompanied by a 
seven-fold rise in the intranuclear calcium level (Fig 2B). Subsequent addition of  the calcium 
ionophore ionomycin to the cells led to an even higher increase establishing that our 
measurements were not performed under saturating conditions.
Taken together these results indicate that reversible hypercondensation of  interphase chromatin 
occurs in the absence of mitotic histone modifications, likely as a result of increased intranuclear 
calcium levels, and leads to a stop in DNA metabolism.  
Accessibility of proteins to different chromatin condensation states
Next, we assayed the impact of  chromatin condensation levels on the accessibility of nuclear 
proteins. 
Large number of nuclear proteins bind to or are incorporated into chromatin structures throughout 
the cell cycle. We therefore tested whether chromatin condensation level affects their access to 
and their dynamics at chromatin. We selected a nucleosome core histone (H2B) and a 
heterochromatin binding protein (HP1) as representative chromatin proteins and analyzed their 
chromatin access and mobility by photobleaching and photoactivation experiments.
The nucleosome protein H2B-GFP was not redistributed upon hyperosmotic chromatin 
hypercondensation (Fig 3A). Fluorescence recovery after photobleaching (FRAP) analysis 
showed, in accordance to previous reports12, that the half-time of recovery (t1/2) in interphase 
chromatin for this core histone was about 180 min. Upon hyperosmolar treatment, only about 5% 
fluorescence recovery could be measured within the same time, indicating that the access to and/
or release of the core histone H2B from fully condensed interphase chromatin was affected. 
Chromatin proteins that are not core components of the nucleosome often associate less tightly  to 
chromatin and DNA than histones. The heterochromatin protein HP1α binds to methylated histone 
H3 and accumulates in heterochromatin. We measured the half recovery time of  GFP-HP1α in 
interphase heterochromatin of HeLa cells and compared it with hypercondensed chromatin in 
interphase and mitotic cells. In interphase heterochromatin the t1/2 was 2 s (Fig 3B), which fits well 
with previously reported half recovery times of 1 to 10 s.18,19 In hypercondensed interphase 
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chromatin though HP1α recovery in the FRAP analysis was slower with a t1/2 increased to 20 s. To 
clarify whether HP1α was transiently trapped in the hypercondensed interphase chromatin, we 
performed photoactivation experiments and measured the dissociation of  fluorescent PAGFP-
HP1α molecules from the heterochromatin spots in the photoactivated area. Analysis of  the 
fluorescence decay curves (Fig 3C) revealed that HP1α t1/2 of dissociation from interphase 
heterochromatin was 8 s, compared to a 6.5 fold slower t1/2 of  52 s in hypercondensed interphase 
chromatin. These results indicate a reduced mobility and a transient trapping of HP1α. 
Taken together we could demonstrate that the hypercondensed interphase chromatin was less 
accessible and reduced the exchange of chromatin proteins like core histones and 
heterochromatin binding proteins.
We then measured the access of non-chromatin proteins to the differently condensed chromatin. 
We chose GFP as a neutral probe protein and imaged the same cells before and after 
hyperosmolar treatment to directly compare the distribution of proteins relative to chromatin within 
the same cell. Furthermore, we compared the results to mitotic chromatin.
Fig 4 shows confocal optical sections of living cells displaying the distribution of the inert tracer 
protein GFP relative to H2B-mRFP labeled chromatin. The relative distribution was then analyzed 
quantitatively first by plotting the GFP signal intensity versus the histone-labeled chromatin along 
a line across the nucleus (linescan analysis, Fig 4B) and second by a correlation analysis (Fig 4C). 
The latter included both the display of all red and green pixels within the nucleus, excluding the 
nucleoli, in intensity scatter plots, and the calculation of the Pearson’s coefficient R as a measure 
for correlation (+1), anti-correlation (-1) or no correlation (0) of two color channels in images.20
In mitosis the GFP was mostly excluded from chromatin, visible as dark areas where the 
chromosomes are located (Fig 4A, left column). The exclusion is displayed in the linescan by a 
drop of  the GFP intensity and inverse progression of the chromatin intensity. The scatter plot 
showed a distribution in a sharp cone of  moderate negative slope, with the lowest GFP intensities 
in the region of occupied by the chromosomes. Finally, the Pearson’s correlation coefficient of R = 
-0.8 ± sd 0.2 clearly demonstrated an anti-correlation of  GFP and mitotic chromosomes. In the 
interphase cell (Fig 4A, middle column) GFP showed an overall much more homogeneous 
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distribution throughout the nucleus with exception of  the nucleoli, corroborated further by the 
linescan analysis depicting a reduction of GFP in the nucleoli (Fig 4B, arrowhead). In some larger 
heterochromatin spots we could observe some reduction of the GFP concentration (Fig 4B, arrow). 
The scatter plot displayed the GFP and chromatin pixel intensities as a cloud in the center of the 
plot and the R-value of -0.1 ± sd 0.1 close to zero indicated no correlation (Fig 4C). After induced 
condensation of  interphase chromatin to mitotic chromosome volume, a chromatin network like 
structure became apparent. The GFP redistributed mostly to the regions not occupied by 
chromatin, which corresponded to an enlarged interchromatin space (Fig 4A, right column). The 
GFP exclusion from condensed interphase chromatin was clearly shown by the inverse correlation 
of the linescan data (Fig 4B) and the shift towards a negative slope on the scatter plot and the 
negative R-value of -0.6 ± sd 0.1 (Fig 4C).
To test whether this exclusion of proteins from the compacted chromatin was a general 
phenomenon for non chromatin bound nuclear proteins we extended this analysis to several 
nucleoplasmic proteins of increasing size up to 230 kDa (Fig S1). As for GFP, all proteins tested 
independent of  their size showed a similar level negative correlation with mitotic as well as 
interphase hypercondensed chromatin.
In summary, making use of  a hypertonic treatment we could achieve in interphase cells a 
chromatin condensation level similar to mitotic chromosomes in the absence of  the typical mitotic 
histone modifications and likely due to increased intranuclear calcium level. Increasing the 
chromatin condensation lead to a slowed exchange of chromatin proteins. Furthermore, although 
in general interphase chromatin was accessible to non-chromatin proteins within a size range of 
30-230 kDa, upon hypercondensation they redistributed away and exhibited an anti-correlated 
distribution to the same level than to mitotic chromatin. This concentration reduction of non 
chromatin proteins could therefore, concomitantly with other chromatin modifications, be involved 
in the shutdown of DNA metabolism in mitosis. These data are also consistent with the results from 
our recent analysis of the mobility and access of single streptavidin proteins to heterochromatin 
where these interphase chromatin domains exhibited quite some permeability to this neutral 
average sized protein.13  
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It has been debated over the past years whether and how  chromatin can exclude nuclear factors 
and the contribution of this effect for DNA metabolism and heterochromatin function. Different 
studies indicated that macromolecules have access to interphase chromatin. However, these 
studies have used carbohydrates like dextrans, which may behave differently from nuclear 
proteins.21,10 In addition, access to chromatin was not analyzed  at different condensation levels. 
Photodynamic studies showed that chromatin in interphase and mitosis is accessible to chromatin 
factors like histones and heterochromatin proteins.14,22,19 Our data also showed that condensed 
chromatin was accessible to nucleosomal proteins and other chromatin associated factors that are 
involved in heterochromatin maintenance. On the other hand, our results indicate that the 
concentration of  nucleoplasmic proteins that are not associated with nucleosomes is low  in 
chromatin with higher condensation level.  We suggest that the partial exclusion of nucleoplasmic 
proteins is due to increased structural restrictions and dense environments occupied by condensed 
chromatin and concentrated chromatin binding factors. In the condensed chromatin structures the 
competition for available volume favors high affinity chromatin binding factors and decreases the 
number of  nucleoplasmic proteins with less or no affinity to those structures. In mitosis the reduced 
access of  proteins could, in addition to specific chromatin modifications, reduce genome wide 
accessibility and, thereby, contribute to the mitotic shutdown of transcription, replication and other 
DNA dependent processes. The modulation of protein access and consequently local protein 
concentration could constitute a general mechanism for the regulation of binding dynamics, 
enzymatic activities and DNA metabolism.
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Figure legends
Fig 1 Manipulation and quantification of chromatin condensation states
Individual HeLa cells expressing H2B-GFP as a marker for chromatin23 were visualized starting in 
mitosis (left panel) into G1 (mid panel) and following incubation in hyperosmolar medium (right 
panel). The cells were grown in DMEM with 10% fetal calf  serum, 5 mM L-glutamine, 5 g/ml 
Gentamycine and the hypercondensation medium was composed of a dilution of 10x PBS in 
growth medium to yield 4x PBS equivalent to a 500 mM saline solution. Cells were in plated in 8-
well Ibidi chambers (Ibidi, Munich, Germany). Live cell microscopy was performed with a Zeiss 
LSM510Meta confocal setup on a Zeiss Axiovert 200M inverted microscope with a 63x phase 
contrast plan-apochromat oil objective NA 1.4 (Carl Zeiss, Germany). The microscope is housed in 
a humidified chamber heated to 37°C (Okolab, Ottaviano, Italy). For  acquisition the main beam 
splitter was HFT UV/488/543/633, GFP was excited by 488 nm Argon laser and detected with a 
500-530 nm bandpass filter. Acquisition settings were identical for individual cells in repeated 
imaging experiments. At each time-point complete high resolution confocal z-stacks were acquired 
and projections are shown. Scale bar 5 µm. Chromatin volume calculations were derived from 
complete z-stacks and processed in Image J. Images were gauss filtered and background 
subtracted, then thresholded and the volumes calculated with the voxel counter plugin. The bar 
diagram summarizes the chromatin volume data as mean +/- standard deviation (N = ten cells) 
relative to the value for G1 interphase chromatin in the same cell. 
Fig 2 Different pathways of chromatin condensation in mitosis  and hyperosmolar 
condensation
A) Histone H3 is modified by phosphorylation at serine 10 during mitosis and was detected in 
formaldehyde fixed HeLa H2B-GFP cells using anti-phospho H3S10 specific antibodies. For 
immunofluorescence staining, cells were washed in PBS and, in case of hyperosmolar treatment 
incubated for 15 min in 4x PBS, fixed in 3.7% formaldehyde diluted in PBS or 4x PBS respectively 
and permeabilized with 0.25% Triton X100 in PBS. The primary anti-phospho H3 rabbit polyclonal 
antibody (catalog number 06-570, Millipore, Schwalbach, Germany) was diluted in PBS containing 
Martin et al.
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0.2 % fish skin gelatin and detected using goat anti-rabbit IgG (Jackson, Newmarket, UK). In the 
top panel the phosphorylated histone H3 signal (red) co-localizes with the histone H2B-GFP 
labeled chromosomes in the mitotic cell but it is not detected in the interphase cell. In the lower 
panel the chromatin was condensed by hyperosmolar treatment to induce a interphase chromatin 
volume comparable to mitotic chromosomes (see Fig 1). As in the untreated cells, the mitosis 
specific histone H3 phosphorylation is not detectable in the interphase nucleus and only in the 
mitotic chromosomes suggesting a different pathway of  mitotic and hyperosmolar chromatin 
condensation. 
The graph in B) displays intranuclear calcium levels in HeLa cells (N = 10) measured by timelapse 
microscopy using the fluorescent calcium sensor Fluo 3. The Fluo 3 (Invitrogen, Paisley, UK) 
labeling and measurements were performed as described before.17 For untreated cells the initial 
Fluo 3 fluorescence intensity was normalized to 1 and, following the incubation in hyperosmolar 4x 
PBS solution, increased seven fold. To test for saturation effects and dynamic range of  the Fluo 3 
measurement conditions, the calcium ionophore ionomycin was added subsequently to the cells to 
induce maximum calcium uptake. This displays the whole range of  fluorescence intensities 
measurable by the calcium sensor under the same imaging conditions and further suggests that 
the change in chromatin condensation after 4xPBS incubation involves a  significant change in the 
calcium level.  Scale bar 5 µm.
Fig 3 Distribution and mobility of chromatin proteins in different chromatin condensation 
states
HeLa cells stably expressing H2B-GFP as well as HeLa cells transiently transfected with plasmids 
coding for H2B-mRFP and either GFP-HP1α or PAGFP-HP1α were used in photobleaching or 
photoactivation experiments of the respective chromatin proteins as indicated. 
The histone H2B-mRFP plasmid was constructed by cutting out CFP from pH2B-CFP24 with 
BamHI + MfeI and ligating in the mRFP cDNA  cut with EcoRI + BamHI from pRSET-mRFP1.25 
The photoactivatable HP1α construct was created by inserting the human HP1α cDNA derived 
from pBCHGN-HP1-alpha18 cut with Hind III and BamH I into the Hind III and Bgl II of pPAGFP-
Martin et al.
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C1.26 Double transfection of cells was carried out by CaPO4 precipitation method27 or using 
Transfectin reagent (BioRad, Munich, Germany). Live cell microscopy was performed as described 
in Fig 1 and mRFP was excited by a 543 nm HeNe laser and detected using a 585-615 bandpass 
filter. Photobleaching and photoactivation were performed with a short intense pulse of 488 nm 
Argon laser beam. For all experiments, the areas photobleached (ba) and photoactivated (pa) are 
indicated by squares and the times after photobleaching/activation are given in the images. FRAP 
data were corrected for cell translational and rotational movements with the Image J ‘stack_reg’ 
plugin. The datasets were analyzed, evaluated and displayed in Origin 7. The photobleaching and 
photoactivation redistribution data were normalized, averaged and corrected for photobleaching or 
photoactivation by the image acquisition process. The half  equilibrium times t1/2 were derived in 
Origin 7 from bi-exponential decay fit curves.
The photobleaching experiment in A) shows histone H2B-GFP dynamics in interphase HeLa cells. 
Untreated interphase chromatin (top) and hyperosmolar condensed chromatin (bottom) are shown. 
In B) photobleaching experiments with HP1α-GFP are displayed for cells in interphase (top) and 
with hyperosmolar condensed interphase chromatin (bottom). Corresponding fluorescence 
recovery curves are shown on the right as the mean of ten cells with standard deviation. C) depicts 
the photoactivation experiments with HP1α fused to PAGFP. In the images before fluorescence 
activation the nucleus and chromosomes visualized independently with H2B-mRFP fusion are 
encircled by a dotted line. The dissociation of HP1α from chromatin measured by the loss of 
photoactivated fusion protein from the interphase chromatin is shown in the graphs on the right 
(mean of  10 cells with standard deviation). The insets in B) and C) are magnifications of the 
accumulations of HP1α at heterochromatin marked by the arrows. 
Scale bars 5 µm.
Fig 4 Effect of chromatin condensation state on protein accessibility
The distribution of the inert tracer protein GFP, from the plasmid construct EGFP (Clontech, 
Heidelberg, Germany), and histone H2B-mRFP labeled chromatin is shown in representative 
optical sections of  cells in mitosis (left column), in interphase (middle column) and in the same 
interphase cells again after induced chromatin condensation (right column). The double 
Martin et al.
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transfections and live cell microscopy were carried out as described in Fig 3 with identical 
acquisition settings for individual cells in repeated imaging experiments. Image analysis was 
performed with the Zeiss LSM Image Examiner software for fluorescence intensity and 
colocalization measurements. The latter included the Pearson correlation coefficient (R), measured 
by selecting the nuclear areas excluding the nucleoli or for mitotic cells an oval area including the 
chromosomes and cytoplasm. The linescan analysis in B) displays the pixel intensity distribution of 
GFP (green) and chromatin (red) along the yellow  arrow  in the respective merged image in A). 
Regions with reduced protein concentration correspond to heterochromatin (arrow) and nucleoli 
(arrowhead). In C) the scatter plots display the pixel of the merged image according to the intensity 
values of the red and green channel and the frequency of  the red-green pixel combination is coded 
by the color (hot colors represent higher frequencies). The red line demarcates the pixels 
corresponding to the mitotic chromosomes as well as to the interphase nucleus excluding the 
nucleoli (referred to as nucleoplasm). The Pearson correlation coefficient (R) is the mean ± 
standard deviation of 10 midsections in individual cells. Scale bar 5 µm.
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Figure S1
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Fig S1 Effect of chromatin condensation 
state on accessibility of nucleoplasmic 
proteins of different size
Distribution of fusion proteins of different size 
GFP-DNA Ligase I, 27 GFP-Dnmt1 28 and GFP-
PCNA 29 in representative optical sections of live 
HeLa cells relative to chromatin labeled with H2B-
mRFP in interphase A), mitosis B) and in C) the 
same cells as in A) upon hyperosmolar treatment 
yielding hypercondensation of chromatin to the 
level of mitotic chromosomes. The Pearson’s 
correlation coefficients (R) given above the images 
were calculated excluding the nucleoli  (mean of ten 
cells). The linescans below the images show the 
pixel intensity distribution along the direction of the 
arrow in the merged images. 
In A) as with GFP alone the proteins were 
homogeneously distributed in the nucleoplasm as 
described before.27,28,29 The lowest level of the 
fusion proteins was found in nucleoli and a slight 
r e d u c t i o n c o u l d b e m e a s u r e d i n l a r g e 
heterochromatin regions as displayed in the images 
and linescans. The increasing size of the proteins 
had no influence on their chromatin access in 
interphase nuclei as demonstrated by the 
correlation analysis (nucleoli  excluded) with R-
values between -0.13 and -0.2 indicating almost no 
correlation. 
In B) cells in mitosis are shown with the 
chromosomes mostly excluding the proteins, 
supported by the drop of the protein fluorescence 
intensity in the area locating the condensed 
chromosomes in the linescans. The strong negative 
correlation coefficient with R-values of -0.6 and 
-0.4, respectively, further confirms the exclusion of 
non chromatin nuclear proteins from chromosomes. 
The GFP-Dnmt1 was not included in the mitosis 
analysis since it associates with constitutive 
heterochromatin from late S-phase to early G1.28 
The hypercondensation of interphase chromatin in 
C) again leads to an exclusion of the fusion 
proteins from the condensed chromatin structures 
and an accumulation in the enlarged interchromatin 
space, This is also visible in the linescans by the 
inverse correlation of the protein and chromatin 
labeling intensity curves. Importantly, for interphase 
nuclei  with induced hypercondensation of 
chromatin the Pearson coefficient for GFP fusion 
proteins drops to a level similar to mitotic cells R= 
-0.45 and -0.5 respectively. 
In D) optical sections of fixed HeLa cells stained 
with an antibody to PCNA in mitosis, interphase 
and with interphase chromatin condensed to the 
mi to t ic  chromosome vo lume are shown. 
Immunofluorescence staining was performed as 
described earlier.30 As with the GFP fusions, in 
mitosis no protein labeling was visible in the 
chromosome area labeled with the DNA dye 
Hoechst 33258 whereas in interphase PCNA was 
distributed in the whole nucleus with some 
reduction in the nucleoli. Upon hyperosmolar 
condensation of interphase chromatin redistribution 
of the proteins could be observed with a 
concentrat ion of protein in the enlarged 
interchromatin regions. 
Scale bars 5 µm.
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ABSTRACT Genome activity and nuclear metabolism clearly depend on accessibility, but it is not known whether and to what
extent nuclear structures limit the mobility and access of individual molecules. We used ﬂuorescently labeled streptavidin with a
nuclear localization signal as an average-sized, inert protein to probe the nuclear environment. The protein was injected into the
cytoplasm of mouse cells, and single molecules were tracked in the nucleus with high-speed ﬂuorescence microscopy. We
analyzed and compared the mobility of single streptavidin molecules in structurally and functionally distinct nuclear compart-
ments of living cells. Our results indicated that all nuclear subcompartments were easily and similarly accessible for such an
average-sized protein, and even condensed heterochromatin neither excluded single molecules nor impeded their passage.
The only signiﬁcant difference was a higher frequency of transient trappings in heterochromatin, which lasted only tens of milli-
seconds. The streptavidin molecules, however, did not accumulate in heterochromatin, suggesting comparatively less free volume.
Interestingly, the nucleolus seemed to exclude streptavidin, as it did many other nuclear proteins, when visualized by conventional
ﬂuorescence microscopy. The tracking of single molecules, nonetheless, showed no evidence for repulsion at the border but
relatively unimpeded passage through the nucleolus. These results clearly show that single-molecule tracking can provide
novel insights into mobility of proteins in the nucleus that cannot be obtained by conventional ﬂuorescence microscopy. Our
results suggest that nuclear processes may not be regulated at the level of physical accessibility but rather by local con-
centration of reactants and availability of binding sites.
INTRODUCTION
Although the nucleus is the hallmark of all eukaryotic cells,
remarkably little is known of its internal structure and func-
tion. The development of antibodies and, more recently, the
ability to tag proteins fluorescently have revealed a complex
structure with multiple discrete subcompartments involved in
RNA and DNA metabolism (1,2). Unlike cytoplasmic or-
ganelles, however, subnuclear compartments are not sur-
rounded by membranes. This raises the question of how they
arise and whether they impose constraints on the accessibility
andmobility ofothermolecules. Such constraintswould impact
and thereby control nuclear functions; e.g., restricted access to
chromatin or subsets thereofwould have as a consequence their
transcriptional silencing. Furthermore, such general restricted
access to a particular subnuclear compartment in combination
with sequestration of subsets of factors to the same compart-
ment mediated by protein or protein–nucleic acid interactions
would increase not only the speed of individual nuclear reac-
tions but also their specificity (3). It is therefore necessary to
elucidate whether and how the physical structure of the nucleus
affects the dynamics and access of proteins.
Earlier studies with fluorescent dextrans showed that dif-
fusion in the cell is four to eight times slower than in aqueous
solutions (4,5). Moreover, diffusion measurements of mac-
romolecules in cells using fluorescence photobleaching, cor-
relation microscopy, and time-resolved anisotropy revealed
unexpectedly highmobilities (6). From such studies, a viewof
the cell’s interior as a watery but crowded environment rather
than a homogeneous viscous gel has emerged.
Recent studies have now combined fluorescent macromol-
ecules with subnuclear compartment labels. Labeling whole
chromatin with either fluorescent histones or with DNA dyes
and measuring the intranuclear steady-state distribution of
injected dextrans relative to chromatin density provided ev-
idence for a high degree of penetration of the probes into
doi: 10.1529/biophysj.107.115014
Submitted June 14, 2007, and accepted for publication November 16, 2007.
Ulrich Kubitscheck and M. Cristina Cardoso contributed equally to this
work.
Address reprint requests to Ulrich Kubitscheck, Institute of Physical and
Theoretical Chemistry, Rheinische Friedrich-Wilhelms-University, Wegelerstr.
12, 53115 Bonn, Germany. E-mail: u.kubitscheck@uni-bonn.de; or to M. C.
Cardoso, Max Delbru¨ck Center for Molecular Medicine, Robert Ro¨ssle Str. 10,
13125 Berlin, Germany. E-mail: cardoso@mdc-berlin.de.
David Gru¨nwald’s present address is Dept. of Anatomy and Structural Biol-
ogy, Albert Einstein College of Medicine, Bronx, NY 10461.
Volker Buschmann’s present address is PicoQuant GmbH, 12489 Berlin,
Germany.
Abbreviations used: GFP, green fluorescent protein; ASF/SF2, alternative
splicing factor/splicing factor 2; ESI, electron spectroscopic imaging; FLIP,
fluorescence loss in photobleaching; MeCP2, methyl cytosine binding pro-
tein 2; NLS, nuclear localization sequence; SAv-Cy5, streptavidin-Cy5; SMT,
single-molecule tracking; SNR, signal/noise ratio.
This is an Open Access article distributed under the terms of the Creative
Commons-Attribution Noncommercial License (http://creativecommons.org/
licenses/by-nc/2.0/), which permits unrestricted noncommercial use, distri-
bution, and reproduction in any medium, provided the original work is
properly cited.
Editor: Thomas Schmidt.
 2008 by the Biophysical Society
0006-3495/08/04/2847/12 $2.00
Biophysical Journal Volume 94 April 2008 2847–2858 2847
RESULTS
chromatin (7–9). The facts that dextrans do not have a rigid
shape and that the polymer preparations are not always ho-
mogeneous in size introduce some variability in the results
from different reports. Nevertheless, gradual exclusion from
chromatin was observed for dextrans of 77 kDa or larger (10).
Kinetic studies have also been performed investigating
RNA movement through nuclear subcompartments using
fluorescence photobleaching or uncaging as well as single-
molecule video microscopy (11–15). The outcome of these
studies indicated that most regions of the nucleus are acces-
sible to RNA particles, although some results pointed to a
preferential movement through the interchromatin space (12),
and the reports differed on its energy dependence (11,13).
A profusion of kinetics studies in recent years (16) have
measured themobility of fluorescently tagged nuclear proteins,
mostly employing fluorescence photobleaching/activation
and in some cases also fluorescence correlation microscopy.
Such analyses provided a highly dynamic view of the nu-
clear interior with proteins diffusing rapidly within the nu-
cleus and most often showing a fast exchange at their binding
sites. The experimental limitations of such photobleaching/
activation measurements and corresponding data analysis
have recently been discussed (17,18) and include a relatively
low temporal and spatial resolution as well as the difficulty in
extracting accurate physicochemical parameters (e.g., resi-
dence times). Because most of the factors measured have en-
dogenous binding partners, probing the structural accessibility
of the nuclear interior independent of their specific interactions
was not feasible. Although in other reports GFP§§ was used as
an inert tracer protein to probe the nuclear interior, no corre-
lation with the different subnuclear compartments was made.
In this study, we set out to measure how a single protein
travels through the nucleus and to determine whether its
movement is controlled by subnuclear compartmentalization,
in particular whether dense chromatin regions or the nucle-
olus restricts its access and/or mobility.
MATERIALS AND METHODS
Cell culture and transfection
Mouse C2C12myoblasts were cultured as described previously (19). For live
cell analysis, cells were seeded onto either one-well LabTek chambers (Nalge
Nunc International, Rochester, NY) or glass-bottom dishes (MatTek, Ash-
land, MA). Transfection using the CaPO4-DNA coprecipitation method (20)
and microinjection were performed 1 and 2 days later, respectively. Mouse
RAW264.7 macrophage cells were grown in RPMI-1640 medium. The hu-
man Sk-N-SH neuroblastoma cell line was grown in Minimum Essential
Medium supplemented with fetal bovine serum.
Plasmids
As reference label for the interchromatin space (‘‘speckled compartment’’)
and for pericentric heterochromatin, we transfected cells with plasmids coding
for fusion proteins of ASF/SF2-GFP (21) or MeCP2-GFP (22), respectively.
To monitor the cell cycle stage, cells were additionally transfected with RFP-
PCNA (23). Only non-S-phase cells were selected for measurements.
Probe preparation and microinjection
SAv-Cy5 (20 mM; Amersham Life Sciences, Arlington Heights, IL; labeling
ratio four to five molecules per protein) and biotin-NLS (1 mM) were mixed
1:5 ;30 min before the injection and, after 15 min of incubation at room
temperature, centrifuged at 13,000 rpm for 15min. For the SMT experiments,
the solution was further diluted 1:10 with PBS before centrifugation. Micro-
injection was carried out with an Eppendorf injection and micromanipulation
setup. The parameters for cytoplasmic microinjection were set to 0.7-s in-
jection time with 20-fPa injection pressure and 15-fPa holding pressure.
Imaging and measurements were started 60 min after microinjection to allow
cells to recover, which was ascertained by examining the cellular morphology.
Confocal microscopy and
ﬂuorescence photobleaching
Steady-state distributions for NLS-SAv-Cy5 complexes were analyzed by live
cell microscopy using a confocal laser scanning microscope LSM510Meta
(Carl Zeiss, Jena, Germany) equipped with a 633 planapochromat phase-
contrast oil-immersion objective, NA 1.4, heated to 37C. GFP was excited
with the 488-nm line of an argon ion laser, whereas Cy5 was excited at
633-nm light from a HeNe laser. The main beam splitter for both settings was
a UV/488/543/633 filter, and the secondary beam splitter was NFT545. For
the detection of GFP fluorescence, we used a band-pass filter BP500-530, and
for Cy5 detection, a long-pass filter LP650. The constitutive heterochromatin
domains were marked by the MeCP2-GFP label, and the nucleoli were
identified according to the phase-contrast image. In these domains, the re-
spective mean fluorescence intensities were calculated in the red channel and
normalized to the maximum values. The time series and FLIP experiments
were done on the same equipment using 100% power of the 633-nm HeNe
laser for photobleaching. The FLIP was performed by bleaching a spot of
3.6-mm diameter for 554-ms duration followed by one imaging scan of 0.8-s
duration and repeated 200 times.
Single-molecule microscopy
Single-molecule experiments were performed at room temperature using an
inverted wide-field microscope equipped with a 633 NA 1.4 objective lens
employing three fluorescence channels (24,25). For identification of the
pericentric heterochromatin, cells were transfected with MeCP2-GFP. In
these cells, the pericentric heterochromatin and nucleoplasmic trajectories
were recorded. The nucleoplasm was defined as the nuclear space excluding
theMeCP2 domains. Therefore, the nucleoplasmic trajectories also contained
a small fraction of traces occurring in the nucleoli. Because the nucleoli
displayed a lowconcentrationof SAv-Cy5molecules (42%, seeTable S1) and
occupied on average only 35% of the non-MeCP2-GFP regions within the
nuclei, this gives an approximate contribution of 15%. Single-molecule
experiments aimed at analyzing the trajectories within the nucleoli were
performed using C2C12 cells transfected with ASF/SF2-GFP. In these ex-
periments, nucleoli were identified according to their exclusion of ASF/SF2-
GFP. For all measurements, non-S-phase cells were selected according to
their RFP-PCNA subnuclear distribution (26), and the RFP fluorescence was
bleached completely before microinjection of NLS-SAv-Cy5 into the cyto-
plasm. After imaging of the green channel with an Axiocam (Zeiss), movies
were recorded in the red channel and illustrated the intranuclear motion of
SAv-Cy5 molecules after their nuclear import. Movies comprising 2000
frameswere acquired at a frame rate of 191Hz using an image integration time
of 5 ms. A total of 22 cells were examined yielding more than 40 single
movies. The green and red fluorescence channels were scaled and aligned to
each other as described (27).
Image processing of video images
Before data analysis, all images were filtered using a FFT band-pass filter
(high frequency threshold, 2 pixels; low frequency threshold, 20 pixels)
2848 Gru¨nwald et al.
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using ImageJ (W. S. Rasband, ImageJ, U.S. National Institutes of Health,
Bethesda, MD, http://rsb.info.nih.gov/ij/,1997–2005) to facilitate the auto-
matic detection of single-molecule signals. The effect of the filter can be
noted in Fig. 1 C (lower panels). Identification and tracking of the single-
molecule signals were performed using Diatrack 3.0 (Semasopht, Chavannes,
Switzerland), a commercial software package developed specifically to
identify and localize single-particle signals and also to detect single-particle
tracks. A maximal displacement of 15 pixels from frame to frame was al-
lowed, and a point spread function of 1.7 pixels corresponding to 325 nm
was assumed. The application of an automated scheme to our data was not
straightforward because the single-molecule data often featured low SNR
ratios. For this reason, we visually verified each detected single-molecule
track identified by Diatrack in the original, unprocessed data. The analysis
of trajectories was performed by means of user-written macros in Origin 7.5
(Microcal, Northampton, MA). The tracks were assigned to the following
compartments: pericentric heterochromatin, nucleoplasm, nucleoli, and cy-
toplasm. Each compartment was marked in a specific color using IPLab, and
this false color reference image was used for compartment assignment of the
individual tracks. All tracks in the cytoplasm and a 10-pixel border region at
the nuclear envelope were discarded to avoid evaluation of molecules being
imported into the nucleus. Furthermore, all tracks within a distance of eight
pixels from the image border were discarded.
Trajectory analysis
Identification and tracking of the single-molecule signals and analysis of the
trajectories were performed as described elsewhere (27). The probe mole-
cules moved in all three spatial directions; therefore, most molecules were
observed for only a few frames because our focal depth was limited to less
than 6400 nm (28). Such tracks were too short for an analysis based on an
approach to analyze stochastic motion, namely the plot of the mean-square
displacement of single molecules against time (29). A jump distance analysis
of the trajectories was performed. In this type of analysis, the probability that
a particle starting at a specific position will be encountered within a shell of
radius r and width dr at time t from that position is considered. For a single
species diffusing in two dimensions (30),
pðr; tÞdr ¼ 1
4pDt
e
r2=4Dt
2p r dr (1)
if we identify the starting position with the origin. Experimentally, this
probability distribution can be approximated by a frequency distribution,
which is obtained by counting the jump distances within respective intervals
[r, r 1 dr] traveled by single particles after a given time. For each
compartment, the displacements within 2 to 20 frames were calculated and
drawn in a histogram to visualize the global displacement distribution as a
function of time. In cases of particles with multiple diffusive species, the
jump distance distributions cannot satisfactorily be fitted by Eq. 1, assuming
a single diffusion coefficient. Such different mobility populations can be
detected and quantified by curve fitting taking several diffusion terms into
account (27).
Three-dimensional movement and tracking
If single molecules are tracked, all three degrees of freedom have to be
considered. In case of free and isotropic diffusion in the three-dimensional
space, all degrees of freedom are equivalent, and the observation of the
movement in respect to a single axis is sufficient to characterize the move-
ment of the probe in the three-dimensional space. Therefore, a time sequence
of images is a valid two-dimensional representation of the three-dimensional
movement of the molecule. For the limited focal depth of the SMT setup, it
was considered that the assumption above holds.
For tracking of particles within the nucleolus or the heterochromatin re-
gion, there was the possibility that the molecule traveled below or above the
compartment but within the focal depth of the microscope. To reduce false-
positive observations, we restricted the analysis for the nucleolus and the
chromatin region to signals presenting a higher SNR than accepted in the
nucleoplasm. A high SNR is most likely a result of the molecule being central
in the focal plane rather than at the border of the depth of field. Effectively
such a SNR-based filter reduces the depth of field below the 6400 nm we
estimate for the nucleoplasm. The z extension of a nucleus in a living
fibroblast cell is in the range of several micrometers. The focal plane was
adjusted to the center of the labeled compartment. Although the nucleolus
can span the entire nucleus, the pericentric heterochromatin compartments
are more likely restricted to less than 2 mm.
Electron spectroscopic imaging
Electron spectroscopic imaging (ESI) was performed as previously de-
scribed (31,32). Nitrogen and phosphorus maps were collected using a
transmission electron microscope (Tecnai 20 (FEI)) fitted with an electron
imaging spectrometer (Gatan). Cryopreservation of the macrophage cells
was performed by freeze-slamming and cryosectioning (Leica). Frozen
sections were transferred under liquid nitrogen (Gatan) to the column of the
electron microscope (Tecnai20 (FEI)), where they were freeze-dried before
imaging.
RESULTS AND DISCUSSION
Distribution of SAv within the cell nucleus
In a first series of experiments, the overall distribution and
potential interactions of SAv-Cy5 within the cell nucleus
were examined by live-cell confocal laser scanning micros-
copy and fluorescence photobleaching experiments. SAv-
Cy5 was chosen as a mobility probe because it represents an
average-size protein (60 kDa) and has no known binding sites
within the nuclear interior. SAv-Cy5 was preincubated with
a biotinylated nuclear localization sequence peptide (NLS-
biotin), and this complex was microinjected into the cytoplasm
of living mouse myoblast C2C12 cells (Fig. 1 A), which
expressed GFP-tagged MeCP2 (22). The latter recognizes
5-methylcytosines, which are very abundant in mouse con-
stitutive heterochromatin around centromeres, and thus, peri-
centric heterochromatin was very selectively marked by
green fluorescence (Fig. 1 B, central panel). The complex
was imported into cell nuclei within a few minutes (Fig. 1 B,
right panel). In the absence of NLS-biotin, no detectable
import of SAv-Cy5 into the nucleus was detected over 30
min. Careful examination of the confocal images did not
show signs of aggregation or accumulation processes of SAv-
Cy5 within specific nuclear domains (Fig. 1 and Fig. S1).
Rather, the probe fluorescence was homogeneously dis-
tributed with a slight reduction within the pericentric het-
erochromatin and unambiguous reduction within nucleolar
domains, which was already apparent when the first nuclear
SAv-Cy5 fluorescence was detected (Fig. 1 B, right panel,
60 s). A quantitative analysis revealed that the concentra-
tion of the probe molecules was reduced by only 4% within
the pericentric heterochromatin domains, whereas it was
significantly reduced within the nucleoli to 42% of the nu-
cleoplasmic level (Table S1). Clearly, the pericentric het-
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FIGURE 1 NLS-SAv-Cy5 complexes in living cells and
their nuclear import. (A) Scheme of the experimental
approach for confocal imaging and photobleaching exper-
iments and for single-molecule detection. Mouse myoblast
C2C12 cells transfected with plasmids coding for MeCP2-
GFP (green) were microinjected into the cytoplasm with
preformed NLS-SAv-Cy5 complexes as tracer molecules.
Nuclear import was followed by confocal microscopy
(CLSM), and after its completion, photobleaching exper-
iments were performed. In a separate experimental setup,
single molecules were tracked using a widefield fluores-
cence microscope (SMT). (B, left panel) Phase contrast
(PC) images of a nucleus, time points of the image
sequence as indicated. (B, middle panel) Green channel
showing the distinct MeCP2-GFP labeling of the pericen-
tric heterochromatin. (B, right panel) confocal time lapse
images acquired in the red channel after the cytoplasmic
microinjection of NLS-SAv-Cy5 complexes, demonstrat-
ing efficient nuclear import. (C) In the single-molecule
setup, single SAv-Cy5 molecules could be observed while
entering into the nucleus (white arrows) across the nuclear
envelope (red dotted line). Further molecules could be
identified and tracked within cytoplasm or nucleus (black
arrows). In the upper panel unprocessed data are shown; in
the lower panel, the effect of bandpass filtering used for
further processing is demonstrated. Scale bars, 5 mm.
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erochromatin was not packed densely enough to produce a
significant exclusion of proteins of the size of SAv, which is
similar to measurements of the distributions of fluorescently
labeled sugars (7,9).
To more rigorously control for possible interactions of our
probe molecules with intranuclear structures, we performed
FLIP experiments. On repeated bleaching of selected spots
within nuclei, the fluorescence intensity inside the remaining
nuclear space decreased homogeneously (Fig. S2). Alto-
gether, the confocal and photobleaching data clearly indicated
that SAv-Cy5 did not bind noticeably within any nuclear
domain and suggested that compartment borders presented no
major hindrances for the molecules to enter and leave distinct
nuclear compartments.
Single-molecule tracking allows real-time
imaging of intracellular molecular motions
We recently demonstrated that single SAv-Cy5 molecules in
aqueous buffer solution may be visualized by high-speed
single-molecule microscopy at a frame rate of 340 Hz (20).
Because it is generally assumed that the intracellular viscosity
is at least four times higher than in aqueous solution (6), we
were confident that movies recorded at frame rates of 200 Hz
would produce realistic real-time movies of the intracellular
motion of SAv-Cy5 molecules. SAv-Cy5 coupled to NLS-
biotin was microinjected at a low concentration so that the
diffraction-limited signals originating from single probe
molecules within the cell nuclei could be singled out. One
hour after the microinjection, single cell nuclei were imaged
in the green fluorescence channel to identify the nucleoplas-
mic, pericentric heterochromatin and nucleolar compart-
ments. Then, SAv-Cy5fluorescencewas excitedwith 633-nm
laser light, and single-molecule signals were recorded with
high temporal and spatial resolution for ;10 s with a frame
rate close to 200 Hz (see Movie S1). In Fig. 1, three sample
frames from one of the movies are shown, where, e.g., the
entry of a single probe molecule into a cell nucleus can be
observed (white arrows). Further mobile single molecules
within the nucleus or the cytoplasm (black arrows) can be
recognized as diffraction-limited bright spots.
Such movies showing the intracellular motion of single
molecules contain a wealth of information. To extract this
information we identified and localized the single-particle
signals and the corresponding single-molecule trajectories.
Because we had taken the GFP reference images for all nu-
clei, we could exactly locate each track within the context of
the different intranuclear domains (Fig. S1).
Individual trajectories reveal predominantly
highly mobile probe molecules
A plot of all probe molecule trajectories observed within a
10-s time window within the corresponding green reference
image provided a direct first impression of the intranuclear
probe molecule mobility (Fig. 2). It was immediately obvious
that the great majority of the molecules were mobile. At first
glance, the trajectories within the pericentric heterochromatin
showed no obvious difference from those in the nucleoplasm.
Most importantly, it appeared as if the probe molecules could
jump into and roam through the pericentric heterochromatin
with apparently no hindrance (Movie S1). Most trajectories
were relatively short with a mean length of 6.2 frames (me-
dian four frames) for this cell, which supported the existence
of a high mobility because highly mobile molecules tend to
leave the focal plane very rapidly (28).
In the next step, we distinguished twomain classes of traces:
whereas most molecules traversed larger distances, others
stayed in confined regions (Fig. 2). The individual positions of
tracks belonging to the second class were typically scattered
in small regions with diameters of;100 nm (Fig. 2). This size
corresponded to the localization precision of the instrument,
which is mainly limited by the SNR of the single-molecule
signals (33). Therefore, either thesemoleculeswere completely
FIGURE 2 Individual SAv trajectories within a MeCP2-GFP-labeled cell
nucleus. Trajectories of single NLS-SAv-Cy5 (Fig. 1 C and Movie S1)
showing different mobilities and located in different nuclear subcompart-
ments were located and identified with Diatrack 3.0. The MeCP2-GFP
reference image was recorded before the acquisition of the single-molecule
movie and inserted as a background for the trajectory plot. The figure shows
all trajectories identified in the data of Movie S1. The dark gray lines show
the borders of the MeCP2 domains (light gray), and the white line indicates
the nuclear region considered for the evaluation. The overlaid single-
molecule tracks are shown in different colors to better distinguish tracks
that appear in the same nuclear region. In total, 63 tracks were identified at
this measurement, and each 10 consecutive tracks are drawn in the same
color. The radius of the spots (100 nm) corresponds to 2s with s designating
the experimental localization precision of 650 nm. Hence, movements
beyond that radius represent true diffusional steps with a probability of 95%.
Scale bar, 1 mm.
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immobile, or their restricted motion within the 100-nm-sized
region could not be further resolved. Binding processes can
lead to the occurrence of this behavior, as was observed in the
case of intranuclear splicing factor mobility (34,27). For ex-
ample, for single uridine-rich small nuclear ribonucleoprotein
particle (U1snRNP) we observed immobilization in ;75%
of all trajectories analyzed, and measured local dwell times
often longer than 150 ms in live cells. However, such a be-
havior was neither expected nor observed for a nonfunctional,
ectopic protein such as SAv, and our photobleaching results
(Fig. S2) directly argued against binding of SAv to intracel-
lular structures. Thus, we concluded that the virtually mo-
tionless molecules were actually trapped in local structures
with dimensions smaller than the 650-nm localization pre-
cision of our instrument. The intranuclear space is filled with
an extremely complex and intricate network of chromatin fi-
bers, which presumably form all types of structures including
caves and mazes. Mobile protein molecules encountering
such structures may be caught and transiently trapped there
until their own stochastic motion—or chromatin movements—
lead to liberation.
The analysis of individual molecule trajectories provided
further insights into the intranuclear probe dynamics. An
example is given in Fig. 3, where the last frame represents a
maximum-intensity projection of the frames shown. The
trajectory revealed a molecule that was obviously moving
from one trap to another. Although trapping of the molecule
leads to an accumulation of signal, the mobile part of the
trajectory presents a fading signal in the time projection be-
cause of the short time the molecule is observed at any one
position. Hence, trapping was a reversible process and some-
timespersisted long enough that such traces could be identified.
The existence of structural traps would be further sup-
ported if trapping would occur repeatedly in the same spatial
intranuclear regions. SAv distributed homogeneously within
the nucleus and showed no specific binding sites. Therefore,
the observation of two different molecules at exactly the
same site by pure chance would be exceptionally improbable
considering the extremely low concentration used in our
experiments, which argues for the existence of stable struc-
tural traps in the nucleus. But indeed, such events were ob-
served (Fig. S3).
Different modes of mobility were present within
the cell nucleus, but probe molecules were
extremely mobile within all three compartments
To obtain a general picture of the SAv-Cy5 mobility, we
analyzed the distances covered by the probe molecules be-
tween subsequent frames, the so-called jump distances. Be-
cause the probe molecules moved in all three spatial
directions and our focal depth was limited to less than 6400
nm (28), most molecules were observed for only a few
frames. Fig. 4, A, C, and E shows the jump distance distri-
butions for SAv-Cy5 molecules that were observed within
nucleoplasm, pericentric heterochromatin, and nucleoli, re-
spectively, with the largest number observed within the nu-
cleoplasm. All three distributions could not satisfactorily be
fitted assuming a single diffusion coefficient (Eq. 1), in con-
trast to jump distance distributions of molecules moving in
free solution (35,33). An advantage of the jump distance
analysis is, nonetheless, that different mobility populations
can be detected and quantified by curve fitting (27). For the
SAv-Cy5 data, a sum of three diffusion terms was required,
and the fitting results were indicated by the red lines in Fig. 4,
A, C, and E. Two fractions, f2 and f3, corresponded to fast
motion with diffusion coefficients of D2 ¼ 0.8 mm2/s and
D3 ¼ 5 mm2/s, whereas the first fraction f1 corresponded to
molecules that appeared motionless on the time scale of the
measurements (Table 1). This latter fraction corresponded to
those molecules that were interpreted above as trapped.
The data in Table 1 suggested differences between com-
partments in the ratios of shorter to longer jumps, which were
only apparent and partly caused by differences in the sub-
compartment size and geometry. Therefore, we conclude that
the general mobility pattern in all three nuclear compartments
was comparable.
Single-molecule tracking revealed short-lived
trapping of the probe molecules
SAv-Cy5 molecules of fraction f1 (Table 1) did not move
beyond the average localization precision of our system,
namely sp ¼ 50 nm (s2p ¼ 4D1 t; with t ¼ 5 ms). This
fraction corresponding to trapped molecules occurred pre-
dominantly within the pericentric heterochromatin (49% in
f1), less within the nucleoplasm (25% in f1), and least within
the nucleoli (10% in f1). The latter value was especially
striking because there was still a 2.5-fold reduction between
nucleoplasm and nucleoli. The fact that a noticeably smaller
fraction of trapped molecules was observed here than in the
pericentric heterochromatin suggested that the nucleolar en-
vironment contained fewer traps for SAv-size molecules than
pericentric heterochromatin.
To highlight the distinct properties of the three compart-
ments, we divided the jumps into two fractions and examined
their time dependence. The first fraction contained jumps of
trapped molecules, with jump distances smaller than 2sp:
The second fraction contained the mobile molecules per-
forming jumps between 100 and 700 nm. Fig. 4, B, D, and F,
shows the time dependence of these fractions. It was obvious
that the number of observations for both fractions decreased
very rapidly with time. Although this was expected for mo-
bile molecules because they frequently and rapidly jumped
out of the focal plane, it was not so for trapped molecules. For
these, the decay time, rather, reflected the time span for which
they were motionless. The number of the total trapped events
detected decayed rapidly with a kinetics that could be de-
scribed by a biexponential decay with an averaged time
constant of 22–25 ms for the pericentric chromatin domains
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and nucleoplasm and even faster (7 ms) for the nucleoli.
Clearly, the immobilization or trapping incidents were short-
lived in comparison to functionally relevant binding events,
as in the case of splicing factors, which displayed a threefold
larger immobile fraction with average binding times of .60
ms (34). The short trapping times of the SAv-Cy5 explain
why they could not be measured in the bulk photobleaching
experiments, which were performed at much longer time
scales (Fig. S2).
Altogether, we conclude that on a time scale .100 ms,
SAv was freely mobile in all nuclear compartments. How-
ever, on the millisecond timescale, many more molecules
were trapped within the pericentric heterochromatin than
within the nucleoplasm and especially the nucleoli. The
different trapping abilities could in part be related to SAv
complexation with the NLS peptide.
Compartment borders did not form barriers
In contrast to cytoplasmic organelles, functional compart-
ments in cell nuclei are not separated from each other by
membranes. The question of how nuclear subcompartments
are maintained is therefore a matter of debate. In principle,
even molecules that, at equilibrium, are equally concentrated
in two distinct domains may encounter hindrance in crossing
the domain borders. Thus, we analyzed in detail the jumps
performed by molecules that crossed between nucleoplasm
and pericentric heterochromatin and between nucleoplasm
and nucleoli, respectively. The distance distributions of these
jumps are shown in Fig. S4. For both types of compartment
crossings, broad distributions of jump distances were found.
Very short jumps were underrepresented compared with the
distribution within the compartments (compare to Fig. 4)
because of the selection criterion that a border had to be
crossed. Still, it was remarkable that all jump distances up to
800 nm occurred, indicating that the border region of neither
compartment represented a significant hindrance for the SAv-
Cy5 probe. This view was supported by the visual impres-
sions from the movies, where one could see in several cases
that the probe molecules changed from the nucleoplasm into
the perichromatin domains with no apparent hindrance or
delay. Finally, it could be clearly seen that, for jumps cross-
ing the pericentric heterochromatin, the ratio of short jumps
to longer jumps was significantly higher than for the nucle-
olus, strengthening the result of a higher mobility in the nu-
cleolus (Fig. 4 and Fig. S4).
Different environments in the nucleus
On the basis of the almost 60% lower accumulation of SAv-
Cy5 in the nucleolus (Table S1), we postulated that there is
FIGURE 3 Repeated trapping of a single SAv molecule. An example of a
molecule switching between different modes of motion is shown in a
magnified view. (A) The raw data sequence, filtered with an FFT band pass
(see Material and Methods), is shown. The last image shows a maximum
projection of the trace. Scale bar, 1 mm. Individual frames are marked in a
color corresponding to the fitted positions shown in B. Although the
molecule was seen in a fixed state at the beginning (red positions, state
1), it was released after 12 frames (blue, state 2) but was trapped again for
eight more frames (cyan, state 3). (B) The positions of the molecule observed
in A were fitted and plotted on a nanometer scale.
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less free volume available than in the surrounding nucleo-
plasm. This would be in accord with measurements of protein
concentrations in different nuclear bodies performed in Xen-
opus egg nuclei (36). The lower percentage of immobilized
molecules (Fig. 4) and the fact that the nucleolar border did
not impede the access of SAv-Cy5 molecules (Fig. S4) nev-
ertheless reflect a highly permeable compartment. This is
surprising because this nuclear subcompartment is thought to
be a mass-dense structure comprised of rDNA, RNA poly-
merase I transcription/splicing apparatus, rRNA transcripts,
preribosomes, and many proteins that are not involved in ri-
bosome biogenesis. To address this question, it is important to
consider whether the viscosity of the nucleolus is high be-
cause of a high concentration of nucleic acid and protein or
whethermolecules experience a reduced free volume but have
unimpeded access. Therefore, we measured the relative mass
density of the nucleolus and nucleoplasm from sections of
conventionally fixed cells by ESI and from freeze-dried cryo-
sections of cryofixed cells.
With ESI, the biological structure is visible without heavy
atom contrast agents (e.g., uranium salts) because of energy
loss events detected by an imaging electron spectrometer.
FIGURE 4 Global distributions of jump distances in the
nuclear subcompartments. The distributions of jump dis-
tances occurring between subsequent frames (within 5.22
ms) are shown in panels A, C, and E for the three
compartments. The distributions were fitted with a three-
component model using the diffusion coefficients D1 ¼
0.15 mm2/s (for the fixed fraction), D2 ¼ 0.8 mm2/s, and
D3 ¼ 5 mm2/s. The data could not be fitted satisfactorily
assuming only one or two diffusing components. The
fraction of molecules in each mobility class varies strongly
between compartments (see Table 1). In panels B, D, and
F, the loss of observations over time was monitored for the
different compartments. The jumps were binned into two
classes: displacements ,100 nm (corresponding to the
twofold localization precision) and .100 nm. The limited
compartment size of pericentric heterochromatin and the
nucleolus makes the observation of large jumps less
probable, and hence, very long jumps .700 nm were not
considered.
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Background mass contributions from the embedding resin
can be removed in the analysis. Intensity values in an image
recorded at 120 eV, before the carbon K edge, provide a
direct measure of the mass density. Relative mass densities of
various regions of interest can also be obtained. A region
corresponding to a nucleolus and a region corresponding to
the nucleoplasm are shown (Fig. 5 A). The ratio of the mean
intensity of these two regions was 112/58 ¼ 1.93. The mean
ratio of nucleolus mass density to nucleoplasm mass density,
measured for eight nucleoli in six cells, was 1.646 0.34 and
varied from 1.20 to 2.17. The variation between measure-
ments may be related to the degree of extraction of soluble
protein from the nucleoplasm during the fixation, dehydra-
tion, and embedding procedure. It is possible that the degree
of extraction is greater from the nucleoplasm than from the
nucleolus. To avoid this complication, and to obtain a ratio of
mass density between the nucleolus and nucleoplasm that
accurately reflects that of an intact cell, we cryofixed a pellet
of RAW cells (macrophages) by freeze-slamming. The cell
morphology indicated good cryopreservation with a minimal
degree of ice crystal damage. The mass density of the nu-
cleolus relative to that of the nucleoplasm in the regions in-
dicated (Fig. 5 B) was 62/47 ¼ 1.32. The average ratio
measured from 12 nucleoli in 12 cells was 1.556 0.32. These
measurements clearly indicate substantially less free space
within the nucleolus in relation to the surrounding nucleo-
plasm, which likely is a major reason for the lower concen-
tration of proteins such as the SAv-Cy5 with no binding sites
in this compartment.
Although the nucleolus showed a higher mass density, the
probe molecules had no hindrance in penetrating the nucle-
olus and were highly mobile within it. Therefore, we further
analyzed the ultrastructure of this compartment by acquiring
high-resolution electron spectroscopic images of the nucle-
olus. Nitrogen and phosphorus mapping by ESI can be used
to delineate protein- from nucleic acid-based structures and
provide structural detail without the use of heavy atom con-
trast agents. The phosphorus map provides contrast pre-
dominantly of nucleic acid. Chromatin fibers, for example,
were readily apparent (Fig. 5,C–G, yellow fibers in the region
labeled ‘‘Nucleoplasm/Chromatin’’). If the phosphorus sig-
nal is subtracted from the nitrogen signal, protein structures
that do not overlap with chromatin can be visualized (blue
signal in Fig. 5, E–G). Features of nucleolar structure could
be identified with this approach, such as the chromatin on the
periphery (Ch), chromatin within the nucleolus (NuChro-
matin), the granular compartment (GC), and the dense fi-
brillar component (DFC). It is apparent that the nucleolus
could be permeable to proteins, such as SAv-Cy5 (5.3-nm3
4.5-nm barrel-shaped structure). The structural features that
support this are:
1. Channels through the interior of the nucleolus (Fig. 5 G,
arrowhead).
2. Gaps of 10–30 nm between granules (preribosome sub-
units) in the granular component.
3. Spaces between RNA fibers in the dense fibrillar compo-
nent (DFC). Although there is also a high concentration of
protein in this subcompartment, it may reflect protein that
became fixed in place during fixation and dehydration
steps. It should be possible for small molecules to diffuse
through this provided they do not bind to the RNA or the
RNA-associated proteins. Molecules from the nucleo-
plasm could easily penetrate the nucleolus through regions
where the peripheral chromatin density was not extreme,
such as that seen in Fig. 5 D, or through the granular
component, which is typically observed on the periphery
of the nucleolus.
Our main conclusions are summarized in Fig. 6. Nucleo-
plasm and pericentric heterochromatin are dominated by the
presence of chromatin fibers, albeit to different densities,
whereas the nucleolus is composed largely of ribonucleo-
protein particles, i.e., ribosomes. It should be noted that the
nucleoplasm is a very heterogeneous compartment, and, for
simplicity, splicing speckles, Cajal bodies, and other nuclear
bodies were not considered. Because pericentric hetero-
chromatin in the mouse constitutes 10% of the total genome
and occupies a volume of ;5% of the nucleus (data not
shown), this results in a twofold higher chromatin concen-
tration on average in the pericentric heterochromatin sub-
compartment and consequently less free space. This agrees
with measurements of the relative concentration of GFP-
tagged histone distribution (37). In the case of the nucleolus,
based on the almost 60% lower accumulation of SAv and the
1.5 times higher mass density, we conclude that there is less
free volume available than in the surrounding nucleoplasm.
In general, the nuclear subcompartments were easily acces-
sible to a small protein such as SAv, and their borders did not
form barriers because molecules could move unimpeded in
and out of each compartment. Obviously, the pericentric
heterochromatin was not packed densely enough to produce
significant exclusion of proteins of the size of SAv, and,
hence, reduced heterochromatin physical accessibility per se
should not be a major determinant of genome silencing.
Different mobility distributions were detected on a millisec-
TABLE 1 Fraction of molecules in each mobility class
derived from the analysis of jump distances occurring within
5.22 ms
Nuclear domain
f1*
y D ¼
0.15 mm2/s
f2
y D ¼
0.8 mm2/s
f3
y D ¼
5 mm2/s f2 1 f3
Nucleoplasm 25 6 1 32 6 1.5 43 6 2.5 75
Pericentric heterochromatin 49 6 1 34 6 2 17 6 2 51
Nucleoli 10 6 1 57 6 1 33 6 2.5 90
*The first fraction with D ¼ 0.15 mm2/s corresponded to the immobile
fraction (because sp ¼ 50 nm 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
43 0:15mm2=s3 0:005 s
p
and f2 1 f3 to
the total mobile fraction).
yThese fits were performed with the diffusion coefficients held constant
to obtain results for the amplitudes that were directly comparable. Free fits
yielded similar results with only slight deviations from the given parameters.
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ond time scale by SMT with short-term trapped molecules in
all compartments. In detail, the percentage of trapped SAv
molecules was higher in the pericentric heterochromatin
and lowest in the nucleolus; i.e., it correlated inversely with
the amount of chromatin. Also, the retention or decay times
of immobile molecules in heterochromatin and nucleoplasm
were longer (.20 ms) than in the nucleolus (;7 ms).
These observations suggested that molecular trapping is
FIGURE 5 ESImass-densitymeasure-
ments of the subnuclear compartments.
(A) ESI of an Sk-N-SH neuroblastoma
cell nucleus. The image was recorded at
120 eV energy loss. Sample preparation
involved fixation in 2% paraformalde-
hyde for 30 min, followed by fixation in
0.5% glutaraldehyde overnight. Cells
were dehydrated in ethanol and embed-
ded in Qetol resin. Then 70-nm sections
were picked up on 400-mesh electron
microscopy grids, which were subse-
quently coveredwith a 3-nm carbon film
picked up from the surface of water. The
ratio (nucleolus divided by nucleo-
plasm) of the average intensity values
of the two regions indicated is 1.93. (B)
Bright-field image of a macrophage cell
(RAW) cryopreserved by slam-freezing.
The frozen hydrated sections were
picked up onto a copper grid coated
with a 3-nm carbon film. The grid was
transferred to the electronmicroscope at
liquid nitrogen temperature. The section
was freeze-dried in the microscope col-
umn before imaging. The removal of
water and the absence of a resin embed-
ding material allow for very high con-
trast without the need for heavy atom
contrast agents. The images, therefore,
provide mass-density information. The
ratio (nucleolus divided by nucleo-
plasm) of the average intensity values
of the two regions indicated is 1.32. (C)
Low-magnification mass-sensitive im-
age of an Sk-N-SH cell recorded at 120
eV. (D) Net phosphorus image of a field
from the nucleus presented in C. The
arrows inC andD provide a fiduciary for
each image and indicate the slight rota-
tion between the images recorded at
different magnifications. (E) The net
phosphorus image was subtracted from
the net nitrogen image (the resulting
signal was represented in shades of
blue). The net phosphorus signal (yel-
low) was superimposed on the nitrogen-
phosphorus signal. GC, DFC and Ch
represent granular component, dense
fibrillar component, and chromatin, re-
spectively. (F) High magnification of a
field in E. Chromatin fibers can be visu-
alized in the nucleoplasm, bordering
the nucleolus, and within the nucleolus
(referred to as NuChromatin in G). (G)
Identification of different regions and
structures associated with nucleolus.
Scale bar represents 4 mm in A–C,
1 mm in D and E, and 280 nm in F.
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possibly a result of short-term nonspecific chromatin inter-
actions.
An alternative explanation for the very large differences
detected in local mobility (Fig. 3) would be strongly differing
local viscosities. However, this possibility could clearly be
ruled out by our data. Small local domains of higher viscosity
would not be stable over time but would rapidly be smeared
out and vanish. However, we observed that the structural
properties leading to the immobilization or trapping were
stable over time (Fig. S3). We, therefore, conclude that short-
term trapping of proteins is responsible for their slower dif-
fusion within the cell nucleus.
In summary, our results indicate that nuclear structure af-
fects the mobility and local concentration of proteins andmay
thus contribute to the regulation of nuclear processes. The
transient, short-time trapping of proteins at chromatin may be
a feature of the functional architecture of the nucleus and a
general strategy to scan the genome for potential binding sites.
An additional function of the cationic NLS could also be to
enhance such binding. The observation that single molecules
move freely in and out of the nucleolus sheds new light on the
accessibility of this most prominent structure of the nucleus.
Althoughwide-field epifluorescence images suggest a blocked
access, the single-molecule tracings and ESI presented here
rather argue for a reduced free volume in combination with a
lower ability to trap molecules, i.e., lower retention. This free
accessibility of the nucleolus has obvious consequences for
possible modes of regulation and underscores the importance
of SMT in studying the access and interaction of proteins with
subcellular compartments.
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Online Supporting Table 
Table SI. Quantitative analysis of the nuclear distribution of NLS-SAv-Cy5. 
Nuclear 
compartment 
Mean Fluorescence 
(CLSM) $ 
Relative Particle 
Density (SMT) § 
Nucleoplasm 1 1 
Pericentric 
Heterochromatin 
0.96 ± 0.09 0.83 ± 0.16 
Nucleolus 0.42 ± 0.05 0.58 ± 0.12 
$ Mean intensity of the Cy5 fluorescence was determined in MeCP2-GFP 
labeled pericentric heterochromatin, the nucleoli and remaining nucleoplasm 
from confocal microscopy (CLSM) images (see Fig. S1). 
§ In the single molecule tracking data (SMT) the number of particles per total 
compartment area was calculated. The particle number was extrapolated from 
the number of jumps. 
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Online Supporting Figures 
Figure S1. Steady state distribution of NLS-SAv-Cy5 complexes in nuclear 
subcompartments. 
(A) A C2C12 cell expressing MeCP2-GFP was microinjected into the 
cytoplasm with NLS-SAv-Cy5 complexes, and imaged 90 min later by 
confocal laser scanning microscopy. (B) The complexes distributed 
homogeneously in the cytoplasm and nucleus but showed a much lower 
concentration in the nucleoli, (C) which were identified according to the phase 
contrast (PC) image. (D) For the quantitative analysis of steady state 
distributions (see Table SI) the boundaries of the nuclei were determined in 
the green fluorescence (MeCP2-GFP) or phase contrast image. A border 
region near the nuclear envelope (width 0.95 µm, orange) was excluded from 
the analysis. The pericentric heterochromatin was identified by the bright 
MeCP2-GFP signal (yellow). Nucleoli (blue) were marked according to the 
phase contrast image. Scale bar, 5 µm. 
Figure S2. NLS-SAv-Cy5 complexes do not form aggregates and are 
completely mobile within the nucleus and cytoplasm.  
Fluorescence photobleaching experiments were performed in C2C12 mouse 
cells expressing MeCP2-GFP (green, pericentric heterochromatin), which had 
been microinjected into the cytoplasm with NLS-SAv-Cy5 (red) 90 min before. 
(A) For FLIP, the Cy5 fluorescence was bleached within a small spot (BA) in 
the nucleus (N) with 100% laser power at 633 nm followed by acquisition of 
an image. This cycle was repeated 200 times and numbers above the NLS-
SAv-Cy5 fluorescence image indicate the imaging/bleaching cycle. At the end 
of the FLIP experiment the nuclear and cytoplasmic Cy5 fluorescence was 
completely lost. The FLIP curve in (B) shows the loss of Cy5 fluorescence (as 
mean fluorescence intensity, FI) in the nucleus (red curve) averaged for 10 
cells. A fast loss of the nuclear fluorescence indicated a very high mobility and 
no binding or aggregation of the NLS-SAv-Cy5 complexes. 
 
Figure S3. Temporal stability of trapping sites in the nucleoplasm. 
The existence of structural traps would be supported, if trapping could occur 
repeatedly in the same spatial intranuclear regions. The observation of two 
different molecules at exactly the same site by pure chance is, however, 
exceptionally improbable considering the extremely low concentration used in 
our experiments. However, we did observe such an event. The first molecule 
entered into the confined region at frame 421 and remained there for 41 
frames. The same region was revisited at frame 522 and finally at frame 883. 
Revisiting events were rare, but still they show the temporal stability of 
nuclear structures. Scale bar, 5 µm. 
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Figure S4. Streptavidin can cross compartment borders without hindrance. 
Examples for tracks of molecules diffusing rapidly between the nucleoplasm 
and the heterochromatin (dark green, A and B) and to the nucleolus (bright 
green, C). (D) Jump distance distributions of particles crossing compartment 
borders. The relative frequency of short jumps is significantly decreased 
compared to the individual compartments (see Fig. 4), since crossing of the 
border is more probable when a particle performs a large jump than for an 
almost immobile particle. Scale bar, 1 µm. 
 
Movie 1. Probing mammalian nuclear compartments with single streptavidin 
molecules. 
The movie shows NLS-SAv-Cy5 molecules after microinjection into the 
cytoplasm. An overlay of the heterochromatin compartment staining (green) 
and the NLS-SAv-Cy5 moving through the cell (red) is shown.  The data was 
recorded at 191 Hz, and the display rate is 20 Hz, which corresponds to about 
10-fold slower motion. On the right hand side raw single molecule data are 
displayed; on left hand side the SMT raw data were processed using a 2-20 
pixel band pass filter. One pixel corresponds to 96 nm and the whole object 
field shown is 12.2 µm x 12.2 µm. NLS-SAv-Cy5 is concentrated around the 
nuclear border, while single molecules can be distinguished inside the 
nucleus. 
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4 Discussion and outlook
The relationship between nuclear structure and function and its impact on the 
regulation and performance of cellular functions are studied today more and 
more in living cells. With the development of new microscope techniques we 
gain higher resolution in space and time for the observation of molecule 
distribution and mobility. We have analyzed the influence of nuclear structures 
on the localization and movement of proteins and its implications for the 
regulation of the nuclear metabolism in living cells. During these investigations 
we developed techniques to label nuclear structures, improved and 
characterized the delivery of molecules and studied the distribution and 
mobility of molecules by confocal and single molecule fluorescence 
microscopy in living cells. 
4.1 The labeling of nuclear substructures in living cells
In this work different DNA dyes were compared and tested for their usefulness 
in labeling chromatin in living cells. The purpose was to use fluorescent dyes 
as costainings in confocal fluorescence microscopy studies to test molecule 
distribution and dynamics with respect to chromatin in living cells. General 
requirements for a live cell DNA dye are membrane permeability, 
stoichiometric labeling without sequence specificity, low cytotoxicity, 
complementation with many other fluorophores, a high fluorescence yield and 
low photobleaching as well as non-harmful excitation.
We have tested five nucleic acid dyes (propidium iodide [PI], TOTO-3, 
TOPRO-3, Hoechst 33258 and DRAQ 5), from which only Hoechst and 
DRAQ5 show membrane permeability and could be used in living cells. The 
DNA dye DRAQ5 fulfills several of the requirements listed above. It exhibits a 
good correlation with the labeling of chromatin like histone GFP fusion proteins 
and its fluorescence excitation and emission is in the deep red spectrum of 
visible light (λex= 647 nm \ λ em= 670 nm). Furthermore, it displays almost no 
photobleaching, low cytotoxicity and can be easily applied to living cells. The 
disadvantages of DRAQ5 are that it inhibits cell cycle progression in late S/G2 
phase, which make its  long time use over several cycles impossible. A minor 
point is the decrease of labeling over many hours  in certain cell types with 
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efficient detoxifying metabolism (Martin et al., 2005). Altogether DRAQ5 fulfills 
several of the requirements for a live cell DNA dye. The Hoechst family of 
DNA dyes is one of the few alternatives for DNA specific, cell permeable dyes, 
but is highly toxic to live cells  and requires harmful UV excitation, which leads 
to a very restricted observation time (Durand and Olive, 1982). Furthermore 
one has to take into account interference effects  of dye molecules that bind to 
DNA with the dynamics on chromatin proteins (Davis and Bardeen, 2003).
The general advantage of fluorescent dyes over fluorescent fusion proteins is 
that they are easily introduced into cells. Upon addition to the growth medium 
labeling occurs within minutes. Transfections are more complex procedures 
and it takes several hours until expression. Finally, in live cell experiments it 
could be useful to identify the DNA and chromatin only from a defined time 
point on in an experimental series e.g. timeseries imaging, photobleaching of 
fluorescent dyes or proteins with similar spectral properties. On the other hand 
fluorescent fusion proteins are not toxic at moderate expression level and 
enable long term observations without disturbing cellular functions (Kanda et 
al., 1998).
Figure 6: Summary of methods used to label nuclear structures in live cells.
A relatively novel method to non-invasively introduce molecules into living cells 
for labeling purposes is  the use of membrane penetrating peptides also termed 
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cell penetrating peptides  (CPP) (Wadia and Dowdy, 2002). We exploited this 
mechanism and developed a peptide combining membrane penetration with 
the ability to accumulate and thereby label the nucleoli of living cells. The 
peptide consists of 10 arginines in the D-conformation to prevent proteolytic 
degradation and is coupled to a fluorescent dye molecule for visualization in 
fluorescence microscopy. The nucleolar marker can simply be added to the 
culture medium of living cells and then quickly labels  the nucleoli of different 
cell types with high efficiency and no harmful side effects (Martin et al., 2007a).
The combination of DNA and chromatin labeling by dyes and protein fusions 
with permanent, photoactivatable or photoconvertable GFP versions in diverse 
colors as well as transducible fluorescent peptide markers are powerful tools to 
study the structure and function of the nuclear components in living cells. A 
summary of the advantages and disadvantages of the different methods is 
given in Fig. 6.
4.2 Delivery of macromolecules by cell penetrating peptides in live cells
Beside the introduction of labeling components the membrane penetrating 
peptides can also shuttle bioactive cargoes like drugs, signal molecules  or 
connected peptides into living cells. Several groups have shown intracellular 
effects transmitted by the introduction of molecules  by CPP into live cells 
(Nagahara et al., 1998; Nolden et al., 2006; McCusker et al., 2007). We have 
analyzed the mechanism of membrane transduction, intracellular fate and 
effects of delivered bioactive peptides and proteins directly in live cells by 
fluorescence microscopy (Tunnemann et al., 2006; Tunnemann et al., 2008). 
With this  approach we have prevented artifacts in the cell permeation and 
localization due to fixation treatments (Richard et al., 2003; Vives et al., 2003). 
In accordance with other studies we found that peptides cross plasma 
membranes of cells via a unique endocytosis independent mechanism that 
does not require energy, but is  linked to the membrane potential and of 
differing efficiency between cell types (Duchardt et al., 2007; Fretz et al., 
2007). In contrast to peptide constructs, the proteins and nanoparticles 
coupled to CPP are taken up exclusively in endocytic vesicles of live cells. The 
lack of detectable transduced CPP proteins and nanoparticles  is probably due 
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to the large MW and a globular conformation added to the CPP. On the other 
hand we could demonstrate intracellular effects  of internalized TAT-Cre-
recombinase protein constructs in a very sensitive recombination assay. The 
Cre recombinase was fused to the transduction peptide domain of the HIV 
transactivator of transcription (TAT). It remains unclear whether and how the 
TAT-Cre escapes from vesicles or whether they enter by transduction.
A major advantage of the application of CPP is that the transduction functions 
with virtually all cell types including primary cells, that are usually very difficult 
to transfect (Mi et al., 2000). On the other hand the labeling of specific cells in 
a tissue is difficult because of the non selective membrane transduction 
affecting many cells or tissues (Fawell et al., 1994). Curiously, in all our 
experiments a few cells always resisted membrane transduction, which could 
represent genetic or epigenetic differences in gene expression among the cells 
in the culture (Tyagi et al., 2001) or in their metabolic state. Other groups have 
shown that the unspecific uptake of CPP can be reduced in some cell types by 
designing peptide constructs  with a protease sensitive linker. This peptide is 
exclusively cleaved on the surface of certain tumor cells  and taken up 
preferentially by this cell type (Jiang et al., 2004).
Our results show that membrane penetration is  a concentration dependent 
process with a requirement for an amino acid composition consisting of poly-
arginines in contrast to non transducing poly-lysines. Very high concentrations 
of CPP added to live cells exert toxic effects most probably due to membrane 
disruptions, but concentration windows with high transduction and low 
cytotoxicity could be determined. Further the transduction potential increases 
with the length of the arginine peptide chain with an optimum at 9-10 Arg and 
is  further improved by the use of protease resistant D-isomers of the amino 
acids (Tunnemann et al., 2008). These result are in contrast to other findings 
that reported a transduction threshold concentration (Fretz et al., 2007) and 
are in more agreement with a report suggesting a dependency on the peptide 
to cell ratio (Hallbrink et al., 2004). Accordingly, in our study very low 
concentrations of the optimal performing poly-arginines also did not show 
transduction, most probably due to a low charge to membrane area ratio. 
These different results on the transduction dependency could be explained by 
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the high variability of transduction between different cell types and the use of 
peptides with different length, varying concentrations and amino acid isomers. 
Although we found a linear dependency of peptide concentration and 
transduction, the control of the amounts of CPP entering the cells  remains 
difficult since the transduction process can not be stopped.
The intracellular fate of CPPs is determined to a large extend by their similarity 
with nuclear and nucleolar targeting sequences that contain a high number of 
basic charged amino acids. This  leads to the accumulation of CPP like TAT 
and poly-arginines  in the nucleolus (Martin et al., 2007a). Despite this  fact, we 
could show a high mobility, fast exchange rates and overall intracellular 
availability of a TAT-p21WAF/Cip-PBD construct. Additionally, the functional 
interaction of the PCNA binding domain (PBD) peptide with PCNA exhibited a 
biological effect and affected cell cycle progression. 
Figure 7: Application of cleavable peptide constructs for efficient intracellular release 
of cargo peptides. The TAT-PBD construct with a double cysteine linker was coupled 
with streptavidin Cy5 and transduced into C2C12 mouse myoblasts. The two different 
labels, FITC and Cy5, are located in the cytoplasm and nucleus of the cell. Only the 
TAT coupled Cy5 label accumulates in the nucleoli  indicating a cleavage of the 
disulfide bond and release of the PBD-FITC. The predicted differential distribution and 
accumulation of the labeled peptides visualized in live cells demonstrate the 
possibilities of this method. Scalebar = 5 µm
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The association of the TAT with nucleolar components probably interferes with 
the binding of the cargo PBD peptide and thus reduces its effect. Our 
preliminary results show, that the use of peptide constructs containing a 
cleavable linker that separates TAT and the cargo in the cytoplasm, results  in 
distinct localization patterns depicted in Fig. 7.
The development of improved approaches using cell penetrating peptide 
constructs  that can be specifically targeted may progress into key technologies 
in the delivery of bioactive peptides, drugs, signal molecules and label in future 
research and molecular medicine (Bullok et al., 2006).
4.3 Mechanisms and effects of chromatin condensation
After exploring the possibilities in labeling of nuclear structures and the 
delivery of molecules to test the dynamics of nuclear organization we 
characterized different methods of inducing chromatin condensation by 
different pathways and the subsequent effects in living cells.
We have analyzed the effects  of hyperosmolarity and ATP depletion on 
chromatin condensation in interphase nuclei and compared these changes 
with the condensed chromosomes in mitosis (Martin et al., 2007b; Martin and 
Cardoso, 2008 submitted at JMB). Although the induced changes in the 
chromatin condensation state occur via different pathways compared to mitotic 
condensation we did observe several common characteristics (Albiez et al., 
2006; Maddox et al., 2006). The chromatin labeled by fluorescent histones 
shows an increase in the labeling intensity in the condensed form compared to 
interphase chromatin. This applies for the condensation in mitosis, by 
hyperosmolarity and during ATP depletion, indicating a reduction of volume by 
closer packing of nucleosomes. Furthermore, the hyperosmolar chromatin 
condensation level is similar to mitosis and an example for a reversible global 
chromatin compaction observable in interphase nuclei (Martin and Cardoso, 
2008, submitted at JMB). Condensed chromatin in terminally differentiated 
cells, in disease or in dying cells could adapt similar levels  of condensation by 
endogenous pathways. 
Our findings have important consequences for the interpretation of 
experiments using NaN3 for ATP depletion or solutions with high salt 
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concentrations in the analysis of molecule dynamics  within the nucleus. 
Although the diffusive mobility of nuclear proteins is  independent of salts  and 
energy in form of ATP (Phair et al., 2004), the enlarged interchromatin space 
on the one hand and the higher condensation of chromatin on the other hand 
is  likely to affect local protein concentration, mobility and access. The direct 
effect of chromatin condensation on protein distribution and mobility was also 
investigated and is discussed in the following chapters.
Most importantly, our results show that external stimuli, manipulations and 
drugs directly or indirectly changing cellular calcium levels, by either energy 
depletion or direct interference with calcium homeostasis, have an effect on 
chromatin condensation and arrest cell cycle progression. These unexpected 
links between energy metabolism, calcium homeostasis, chromatin 
condensation and cell cycle should be taken in account for the design of drug 
screenings and the interpretation of cellular responses. Even small changes  of 
free intracellular calcium levels may affect chromatin condensation and gene 
expression with still unknown consequences.
4.4 Accessibility of chromatin in living cell nuclei
In these sets  of experiments we analyzed also the distribution of proteins and 
chromatin in live cell nuclei following changes in the chromatin condensation 
state. We used confocal microscopy to study bulk localizations of fluorescently 
tagged nucleoplasmic proteins and chromatin proteins. In addition, we 
assessed the accessibility of chromatin by measuring the mobility of 
fluorescent chromatin proteins  histone H2B and HP1α using photobleaching 
and photoactivation in chromatin with different condensation levels. The data 
reveals  ascending exclusion of nucleoplasmic proteins from chromatin with 
increasing condensation level. The mitotic condensed chromosomes and 
interphase chromatin condensed to the mitotic level by hyperosmolarity show 
reduced concentrations of nucleoplasmic proteins. But in the same time 
chromatin proteins localize and accumulate in these condensed chromatin 
structures (Martin and Cardoso, 2008, submitted at JMB).
This  observation could be explained by the formation of higher order chromatin 
structures below the resolution limit including 30 nm fibers or condensed 
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heterochromatin substructures involving e.g. MBD proteins and polycomb 
group proteins (Georgel et al., 2003; Francis et al., 2004). The reduction of 
nucleoplasmic protein concentrations in condensed chromatin could be the 
result of exclusion and inaccessibility below the resolution limit. Small 
inaccessible chromatin structures in close proximity to accessible space, both 
in the scale of 10 – 250 nm, would result in reduced protein concentrations in 
large heterochromatin domains compared to the fully accessible nucleoplasm.
4.5 The effect of chromatin condensation on DNA metabolism
The chromatin compaction in condensed heterochromatin and mitotic 
chromosomes in comparison to loose euchromatin fibers reduces the available 
space between the nucleosomal subunits (Bednar et al., 1998; Dorigo et al., 
2004). The resulting fiber structures might be accessible to proteins on the 
surface but only few proteins could move inside. Heterochromatin proteins, 
e.g. HP1 and other transcriptional repressors, show a fast exchange in 
interphase heterochromatin and mitotic chromosomes, demonstrating the 
accessibility of large condensed chromatin structures (Ng et al., 1999; 
Schmiedeberg et al., 2004) (Martin and Cardoso, 2008, submitted at JMB). 
The accumulation of heterochromatin specific proteins could therefore result in 
a competition with nucleoplasmic proteins for space on the nucleosomal fiber. 
The differences in the association and binding affinities to chromatin lead to 
different immobilization times with short trapping or fast transit of non binding 
proteins and long term stable binding of chromatin factors. This  results in the 
increase of the concentration of chromatin proteins, that could compete with or 
displace proteins and thus  reduce the number of proteins  with lower affinity to 
chromatin components such as  modified or unmodified DNA and histones or 
other recruiting factors.
The transcription and replication of the genetic material is  a fundamental 
aspect of the nuclear metabolism and is regulated at multiple levels. 
Interactions between genetic elements  and proteins in cis  and trans are part of 
these regulatory mechanisms (Huang and Prystowsky, 1996). The start and 
elongation of transcription and replication depends on the opening of 
chromatin to give initiation factors, polymerases and elongation factors direct 
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access to the DNA strand. This includes the release of chromatin condensation 
factors as well as nucleosome remodeling (Alexandrow and Hamlin, 2005). 
The regulation of protein concentrations by occupied and inaccessible 
chromatin could influence these processes in different ways: 1. The interaction 
between genetic sequences in cis and trans may be weakened or inhibited. 
2. The molecule number and thus activity of initiation factors  is reduced and 
decreases the frequency of transcription initiation. 3. The insufficient opening 
of chromatin could result in interference of the RNA polymerases with 
chromatin proteins. This  would cause a reduction of the enzymatic activity and 
processivity by pausing or falling of the template DNA (Levine et al., 1993; 
Dellino et al., 2004).
It was  shown that in interphase the transcription of active genes is a stochastic 
process that also contributes to the heterogeneity of clonal cell populations 
(Blake et al., 2003). Premature terminated RNA fragments, termed 
transcriptional noise, are generated frequently due to premature transcript 
termination, paused transcription and falling off of RNA polymerases from the 
template DNA. Accordingly, a low number of transcripts can still be generated 
from silenced genetic regions (Struhl, 2007; Voliotis et al., 2008). In 
housekeeping genes  the ratio between transcriptional noise and full lenght 
mRNAs is shifted to the finished transcripts due to the unhindered progress of 
the transcription machinery in open chromatin. The formation of condensed 
chromatin could reduce the number of finished mRNAs by reducing the access 
and action of the transcription machinery in less  dense chromatin structures. 
Thus, in condensed chromatin that contains downregulated or silenced genetic 
regions, the level of interrupted transcription processes and unfinished RNAs 
increases. Accordingly the assembly of histone variants that mark active 
chromatin and destabilize the nucleosomal fiber for transcription requires 
accessible chromatin structures (Henikoff, 2008).
Besides transcription also DNA replication is affected by chromatin 
condensation and errors can cause mutations with severe consequences. In 
contrast to transcription, after the licensing of replication during the cell cycle, 
improper DNA synthesis can result in cell death due to a loss  of genetic 
information or inheritance of mutations that lead to genetic diseases. Thus the 
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condensed chromatin has to be completely remodeled and opened for high 
fidelity of DNA synthesis. The affinity of nucleoplasmic proteins to chromatin 
and DNA changes throughout the cell cycle. For example, during S-phase 
following the transduction of signals from the cell cycle regulation network the 
replication machinery assembles  on chromatin (Chevalier and Blow, 1996; 
Fujita et al., 2002). The temporal modulation of chromatin structures during 
DNA or RNA metabolism is thus necessary and the dissociation of proteins 
forming condensed chromatin is achieved by specific modifications like 
phosphorylation or incorporation of histone variants (Contreras et al., 2003; 
Henikoff and Ahmad, 2005; Hirota et al., 2005). Similarly, topoisomerases and 
transcription factors that interact with chromatin proteins can induce the 
remodeling of chromatin (Varga-Weisz et al., 1997; Muller et al., 2001; Poot et 
al., 2004). In accordance with these findings, mutations in the histone 
sequence can prevent chromatin remodeling and reduce gene expression (Xu 
et al., 2005).
4.6 Dynamics of protein movement in the nucleus of living cells
It has been debated over the past years whether and how chromatin excludes 
molecules in the cell nucleus and how this situation could affect DNA 
metabolism and heterochromatin function (Verschure et al., 2003; Görisch et 
al., 2004; Chen et al., 2005). Significant effort has also focused on the analysis 
of the mobility of nuclear proteins and the contribution of molecule dynamics to 
the structure and function of the cell nucleus (Pederson, 2001; Verkman, 
2002). Numerous studies  have revealed a high mobility of fluorescently tagged 
nuclear proteins mostly by fluorescence bleaching, photoactivation, 
fluorescence uncaging or fluorescence correlation microscopy (Politz et al., 
1999; Wachsmuth et al., 2003; Catez et al., 2004). Fluorescence 
photobleaching or activation studies and the corresponding data analysis  have 
a relatively low temporal and spatial resolution and do not provide biophysical 
parameters like modes of movement and individual residence times (Braga et 
al., 2004; Beaudouin et al., 2006). Recent developments of detecting and 
analyzing the movement of single molecules and particles in living cells can 
overcome these limitations. The single molecule tracking (SMT) microscopy 
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enables the determination of single molecule localizations to ≈ 50 nm in 5 ms 
time frames allowing the identification of short term movements  and 
immobilization (Kubitscheck et al., 2000; Grunwald et al., 2006). Because it is 
not yet possible to gain the same spatial resolution for the molecular structures 
in nuclear compartments  by live cell fluorescence microscopy (Shao et al., 
2008), we combined the SMT approach with ESI (Bazett-Jones and Hendzel, 
1999). With this technique it is  possible to determine mass densities and the 
distribution mapping of elements characteristic for nuclear components at 
electron microscopy (EM) resolution (phosphorus – DNA, RNA; nitrogen – 
proteins) (Dellaire et al., 2004; Politz et al., 2005).
4.7 The dynamics of single molecules in the nuclear interior
Our findings using single molecule microscopy are consistent with previous 
studies and show that the nuclear interior is widely accessible for proteins. 
Even condensed chromatin structures  and nucleoli allow molecules to enter 
without hindrance and are thus not closed compartments as suggested before 
(Phair and Misteli, 2000; Handwerger et al., 2004; Politz et al., 2006). The 
neutral Cy5 labeled probe molecule streptavidin coupled to a nuclear 
localization sequence (NLS) was found to diffuse with high mobility in the 
nucleoplasm, heterochromatin and nucleoli.
Slow and fast movements as well as immobilization were observed in all 
nuclear subcompartments. With respect to the different molecular 
environments we show increased trapping and less fast diffusing molecules in 
condensed heterochromatin compared to less dense nucleoplasm. 
Surprisingly the streptavidin molecules show less trapping and a high mobility 
in the nucleoli, but a much lower concentration compared to the nucleoplasm 
(Grunwald et al., 2008). This is  in contrast to the high mass density inside 
nucleoli compared to the nucleoplasm. In the condensed pericentromeric 
heterochromatin the trapping was still increased compared to the nucleoplasm, 
which is in agreement with the mass density and concentration of DNA and 
chromatin proteins (Nielsen et al., 2001; Daban, 2003; Dillon, 2004).
It was shown in previous  studies  that chromatin undergoes constrained 
diffusional movements and chromatin proteins constantly exchange in these 
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structures (Abney et al., 1997; Marshall et al., 1997; Kimura and Cook, 2001; 
Cheutin et al., 2003). On the other hand, nuclear compartments like 
pericentromeric heterochromatin domains are persistent higher order 
structures that are maintained over many cell cycles and form stable clusters 
during differentiation (Brero et al., 2005). The movement of NLS-streptavidin 
molecules between nucleoplasm and heterochromatin without obstruction 
when crossing the compartment borders, supports the view of condensed 
chromatin as accessible structures (Verschure et al., 2003). A decrease of 
mobility, measured by the diffusion coefficients in pericentromeric 
heterochromatin, is consistent with the higher molecular density compared to 
less dense nucleoplasm. Accordingly, the frequency of trapping events 
increases in heterochromatin. These molecular dynamics might be 
substantially different for proteins with different sequence and charge 
composition in comparison to the neutral probe molecule streptavidin. 
Interestingly, we identified the trapping of different molecules  at the same 
nuclear position, which could result from stable molecular structures within the 
localization precision. The structures responsible for repeated trapping, e.g. 
molecular cavities, could be formed by higher order folding of chromatin. 
These trapping sites  would be more frequent in stable and highly organized 
structures like condensed heterochromatin in contrast to loose euchromatin 
fibers in the nucleoplasm.
The data suggest that short trapping events on the one hand result from 
unspecific associations by weak ionic or electrostatic forces between amino 
acids, DNA and RNA. This could account for the observed reduction of mobility 
of macromolecule solutes in the cytoplasm compared to aqueous solutions 
(Lang et al., 1986; Seksek et al., 1997). Otherwise structural features in 
chromatin could account for repeated immobilization events. This may 
represent a substantial basic feature of molecule interaction, which could serve 
to scan molecular complexes for substrates  and binding sites as a first contact 
that precedes specific binding. The existence of specific binding motives  and 
substrates would therefore increase the immobilization times and number of 
immobilized molecules as shown for enzymatically active splicing factors 
(Grunwald et al., 2006).
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The nucleolus as a paradigm of nuclear bodies has a completely different 
structure and composition than heterochromatin (Dehghani et al., 2005; Politz 
et al., 2005). However, similar mechanisms could apply for the localization, 
accumulation or reduction of proteins in the nucleoli. The molecular structure 
of nucleoli in electron spectroscopic images is visible as dense areas with 
scarce available space but also channel like structures and gaps between 
ribosomal particles. We conclude that nucleoplasmic proteins can freely diffuse 
into nucleoli but due to space limitations, no specific interactions, and low 
number of trapping sites quickly transit out of the nucleolus. The channel like 
structures might facilitate the fast transit of nucleolus non interacting proteins. 
Thus the amount of unspecific proteins in this  compartment is kept low. Still it 
remains unclear whether the nucleolar structures identified by ESI are stably 
persistent or highly dynamic due to the mobility of the components  (Leung and 
Lamond, 2003; Olson and Dundr, 2005; Grunwald et al., 2008). The reduction 
of trapping events and times in the nucleolus was surprising when the mass 
density and possibilities for unspecific interactions are taken into consideration. 
A possible explanation for this phenomenon could be the low number of the 
persistent structures as trapping sites in nucleoli caused by the dynamics of 
the nucleolar components. This would be in agreement with our data on the 
high mobility of TAT peptides in the nucleolus (Tunnemann et al., 2006). 
Alternatively, the nucleolar components could create a microenvironment with 
a general electrostatic repulsion of the NLS-streptavidin probe molecules. This 
model would predict, that the visible exclusion of proteins from the nucleolus is 
a result of the high mass density and fast transit of non nucleolar components. 
The nucleolar localization and accumulation of TAT peptides  seems to be a 
consequence of exclusive interactions via specific sequences with a basic 
charge (Hatanaka, 1990; Martin et al., 2007a). The immobilization events of 
proteins and peptides accumulating in the nucleolus  are very likely increased 
in number and time compared to neutral probes like streptavidin. 
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4.8 Compartmentalized micro environments provide an additional 
      regulation level for the nuclear metabolism
In conclusion, a general hypothesis from the results presented here is, that the 
formation and maintenance of nuclear substructures are the result of a 
dynamic competition. The nuclear subcompartments  are accessible to different 
proteins largely independent of size as  well as sequence (Fig. 8). 
Substructures such as  heterochromatin or the nucleolus are enriched in 
specific binding sites for chromatin proteins and nucleolar components 
respectively, where the charge of the protein or peptide is also of importance. 
All proteins move rapidly inside and along the substructures and the trapping 
events we observed might be a mechanism to scan a macromolecular 
structure like chromatin for exposed targets and binding sites.
Figure 8: Model for the distribution and mobility of nuclear proteins
(modified from Grunwald et al., 2008)
Proteins with specific interaction motives, in addition to the short time trapping, 
bind more frequently and for increased duration. Thus, they localize 
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preferentially and accumulate at the respective structure e.g. heterochromatin 
proteins and nucleolar proteins. This is illustrated in Fig. 8 as red particles in 
the yellow structure. The number of proteins with less affinity or binding 
partners becomes moderately reduced by a competition for the space in 
structures like condensed chromatin and in addition by a fast transit through 
the nucleolar compartment. This is  shown in Fig. 8 as the green particles in the 
yellow and grey structure, respectively. The separation of different chromatin 
domains may be achieved by boundary elements and insulators on the DNA 
sequence level or specific chromatin modifications. These create environments 
with spatial distance of biochemically different interaction sites  and prevent the 
transformation of epigenetic states in adjacent chromatin domains (Pikaart et 
al., 1998; Felsenfeld and Groudine, 2003).
4.9 Outlook
In future studies, SMT analysis of proteins  involved in DNA, RNA and protein 
metabolism will increase the understanding of functional nuclear protein 
dynamics. In contrast to neutral probe molecules  like streptavidin, the 
transcription and replication factors contain specific binding motives or have 
enzymatic activity with influence on this  dynamic behavior (Cardoso et al., 
1997). In addition, the protein exchange between nuclear compartments in 
coordination with specific metabolic pathways would give a more complete 
picture of molecular trafficking and processing dynamics in live cells. Going 
further, one could imagine that the next level of single molecule microscopy will 
enable the analysis of the interaction of two or more proteins  with different 
labels at the same time in living cells. Furthermore, it will be of high importance 
to obtain a high resolution view on the nuclear structures  like chromatin, 
nucleoli, nuclear bodies and structural elements in live cells. Resolving the 
structure of chromatin, nucleoli and nuclear bodies to a scale of 50 nm or 
further in live cells, similar to the SMT localization precision, would provide 
direct insight into structure, function and interaction dynamics. Future aims 
include the analysis of the influence of protein and peptide charge on the 
distribution, mobility and accumulation in nuclear subcompartments. The 
charge of a given polypeptide has a profound influence on protein targeting 
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and localization. This  will be combined with the analysis of the dynamics of 
protein and peptide accumulation in the nucleolus.
The present results help to explain the molecular mechanisms of protein and 
peptide accumulation and exclusion as well as interactions in and with nuclear 
substructures. The nuclear protein dynamics  regulates the nuclear metabolism 
and thus cellular function. Understanding the dynamics of the 
compartmentalized nuclear structures and how this relates to nuclear function 
will allow the prediction of effects that go along with alterations of protein 
localization or nuclear structures. These nuclear processes are fundamental 
basic aspects of live and determine the differential use of the genetic 
information on a local and global level. The regulation of gene expression is 
directly linked to the function and fate of any cell starting with the oocyte and 
going through the development, differentiation and disease of tissues, organs 
and organisms. Understanding the genetic program, its  function and regulation 
is a fundamental part of understanding live.
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DFC  - dense fibrillar component
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EM  - electron microscopy
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FC  - fibrillar center
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HIV  - human immunodeficiency virus
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mRFP - monovalent red fluorescent protein
mRNA - messenger RNA
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TAT  - HIV transactivator of transcription
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PCNA - proliferating cell nuclear antigen
PI  - propidium iodide
PML  -  promyeolytic leukemia
S  - Swedberg sedimentation unit
SMT  - single molecule tracking
UV  - ultra violet
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